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Summary in English 
Background 
A hip fracture is a dramatic event with serious consequences. Many patients do not survive 
the first year after the fracture, and those who survive will often experience loss of function 
and increased need of assistance.  Patients suffering a hip fracture are often elderly and frail, 
and many suffer from several medical conditions in addition to the fracture. The patients often 
use several medications, have malnutrition and poor social support. Dementia is very 
common. All these conditions are often seen among patients treated by geriatricians, and it 
has therefore been argued that a hip fracture is a geriatric, rather than an orthopedic disease. 
In many countries geriatricians have been involved in the care of such patients. A structured 
collaboration between orthopedic surgeons and geriatricians is labeled an orthogeriatric 
service. There exists a wide range of models of orthogeriatric care, and despite a lot of 
research, it is still not concluded which orthogeriatric model is most effective. Due to 
demographic changes, an increase in the number of hip fractures can be expected in the 
future. With limited resources it is therefore interesting to know which orthogeriatric model is 
best.  
Delirium, an acute change in cognition and alertness, is a common complication in hip 
fracture patients and is associated with poor outcome, including a dramatically increased risk 
of dementia. There is little knowledge concerning what happens in the brain during delirium, 
and no effective drug treatment exists. Delirium can in many cases be prevented through 
optimizing the quality of medical care. Multidisciplinary geriatric intervention has been 
shown to be particularly effective in preventing delirium in hip fracture patients.  
When this study first was planned, the main objective was to evaluate the orthogeriatric 
service in use at Oslo University Hospital - Ullevaal from June 2008 to January 2012. We 
hypothesised that the intervention could be effective in reducing delirium and thus prevent 
long term cognitive decline. During the work, some further aims have emerged, including 
studying the long-term consequences of delirium and its pathophysiology.  
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Methods 
From September 2009 to January 2012, 329 patients acutely admitted with a hip fracture were 
included in this study. All patients were included in the Emergency Room (ER) at Oslo 
University Hospital, Ullevaal. In the ER, the patients were randomized to stay in either the 
acute geriatric ward or the orthopedic ward. The patients were sent directly from the ER to the 
allocated ward, and had their whole hospital stay in the same ward, except for surgery and a 
few hours in the post operative care unit.  
While the patients were admitted in the hospital they were closely monitored for 
complications, especially delirium. The care givers were interviewed for pre-fracture 
cognitive function and function in activities of daily living (ADL).  
Since the hip fracture patients often are elderly and frail, we believed that they could benefit 
of the expertise and routines established in the acute geriatric ward. We hypothesised that this 
intervention could be effective in reducing delirium and thus prevent long term cognitive 
decline. To explore this hypothesis, the patients were assessed with cognitive tests four and 
twelve months after surgery. In addition to evaluate the effect of the orthogeriatric model, we 
could use these data to explore the effect delirium had on cognition in the long run.  
In relation to the surgery, cerebrospinal fluid (CSF) and blood samples were collected. These 
samples have been analyzed in order to explore possible pathogenic mechanisms in delirium. 
In these analyses we have also included samples collected from hip fracture patients in 
Edinburgh, and elderly patients undergoing other elective surgery in Oslo.  
Results 
We found no evidence that cognitive function four months after surgery was improved in 
patients treated pre- and postoperatively in an acute geriatric ward, compared to usual care in 
an orthopaedic ward. The intervention had, however, a positive effect on mobility in patients 
not admitted from nursing homes.  
Delirium was an important predictor of accelerated cognitive decline in patients that had 
dementia before the fracture.  
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Anticholinergic activity was not higher in CSF or serum in patients with delirium compared to 
those that did not have delirium. In those patients that developed delirium, and did not have 
dementia before the fracture, AA was associated with delirium severity.  
Neopterin (a marker of inflammation) was higher in CSF and serum in patients with delirium. 
This supports a theory of inflammation being important in the pathogenesis of delirium.  
Conclusion 
The orthogeriatic model tested in this study was not effective in reducing delirium or long 
term cognitive decline. There was, however, a trend that the intervention had a positive effect 
on mobility in patients not admitted from nursing homes. 
Delirium is very common among hip fracture patients, and in our study 50 % of the patients 
were affected. We found that delirium was associated with acceleration of cognitive decline in 
patients that had dementia before the fracture.  
Analyses of CSF and blood taken from the hip fracture patients in our study have given 
important new knowledge regarding the pathophysiology in delirium. Yet, much more 
research is needed to increase our understanding of this common, dramatic and serious 
condition.   
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Norsk samandrag 
Bakgrunn 
Eit hoftebrot er ei dramatisk hending, som har alvorlege konsekvenser for dei som vert råka. 
Mange vil ikkje overleve det første året, og av dei som overlever er det mange som vil få 
funksjonsnedsetting og auka trong til hjelp. Pasientar med hoftebrot er ofte gamle og 
skrøpelege og dei har ofte mange sjukdomar i tillegg til brotet. Det er vanleg at dei brukar 
mange medisinar, dei er ofte underernærte og mange lever isolert. Demens er vanleg. Dette er 
tilstandar som er vanlege hos pasientar som vert handsama av geriatarar, og ein har difor 
argumentert med at eit hoftebrot like mykje er ei utfordring for geriatarar som for ortopedar. I 
fleire land har det difor vorte stadig meir vanleg at geriatarar har involvert seg i handsaminga 
av pasientar med hoftebrot. Eit slikt strukturert samarbeid mellom ortopedar og geriatarar 
kallast «ortogeriatri». Det finnast ei mengd ulike modellar, og til tross for mykje forsking, har 
ein ikkje klart å konkludere med kva som er den mest effektive modellen. På grunn av 
demografiske endringar kan ein vente at det blir fleire pasientar med hoftebrot i tida framover, 
og sidan helsevesenet har avgrensa med ressursar, er det viktig å finne ut meir om korleis ein 
mest effektivt kan organisere handsaminga av slike pasientar.  
Delirium er ein tilstand med ein akutt endring i kognisjon og merksemd, og er spesielt vanleg 
hos pasientar med hoftebrot. Tilstanden er knytta til dårleg prognose, inkludert ei dramatisk 
auke i risiko for demens. Vi veit veldig lite om kva som skjer i hjernen ved delirium, og det 
finnast ingen effektive medisinar. Delirium kan i mange tilfelle forebyggast gjennom god 
medisinsk handsaming. Tverrfagleg geriatrisk intervensjon har vist seg spesielt effektivt i å 
forebygge delirium hos pasientar med hoftebrot.  
Då denne studien først vart planlagt, var det viktigaste målet å evaluere den ortogeriatriske 
modellen som var i bruk på Oslo Universitetssykehus - Ullevål frå juni 2008 til januar 2012. 
Vår hypotese var at intervensjonen ville vere effektiv i å redusere forekomsten av delirium og 
gjennom dette forebygge kognitiv forverring på sikt. I løpet av prosjektperioden har også 
andre målsettingar dukka opp, inkludert å studere korleis delirium virkar inn på kognisjonen 
på sikt. Vi har også studert kva som skjer i hjernen ved eit delirium.  
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Metode  
Frå september 2009 til januar 2012 vart 329 pasientar med hoftebrot inkludert i denne studien. 
Alle desse var akutt innlagt på Oslo Universitetssykehus - Ullevål og dei vart inkludert i 
akuttmottaket. Der vart dei randomisert til eit opphald i akuttgeriatrisk avdeling eller i 
ortopedisk avdeling. Pasientane vart sendt direkte frå akuttmottaket til den avdelinga som dei 
vart randomisert til og hadde heile opphaldet i same avdeling med unntak av operasjonen og 
nokre få timar i postoperativ avdeling.  
Medan pasientane var innlagt i sjukehuset vart dei nøye overvåka for komplikasjonar. Vi var 
spesielt nøye med å registere om pasientane fekk delirium. Pårørande vart intervjua slik at vi 
kunne skape oss eit bilete av korleis pasientane fungerte kognitivt og i det daglege før brotet. 
Sidan pasientar med hoftebrot ofte er gamle og skrøpelige trudde vi at dei ville ha nytte av å 
bli handsama i akutt geriatrisk avdeling sidan ein der har mykje erfaring eldre pasienter. Vår 
hypotese var at vi skulle klare å forbygge delirium, og gjennom dette betre den kognitive 
funksjonen på sikt. For å teste denne hypotesa, undersøkte vi pasientane med kognitive testar 
fire og tolv månadar etter operasjonen. I tillegg til å kunne evaluere effekten av vår 
ortogeriatriske modell, kunne vi bruke resultatet av desse testane til å seie noko om korleis 
delirium hadde påvirka den kognitive funksjonen på sikt.  
I samband med operasjonen for hoftebrotet samla vi spinalvæske og blodprøver frå 
pasientane. Vi har analysert desse prøvene for å lære meir om patofysiologiske samanhengar 
ved delirium. Då vi gjorde desse analysene inkluderte vi også prøver som vart samla inn frå 
pasientar med hoftebrot i Edinburgh, og prøver tekne i Oslo frå eldre pasientar som vart 
operert for andre tilstander enn hoftebrot.  
Resultat 
Vi fann ingenting som tyda på at den kognitive funksjonen fire og tolv månadar etter 
operasjonen var betre hos pasientar som vart handsama i akuttgeriatrisk avdeling. Det såg 
imidlertid ut til at gangfunksjonen var forbetra hjå dei pasientane som ikkje budde på 
sjukeheim før brotet.  
Vi fann at delirium var ein viktig prediktor for akselerert kognitiv svikt hos pasientar som 
hadde demens allereie før brotet.  
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Antikolinerg aktivitet (AA) var ikkje høgare i spinalvæske eller blod hos pasientar med 
delirium samanlikna med dei som ikkje hadde delirium. Hjå pasientar som fekk delirium, men 
som ikkje hadde demens før brotet, såg det imidlertid ut til at alvorsgraden av delirium hadde 
ein samanheng med nivået av AA.  
Neopterin (ein markør på inflammasjon) var høgare i spinalvæske og blod hos pasientar med 
delirium. Dette funnet støttar ein hypotese om at inflammasjon er viktig for utvikling av 
delirium.  
Konklusjon 
Den ortogeriatriske modellen som vart testa i denne studien var ikkje effektiv i å redusere 
forekomsten av delirium eller forebygge kognitiv svikt på sikt. Modellen virka imidlertid å ha 
ein gunstig effekt på mobiliteten hjå pasientar som ikkje budde på sjukeheim før hoftebrotet.  
Delirium er særs vanleg hjå pasientar med hoftebrot, og i vår studie vart halvparten av 
pasientane råka. Vi fann at delirium var assosiert med ei forverring av den kognitive svikta 
hjå pasientar som hadde demens allereie før brotet.  
Analyse av spinalvæske og blod tatt frå pasientane i vår studie har gjeve oss viktig ny 
kunnskap om patofysiologien ved delirium. Same kva krevast det mykje meir forsking for å 
betre vår forståing av denne vanlege, dramatiske og alvorlege tilstanden.  
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1 Introduction 
A hip fracture is a dramatic event with serious consequences. Since the patients often are 
elderly and frail, orthogeriatric co-management has become increasingly common. Due to 
demographic changes an increase in the number of hip fractures can be expected in the future.  
Delirium, an acute change in cognition and alertness, is a common complication in hip 
fracture patients and is associated with poor outcome, including a dramatically increased risk 
of incident dementia. No effective drug treatment exists, but delirium can in many cases be 
prevented through optimizing the quality of medical care. Multidisciplinary geriatric 
intervention has been shown to be particularly effective in preventing delirium in hip fracture 
patients.  
When this study first was planned, the main objective was to evaluate the orthogeriatric 
service in use at Oslo University Hospital - Ullevaal from June 2008 to January 2012. We 
hypothesised that the intervention could be effective in reducing delirium and thus prevent 
long term cognitive decline. During the work, some further aims have emerged. 
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 Delirium 1.1
 Definition 1.1.1
Delirium is a syndrome of acute change in cognition and alertness, and altered, often 
psychotic behaviour.  Synonyms include “confusion”, “acute confusional state” and “acute 
brain failure”. According to DSM-5, diagnostic criteria for delirium comprise a disturbance in 
attention and awareness, change in cognition, rapid onset, and the disturbance has to be a 
direct physiologic consequence of a general medical condition(Association, 2013). The DSM-
5 was published in May 2013, and was the update of DSM IV-TR published in 
2000(Association, 2000). The main difference between DSM-5 and DSM IV-TR is that in 
DSM-5 “disturbance in attention” has replaced “disturbance in consciousness” as a core 
feature for delirium. The DSM-5 also emphasizes that in order to fulfil the criteria for 
delirium, the cognitive disturbances can not be explained with another “pre-existing, 
established or evolving neurocognitive disorder” and in particular not coma.  ICD-10 has a 
more restrictive definition of delirium compared to DSM-5(Organization, 2008). Delirium 
prevalence is naturally dependent on which diagnostic criteria are used (Laurila et al., 2003, 
Cole et al., 2003, Neufeld and Thomas, 2013, Rooney et al., 2014). Most delirium studies 
published the last decade have used the CAM and/or the DSM IV-TR criteria for diagnosing 
delirium. 
Regardless of the definition used, the diagnosis of delirium is clinical. No laboratory or 
imaging test can diagnose delirium.   
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Table 1. DSM-IV-TR  Criteria for Delirium 
A. Disturbance of consciousness (i.e., reduced clarity of awareness of the environment) with 
reduced ability to focus, sustain or shift attention. 
B. A change in cognition (such as memory deficit, disorientation, language disturbance) or 
the development of a perceptual disturbance that is not better accounted for by a pre-existing, 
established or evolving dementia. 
C. The disturbance develops over a short period of time (usually hours to days) and tends to 
fluctuate during the course of the day. 
D. There is evidence from the history, physical examination, or laboratory findings that the 
disturbance is caused by the direct physiological consequense of a general medical condition. 
Table 2. DSM-5  Criteria for Delirium 
A. A disturbance in attention (i.e., reduced ability to direct, focus, sustain, and shift attention) 
and awareness (reduced orientation to the environment). 
B. The disturbance develops over a short period of time (usually hours to a few days), 
represents a change from baseline attention and awareness, and tends to fluctuate in severity 
during the course of the day. 
C. An additional disturbance in cognition (e.g., memory deficit, disorientation, language, 
visuospatial ability, or perception). 
D. The disturbances in Criteria A and C are not better explained by another preexisting, 
established, or evolving neurocognitive disorder and do not occur in the context of a severely 
reduced level of arousal, such as coma. 
E. There is evidence from the history, physical examination, or laboratory findings that the 
disturbance is a direct physiological consequence of another medical condition, substance 
intoxication or withdrawal (i.e., due to a drug of abuse or to a medication), or exposure to a 
toxin, or is due to multiple etiologies. 
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Table 3. ICD-10 Criteria for Delirium 
A. Clouding of consciousness i.e. reduced clarity of awareness of the environment, with 
reduced ability to focus, sustain, or shift attention. 
B. Disturbance of cognition, manifested by both: (1) impairment of immediate recall and 
recent memory, with relative intact remote memory; (2) disorientation in time, place or 
person. 
C. At least one of the following psychomotor disturbances: (1) rapid, unpredictable shifts 
from hypo-activity to hyper-activity; (2) increased reaction time; (3) increased or decreased 
flow of speech; (4) enhanced startle reaction 
D. Disturbance of sleep or the sleep-wake cycle, manifest by at least one of the following: (1) 
insomnia, which in severe cases may involve total sleep loss, with or without daytime 
drowsiness, or reversal of the sleep-wake cycle; (2) nocturnal worsening of symptoms; (3) 
disturbing dreams and nightmares which may continue as hallucinations or illusions after 
awakening. 
E. Rapid onset and fluctuations of the symptoms over the course of the day. 
F. Objective evidence from history, physical and neurological examination or laboratory tests 
of an underlying cerebral or systemic disease (other than psychoactive substance-related) that 
can be presumed to be responsible for the clinical manifestations in A-D. 
 Prevalence 1.1.2
Delirium is one of the most common acute medical conditions, and the point prevalence in a 
typical university hospital has been estimated to 20 %(Ryan et al., 2013). This implies that at 
Oslo University hospital - Ullevaal with 800 beds, 160 patients will have delirium at any 
given time.  
Delirium is the consequence of a complex interrelationship of predisposing factors 
(“vulnerability”) and precipitating factors (Inouye, 1999). Dementia and older age are among 
the most important predisposing factors, but even the most robust patient can develop 
delirium if exposed to sufficient stress. The interplay between predisposing and precipitating 
factors are reflected in the fact that two of the wards with highest prevalence of delirium in a 
hospital is the acute geriatric ward (high vulnerability) and the ICUs (severe precipitating 
factors) with reported occurrence rates of up to 50 % in the acute geriatric wards and 80 % in 
ICUs(Siddiqi et al., 2006, Jones and Pisani, 2012, Inouye et al., 2013). In the course of an 
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admission for a hip fracture, 40 - 50 % of the patients will experience delirium (Bruce et al., 
2007).  
 Detection, prevention and treatment of delirium 1.1.3
Despite the fact that delirium is prevalent, possible preventable, and has negative impact on 
prognosis, it is often unrecognized by hospital staff, both by nurses and physicians (Laurila et 
al., 2003, Ryan et al., 2013, Rooney et al., 2014). Since the diagnosis relies solely on clinical 
observation, detection rates are sensitive to the skills, awareness and experience of the 
healthcare personnel. This is illustrated by the wide range of prevalences and incidences 
reported in different studies; the reported prevalence for delirium in hip fracture patients 
varies from 4 to 53 %(Bruce et al., 2007). Several screening and diagnostic tools have been 
developed to improve detection rates and the diagnostic precision(Hall et al., 2012). Two 
recently published reviews conclude that the Confusion Assessment Method (CAM)(Inouye 
et al., 1990), Memorial Delirium Assessment Scale (MDAS)(Breitbart et al., 1997) and 
Delirium Rating Scale Revised-98 (DRS - R98)(Trzepacz et al., 2001) are reliable and 
validated instruments that can be recommended(Wong et al., 2010, Adamis et al., 2010).  
The most used diagnostic tool is the CAM, a four-step algorithm originally validated against 
the DSM-III criteria for delirium. It was developed by Sharon Inouye at Yale University, 
USA, and the original publication claims that the CAM can be completed in less than five 
minutes with sensitivity 94-100 % and a specificity of 90-95 %(Inouye et al., 1990). Other 
studies have, however, reported both sensitivity and specificity to be much lower(Laurila et 
al., 2002) and without proper training of the evaluators, the sensitivity has been reported as 
low as 13 %(Rolfson et al., 1999). Most clinicians find that it takes more than five minutes to 
complete the CAM since it is highly recommended that an objective cognitive test is used to 
inform the CAM (MMSE was used in the original publication). It has also has been argued 
that to perceive delirium as a binary phenomenon is an oversimplification and since delirium 
in reality represent a continuum, it should better be reported on a ordinal scale(Radtke et al., 
2010). This criticism is relevant, but the introduction of CAM has undoubtedly been 
important for progress in delirium research since its widespread use have made it easier to 
compare studies.  
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Delirium can to some extent be predicted clinically(Guenther et al., 2013, Menzies et al., 
2012, Inouye, 1999, Kennedy et al., 2014). It has also been suggested that as many of 30 - 40 
% delirium cases are preventable through optimizing the quality of medical care(Inouye et al., 
2013). Multidisciplinary geriatric intervention seems to be particularly effective in preventing 
delirium in hip fracture patients(Marcantonio et al., 2001, Deschodt et al., 2012, Milisen et al., 
2001, Lundstrom et al., 2007, Lundstrom et al., 1999, Gustafson et al., 1991, Wong Tin Niam 
et al., 2005).  There is no effective pharmacologic treatment once delirium has 
developed(Inouye et al., 2013), but haloperidol is often used to reduce symptoms, also in 
Norway.  
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Figure 1. The Confusion Assessment Method(Inouye et al., 1990). 
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 Outcomes after delirium 1.1.4
Delirium can be an immensely stressful experience for patients and their relatives(MacLullich 
and Hall, 2011). When assessing patients in the outpatient clinic after a hospital admission, it 
is a common experience that one of the issues patients often need to discuss is the “confusion” 
they experienced while admitted. Patients are often embarrassed after a delirious episode 
because they have a notion that they acted strangely and uncivil(Schofield, 1997). The 
hallucinations that often occurs in delirium can be extremely frightening, and delirium can 
induce PTSD(Davydow et al., 2008).  
Delirium has been considered a transient condition, and for most patients it resolves within 
some days, although in some patients the symptoms lasts for several weeks(Meagher et al., 
2012). During the last decade, accumulating evidence indicate, however, that delirium is an 
independent risk factor for poor outcome. In a meta analysis published in JAMA in 2010, 
delirium was associated with an increased risk for death (HR 1.95), institutionalization (OR 
2.41) and a dramatically increased risk of dementia (OR 12.51)(Witlox et al., 2010), see 
section 2.1.6 for details.  
 Pathophysiology 1.1.5
Given the magnitude of the problem, delirium has been greatly understudied.  It is illustrative 
that both European Delirium Association and the American Delirium Society both were 
founded less than ten years ago. In overviews over biomarkers and treatment trials, the most 
striking finding is the low number of patients included in studies(Khan et al., 2011, Hall et al., 
2011, Inouye et al., 2013).  
The interest in delirium from researchers is increasing, but the current knowledge regarding 
the pathophysiologic mechanisms is still scarce.  As a useful theoretical model, a basic 
classification of etiological factors has been proposed:  (a) direct brain insults and (b) aberrant 
stress responses (MacLullich et al., 2008). Insults that directly affect the brain can reasonably 
induce delirium. Examples are hypoxia(Schoen et al., 2011), hypercapnia(Scala, 2011), 
cerebral hypoperfusion(Yokota et al., 2003) and drugs(Gaudreau and Gagnon, 2005). It is 
harder to understand how a diverse array of extra cerebral events like UTI, pulmonary 
infection, myocardial infarction, urine retention, and hip fracture, all can cause the same CNS 
symptoms. It is proposed that delirium in such cases is triggered by aberrant stress responses, 
24 
mediated through the hypothalamic-pituitary-adrenal (HPA) axis, the autonomous nervous 
system and the inflammatory system(MacLullich et al., 2008, Cerejeira et al., 2014, 
Cunningham and MacLullich, 2012). Additional hypothesis of delirium pathophysiology 
include diurnal dysregulation(Fitzgerald et al., 2013, de Rooij et al., 2014), network 
disconnectivity(Sanders, 2011), genetic factors(van Munster et al., 2009), neurotransmitter 
dysregulation (Hshieh et al., 2008, Trzepacz, 2000)neuronal aging(Norden and Godbout, 
2013, Cunningham, 2013), and oxidative stress(Maldonado, 2013, Hughes et al., 2012). 
Variable amounts of data exits to support these different theories. The two most studied is 
“the neurotransmitter hypothesis” and ”the neuroinflammation hypothesis”. The following 
sections will give an overview of these two.  
The neurotransmitter hypothesis 
Regardless of which other factors might be involved, neurotransmitters are likely to play a 
role in delirium pathogenesis. Acetylcholine and the monoamines (adrenalin, noradrenalin, 
dopamine, serotonin) are the neurotransmitters most studied delirium. In general, delirium has 
been associated with acetylcholine deficiency, noradrenalin and dopamine excess, and an 
increase as well as a decrease in serotonin(Maldonado, 2013). The theory that cholinergic 
depletion can be a mechanism in the pathogenesis of delirium has as a basis that acetylcholine 
plays an important role in many of the domains affected in delirium, e.g. attention, perception 
and arousal(Trzepacz, 2000, Hshieh et al., 2008). The theory is supported by the fact that 
substances with strong anticholinergic activities (AA) can induce delirium, with atropine as 
the classic example. It has also been a clinical experience that medications with high 
anticholinergic activity can induce delirium(Han et al., 2001). Several studies have found an 
association between high serum AA and delirium(Campbell et al., 2009, Carnahan et al., 
2002). A positive association between serum AA and delirium severity has also been 
reported(Flacker et al., 1998). But there are also studies reporting no association between 
serum AA and delirium, and the only study that measured serum AA in hip fracture patients 
found no association(van Munster et al., 2007). Cholinergic dysfunction was once proposed 
as a possible “final common pathway” in delirium(Trzepacz, 2000), but reports from the last 
decade suggest that it might not be that simple. It must also be mentioned that 
treatment/prevention trials with cholinesterase inhibitors have not been successful(van Eijk et 
al., 2010, Liptzin et al., 2005, Gamberini et al., 2009).  
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GABA is the main inhibitory and glutamate the main excitatory neurotransmitter, and 
disturbances in these systems are believed to play a role in dementia(Danysz and Parsons, 
2012, Huang and Mucke, 2012). Their role in the pathophysiology of delirium has been 
explored to a much lesser degree and data are limited to case reports (Inouye et al., 2013).  
Clinically, the importance of GABA is suggested by the observation that benzodiazepines 
may precipitate or worsen delirium(Pisani et al., 2009, Kudoh et al., 2004).   
Direct CNS measurement of neurotransmitter concentrations in patients is extremely difficult, 
so one must rely on measurements of precursors and/or metabolites. Amino acids are the 
precursors for the monoamines dopamine, noradrenalin and serotonin, and are accordingly of 
interest in delirium research. Phenylalanine and tyrosine (dopamine and noradrenalin 
precursors) has been found to be elevated in patients with delirium, supportive of a theory of 
higher monoaminergic tone(Flacker and Lipsitz, 2000, van der Mast et al., 2000, 
Pandharipande et al., 2009). For tryptophan (precursor of serotonin) the literature is more 
complicated since both increased and decreased levels have been associated with delirium. 
Lower levels of tryptophan have been found to be associated with postoperative delirium in 
abdominal and thoracic surgery(van der Mast et al., 1991, van der Mast and Fekkes, 2000, 
Robinson et al., 2008, Osse et al., 2012). Higher (and lower) levels were associated with 
delirium in patients in an intensive care unit(Pandharipande et al., 2009) and in a study that 
included patients admitted to a geriatric medical unit no difference in any amino acids was 
found between delirious patients and age matched controls(van der Cammen et al., 2006). In a 
study of hip fracture patients there was no difference in tryptophan between patients with and 
without delirium(de Jonghe et al., 2012).  A possible explanation for these somewhat 
contradictive results is the difference in patient populations.    
Monoamine metabolites (HVA: dopamine, 5-HIAA: serotonin, MHPG: noradrenaline) have 
also been measured in delirium. HVA has been found to be elevated in serum in both surgical 
(Osse et al., 2012) and medical (van der Cammen et al., 2006) patients. The latter study also 
found elevated 5-HIAA in delirium. In a Japanese study of 66 patients with delirium and 16 
healthy controls, both HVA and MHPG were higher in patients with delirium. Interestingly, 
both HVA and MHPG levels decreased in relation to resolution of the delirious episode 
(Nakamura et al., 1997). HVA have also been found to be elevated in CSF in delirious 
patients, but this difference was significant only for those patients with 
hallucinations(Ramirez-Bermudez et al., 2008). CSF levels of 5-HIAA has been measured in 
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one study, and compared to controls had patients with delirium and no prior CNS disease 
elevated levels of 5-HIAA(Koponen et al., 1994).   
The neuroinflammation hypothesis 
Since delirium often occurs in relation to acute illness, the assumption that delirium is 
associated with inflammation can be traced back for centuries(Cerejeira et al., 2014). A 
commonly used marker of inflammation is the C-reactive protein (CRP), and several (but not 
all(de Rooij et al., 2007, Adamis et al., 2007)) studies have found an association with high 
CRP and delirium, both in medical (Macdonald et al., 2007, Ritchie et al., 2014, White et al., 
2005) and surgical patients(Burkhart et al., 2010) and in patients in ICU units(Zhang et al., 
2014).  
Cytokines are small proteins important in cell signaling, especially in the immune system. 
Cytokines from the periphery can enter the brain via different routes, and activated microglia 
in the brain can produce cytokines(Westhoff et al., 2013, de Rooij et al., 2007). Cytokines are 
therefore believed to play a central role in delirium pathogenesis(van Gool et al., 2010). The 
two first studies (both in medical patients) that assessed the association between peripheral 
cytokines (measured in serum) and delirium were a Dutch study  of 165 patients(de Rooij et 
al., 2007) and a study from the UK with 164 patients (cytokines measured in only 60) 
(Adamis et al., 2007). The Dutch study found that more patients with delirium had detectable 
levels of the pro-inflammatory cytokines IL-6 and IL-8. This was in contrast to the UK study 
that found no difference in IL-6 (IL-8 not measured) between patients with and without 
delirium. A possible explanation for this discrepancy is that the Dutch study used a multiplex 
immunoassay for analysis, whereas the UK study used the more sensitive ELISA method. 
Many of the measured cytokines in the Dutch study never reached the detection limit, but no 
such problem was reported in the UK study. When comparing levels of cytokines above the 
detection limit, there was no difference in levels between patients with and without delirium 
in the Dutch study. A similar methodological problem was seen in a study from Portugal 
where five cytokines (IL-8, IL-1ß, IL-6, IL-10 and TNFα) were measured in plasma pre- and 
postoperatively in 101 patients undergoing elective hip arthroplasty. Only IL-10 were 
detectable in all samples, and of the other cytokines were up to 44 % (TNFα postoperatively) 
not detectable. This study found no difference in any of the measured cytokines, but patients 
with delirium had a greater pro/anti inflammatory ratio after surgery, suggesting that delirium 
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is associated to an unbalanced inflammatory response(Cerejeira et al., 2012). A study of 100 
ICU patients (50 with delirium) found that the pro-inflammatory cytokines IL-6 and IL-8, but 
also the anti-inflammatory cytokines IL1-RA and IL-10, were higher in those with 
delirium(van den Boogaard et al., 2011). Another recently published study also investigated 
inflammatory markers in ICU patients. This study included 78 patients (31 with delirium) 
admitted to a mixed ICU in a hospital in Brazil. Blood samples were collected within 12 
hours of enrollment. Patients with delirium had higher levels of the inflammatory markers 
soluble TNF Receptor (STNFR) 1 and 2, adiponectin and IL-1β, also when adjusting for 
sepsis and sedation.  There was however no significant difference in TNFα, IL6 or IL10(Ritter 
et al., 2014).   
CSF levels of cytokines have been measured in two studies in delirium. In a study of 36 
patients with hip fracture, CSF was sampled at the onset of spinal anesthesia. Fifteen of the 
patients developed delirium (nine before surgery). Six cytokines were measured with an 
immunoassay, but only IL-8 (33/36 samples) and IL-6 (3/36 samples) were above the 
detection limit. IL-8 was higher in patients with delirium(MacLullich et al., 2011). A larger 
study from the Netherlands also sampled CSF from hip fracture patients at the time of spinal 
anesthesia. This study comprised 61 patients that all were free from delirium at the time of 
CSF sampling, and 23 of these developed delirium after surgery. Forty-one different 
cytokines and chemokines were measured using an immunoassay, but only 16 of those were 
detectable in more than 50 % of the patients. None of the measured compounds were higher 
in patients with delirium, but fms-like tyrosine kinase-3 (Flt-3L), IL-1RA and IL-6 were 
significantly lower in patients with delirium. Flt-3L is believed to play a role in chronic 
inflammatory states and IL-1RA is an inhibitor of the pro-inflammatory cytokines IL-1α and 
IL-1ß. It is harder to understand that IL-6 was lower in patients with delirium since IL-6 is 
considered to be a pro-inflammatory cytokine. The authors suggest that the findings could be 
interpreted that delirium is the result of a dysfunctional inflammatory state, where reduced 
anti-inflammatory mediators play a more important role than an increased pro-inflammatory 
activity (Westhoff et al., 2013).  
In a postmortem study brain autopsies were performed within 24 hours after death in nine 
patients with delirium and six age-matched controls. In patients with delirium markers of 
microglial activity (HLA-DR and CD 68), astrocyte activity (GFAP) and IL-6 were increased. 
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These findings are in support of increased inflammatory activity in the brain in 
delirium(Munster et al., 2011).  
Another marker of pro-inflammatory status is neopterin, a pteridine produced by activated 
monocytes and macrophages(Murr et al., 2002). A study of 125 patients undergoing elective 
cardiac surgery found increased plasma levels of neopterin in patients with delirium both pre- 
and postoperatively(Osse et al., 2012).   
A role of inflammation is also supported by animal studies. In an animal model of prion 
disease it was showed that aged animals and those with chronic neurodegeneration showed a 
more profound CNS inflammation (IL-1ß expression and neutrophil infiltration) to a 
relatively minor systemic inflammation. The exaggerated immune response could be 
explained by the primary neurodegeneration that had led to a priming of microglia making 
them more responsive to subsequent inflammatory stimuli(Cunningham et al., 2005). The 
same research group also showed that that a challenge with LPS (that initiate an immune 
response) induced acute and transient cognitive deficits (mimicking delirium) only in animals 
with chronic cognitive impairment(Murray et al., 2012)  The “microglial priming hypothesis” 
can in some part explain why a minor insult like a UTI can produce delirium in a patient with 
dementia, but not in more robust individuals(Cunningham and MacLullich, 2012, van Gool et 
al., 2010).   
Delirium pathophysiology - conclusion 
Both the neurotransmitter hypothesis and the neuroinflammation hypothesis are supported by 
data. Of the neurotransmitters, acetylcholine deficiency seems to be theoretically best 
founded, but has only moderate support by data. The data is more convincing regarding a 
higher monoaminergic activity associated with delirium, since elevated levels of both 
monoamine precursors and metabolites have been demonstrated in delirium. It is, however, 
important to realize that (with exception on HVA and 5-HIAA) all the monoamine precursors 
and metabolites have only been measured in the periphery (blood) and this does not 
necessarily mirror CNS levels. Most persuasive is the evidence for the neuroinflammation 
hypothesis since this is supported by several studies in both serum and CSF and also by 
animal models.  
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Since delirium is the result of a complex interrelationship of predisposing and precipitating 
factors (that both directly and indirectly can influence brain functions), it seems unlikely that 
there should be a “final common pathway” in the pathogenesis. This is also the conclusion in 
the most recent reviews(Inouye et al., 2013, Maldonado, 2013, MacLullich et al., 2008). 
Different pathways are likely to be intertwined; e.g. is the cholinergic system balanced with 
monoamine activity(Hshieh et al., 2008) and there has also been described interactions 
between the cholinergic and the inflammatory system in delirium(Cerejeira et al., 2012).  
 Delirium and dementia 1.1.6
Dementia is an important and well known risk factor for delirium (Fick et al., 2002). More 
than 50 % of patients with dementia will experience delirium in the course of an admission to 
a medical ward(Inouye et al., 2013) with even higher figures for demented patients admitted 
for acute surgical conditions(Juliebo et al., 2009, Stenvall et al., 2012). There is accumulating 
evidence that delirium also constitutes an independent risk factor for dementia. Since delirium 
often occurs in relation to acute illness, it is a challenge to design studies that can explore 
whether delirium lies on the causal pathway to dementia, but during the last decade an 
increasing amount of evidence have suggested that this is the case. A meta analysis published 
in 2010 focused on the associations between delirium and long term outcomes (mortality, 
institutionalization, dementia), and found an 12-fold increase in risk of dementia in patients 
that had experienced delirium(Witlox et al., 2010). Only two studies (241 patients in total) 
were included in the analysis on dementia in this meta analysis, but several studies have been 
published afterwards supporting the conclusion.   
In a study of 225 patients scheduled for coronary-artery bypass grafting, a lower percentage of 
patients with delirium than of those without had returned to their preoperative cognitive level 
six months after surgery (24 % vs 40%, p=0.01)(Saczynski et al., 2012). The serious 
consequence of delirium on long term cognition also in people without dementia was clearly 
demonstrated in a newly published study of patients treated in intensive care units (median 
age 61). Only 6 % of the patients had cognitive impairment at baseline, but three months after 
discharge 40 % had global cognition scores 1.5 SD below the population means and 26 % had 
scores 2 SD below population means (similar to scores for patients with mild Alzheimer’s 
disease)(Pandharipande et al., 2013). Similar findings were reported from a study where hip 
fracture patients free from dementia were cognitively tested six months after surgery. After 
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adjusting for other risk factors, delirium in the acute phase emerged as the strongest predictor 
for incident dementia (OR 10.5)(Krogseth et al., 2011).  
Delirium is also shown to be a risk factor for accelerated cognitive decline in patients with an 
already established diagnosis of dementia. In a study from 2009, 408 patients with 
Alzheimer’s disease were followed at six months intervals to determine cognitive trajectories. 
Those patients that experienced delirium during the follow-up period (n=72) had a significant 
acceleration of the cognitive decline(Fong et al., 2009). The follow up period in this study 
was six months, so it was impossible to conclude whether a delirious episode had resulted in a 
permanent deterioration of cognitive trajectories. The same research group have, however, 
more recently published a separate report of the same patients showing that the cognitive 
deterioration lasted for up to five years(Gross et al., 2012). In the same cohort delirium was 
also associated with increased risk of mortality and institutionalization(Fong et al., 2012).  
To summarize; delirium seems to be able to precipitate dementia in patients that are 
cognitively intact, and to induce a more rapid pace of deterioration in those already demented. 
From delirium to dementia and vice versa: pathophysiological mechanisms. 
Since the conditions are clinically linked, the pathophysiologic mechanisms are also likely to 
be linked(Eikelenboom and Hoogendijk, 1999). Different pathophysiological theories exist 
for the increased risk of delirium in patients with dementia. Normal aging is associated with a 
shift in the inflammatory profile towards a more pro-inflammatory state (Ferrucci et al., 
2004). Age and chronic cognitive impairment are also associated with microglial 
priming(Cunningham et al., 2005) and an increased blood brain barrier 
permeability(Zlokovic, 2011), factors that both can contribute to an exaggerated inflammatory 
activity in the brain in response to a minor insult in the periphery (e.g. an UTI).  
Since the understanding of even the basic elements in the pathophysiology of delirium is 
moderate, the pathophysiologic mechanisms linking delirium to dementia is almost absent. 
The link between delirium and dementia has only been demonstrated in epidemiological 
studies, all published during the last 5 - 10 years. But one intriguing study exists that has 
explored pathophysiological mechanisms from delirium to dementia.  In that study, 553 
individuals above 85 years were continuously monitored for delirium and followed with 
cognitive tests at baseline, 3, 5, 8 and 10 years. After adjusting for other risk factors, an 
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episode of delirium dramatically increased the risk of incident dementia (OR 8.7). Delirium 
was also associated with deterioration of preexisting dementia (OR 3.1). Brain autopsy was 
performed in 52 %. In patients with dementia precipitated by an episode of delirium, the 
typical neuropathological markers of dementia were not found. In patients with dementia and 
no history of delirium, all pathologies were in accordance with those described as typical for 
dementia. This finding suggests that the effect of delirium upon permanent cognitive decline 
may not be mediated by classical neuropathologies associated with dementia(Davis et al., 
2012).  
For many patients, a delirious episode is the direct precipitating factor for incident dementia, 
and to study the pathophysiological mechanisms in delirium might therefore represent an 
alternative angle to study dementia pathophysiology.  
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 Orthogeriatrics 1.2
 Definition and historical background 1.2.1
Hip fracture patients are among the frailest patients in a hospital. Median age is more than 80 
years and many suffer from co-morbidities, polypharmacy, poor social support and 
malnutrition(Gjertsen et al., 2008, Ranhoff et al., 2010). Dementia is common, and 40 - 50 % 
will experience delirium perioperatively(Juliebo et al., 2009, Bruce et al., 2007). It has been 
argued that a hip fracture represents a geriatric, rather than an orthopedic disease(Adunsky et 
al., 2005), and for several decades different models of orthopedic-geriatric co-management of 
these patients have been developed. Such a structured collaboration between orthopedic 
surgeons and geriatricians is labeled an orthogeriatric service.  
The first orthogeriatric services was developed in the UK more than 50 years ago(Hempsall et 
al., 1990, Devas, 1974) and the first RCT on orthogeriatric care was performed almost 30 
years ago (Gilchrist et al., 1988). Since then, orthogeriatric services have been established in 
many countries(Pioli et al., 2014). UK is still the country leading the way where early 
involvement of geriatricians has been considered a Golden standard and those hospitals not 
living up to this standard experience economical penalties(Association, 2007).  
 Different orthogeriatric models 1.2.2
Every model where some sort of structured geriatric input is included in treatment of elderly 
patients with fractures can fit under the label “orthogeriatric care”. As expected, a wide range 
of orthogeriatric models exists; from simple models were the geriatric input is limited to a 
liaison service to integrated orthogeriatric units(Kates et al., 2010a).  
Some of these models have been scientifically evaluated. The studies show a considerable 
heterogeneity in design, patient selection, outcome measures and organization of follow up 
assessments. It has thus been difficult to draw conclusions regarding the superiority of one 
particular model.  
Since 2010, four reviews have been published where the authors have tried to summarize the 
current knowledge (Kammerlander et al., 2010, Giusti et al., 2011, De Rui et al., 2012, 
Grigoryan et al., 2014). The authors have categorized the individual studies into main groups 
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and have to some extent pooled data to evaluate what models is most efficient. The authors 
have grouped the orthogeriatric models somewhat different. Kammerlander (adopted by De 
Rui) uses four different categories: 1) orthopedic ward and geriatric consultant service, 2) 
orthopedic ward and daily consultative service, 3) geriatric and rehabilitation ward and 
orthopedic consultant service and 4) orthopedic ward and integrated care. Giusti uses five 
categories: 1) traditional model - orthopedic ward, 2) consultant team - orthopedic ward, 3) 
interdisciplinary care/clinical pathway - orthopedic ward, 4) Geriatric-Led Fracture Service - 
Geriatric/Rehabilitative Ward, 5) Geriatric Co-management Care - OrthoGeriatric Unit. 
Grigoryan uses only three categories: 1) Routine Geriatric Consultation, 2) Geriatric Ward, 3) 
Shared Care. The different reviews have classified some of the included studies differently 
(e.g. is the study from Taiwan(Shyu et al., 2005) considered “integrated care” by 
Kammerlander, but “routine geriatric consultation” by Grigoryan).  
This chapter will give a brief overview of studies where orthogeriatric care is compared to 
usual care. I have adopted the classification from Kammerlander to group studies. Some 
studies are not mentioned in Kammerlander (some are published after the review), and those 
are marked. Some studies are also grouped differently from Kammerlander when this seemed 
more accurate from the original publication(Gilchrist et al., 1988, Shyu et al., 2005, Vidan et 
al., 2005). From some of the orthogeriatric models several reports are published, and those are 
commented together. Models that only are compared to national averages or figures reported 
in the literature are not included.  
Orthopedic ward and geriatric consultant service (Kammerlander 1) 
This is the simplest model. The patients are treated in an orthopedic ward, and the geriatric 
input is limited to a liaison service, often provided by a geriatric team, sometimes labeled 
inpatient geriatric consultant team (IGCT). Eleven studies (reporting from six models) exist in 
this category.  
Gilchrist WJ, 1988(Gilchrist et al., 1988) (Categorized this as “Geriatric and rehabilitation 
ward and orthopedic consultant service” in Kammerlander 2010): This is the worlds first 
RCT on orthogeriatic care including patients from October 1984 to July 1986. In February 
1983 was an orthogeriatric model introduced at an orthopedic ward at this hospital in 
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Glasgow, Scotland. In this ward, the orthopedic surgeons were responsible for the overall care 
of the patients, but a weekly combined round was performed by a geriatrician and orthopedic 
surgeon, followed by an interdisciplinary meeting involving all team members. As control 
group served patients treated in regular orthopedic wards without any orthogeriatric input. 
Patients (only women above 65) were randomized to intervention (n=97) or control (n=125) 
after surgery, and the mean length of stay before randomization was 10 days in both groups. 
There was no significant difference in mortality, LOS or discharge destination. More medical 
conditions were recognized in those randomized to orthogeriatric care.  
My comment: The orthogeriatric input is limited. Start of the intervention was on average 10 
days after surgery, and these two factors can probably explain the lack of effect. 
Kennie DC, 1988(Kennie et al., 1988). This was a prospective randomized study conducted in 
the UK were 108 women (54 randomized to intervention) above 65 years with hip fracture 
were included. The intervention was postoperative, and when patients were judged to be fit 
enough for transfer, those randomized to intervention were moved to a rehabilitation ward (5 
km in ambulance) in a “predetermined random sequence”. Those randomized to intervention 
had their daily medical attention provided by a general practitioner. A geriatrician was 
attending the ward twice weekly. Patients treated in the intervention group had significantly 
better physical independence. Length of stay was also shorter in the intervention group (24 v 
41 days).  
My comment: Selected patients. The intervention had effect, but LOS was so long that it is 
not comparable to today’s standards.  
Gustafson, 1991(Gustafson et al., 1991): Based upon experiences from earlier studies on 
delirium in hip fracture patients(Gustafson et al., 1988), an orthogeriatric model was 
established at this hospital in Umea, Sweden. The new model focused on short waiting time to 
surgery, thrombosis prophylaxis, oxygen therapy and anesthesiologic techniques. A 
geriatrician assessed the patients pre- and postoperatively. To evaluate the effect of the new 
model were 103 hip fracture patients prospectively included from December 1986 to January 
1988. The primary focus of the study was delirium prevention, and outcomes were compared 
to those in the control study with 111 patients included at the same hospital between March 
1983 and June 1984(Gustafson et al., 1988). Fewer patients in the intervention study 
developed delirium (47.6 vs 61.3 %, p<0.05). The intervention also had a positive impact on 
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delirium severity and duration. LOS was reduced after implementation of the new model 
(11.6 vs 17.4, p<0.001), and fewer patients developed postoperative complications.  
My comment: the orthogeriatric service was effective, and the intervention started pre-
operatively. The delirium rates were high also after implementation of the intervention. The 
non-randomized design is acknowledged by the authors as a problem.  
Naglie G, 2002(Naglie et al., 2002): In a prospective randomized study from Canada, 279 hip 
fracture patients above 70 years were included from June 1993 through March 1997. The 
intervention was interdisciplinary care provided in an orthopedic ward. Patients randomized 
to intervention (n=141) were treated in a different ward with separate staff. The intervention 
was use of protocols and standardized orders, early mobilization (twice daily physiotherapy 
Monday – Friday), early participation in self-care and individualized discharge planning. 
Twice weekly there was an interdisciplinary meeting. The intervention showed no effect on 
outcomes three and six months after surgery (mobility, mortality, place of residence). The 
initial LOS was longer in the intervention group (29 v 21 days, p < 0.001), but the mean 
number of days spent in an institution over the first six months after surgery was similar.  
My comment: Nice design, but only postoperative intervention. Selected patients (only 
280/689 eligible patients were included). 56 patients could not be included because no bed 
was available on the interdisciplinary care unit.   
Shuy 2005, 2008, 2010 (Shyu et al., 2005, Shyu et al., 2008, Shyu et al., 2010)(Categorized as 
“orthopedic ward and integrated care” in Kammerlander 2010): This was a single-blinded 
prospective randomized study from Taiwan that recruited 162 patients above 60 years from 
September 2001 to November 2003. All patients were treated in the orthopedic ward. The 
intervention was a geriatric consultation service, a rehabilitation program, and a discharge 
planning service. The rehabilitation continued after discharge from hospital. Significantly 
more patients randomized to intervention had recovered their previous walking ability after 
one (55 vs 37 %, p=0.004) and three months (78 vs 51 %, p=0.001)(Shyu et al., 2005). The 
beneficial effect lasted one(Shyu et al., 2008) and two years(Shyu et al., 2010) after inclusion. 
In addition to better mobility, patients randomized to intervention had significantly fewer 
depressive symptoms at the follow up controls.  
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My comment: Of 935 patients admitted with hip fracture in the inclusion period, only 162 (17 
%) were included in the study. The most important reason was that the patients were either 
too physically or cognitively impaired to meet inclusion criteria. This sample is thus 
representing the fittest fraction of the hip fracture patients. Usual care in the study seems also 
to be limited. The intervention continued after discharge. It also needs to be mentioned that at 
the follow up controls the participants were blinded to allocation, but not the evaluators.  
Ho, 2009, Leung 2011(Ho et al., 2009, Leung et al., 2011) (not in Kammerlander 2010): Two 
different reports from an orthogeriatric model established at Prince of Wales Hospital in Hong 
Kong in August 2005. After the introduction of the program, a geriatrician and a geriatric 
nurse carried out the medical management in the orthopedic ward three times a week. Patients 
treated the first year after implementation of the program (n=278) were compared to those 
treated the year before implementation (n=277). The intervention had impressive results with 
shorter LOS (9.7 v 8.3 days, p=0.001), lower in hospital mortality (4 v 1 %, p=0.02) and 1-
year mortality (20 v 11 %, p=0.005), and a shorter waiting time for surgery (median 2 v 1 day, 
p<0.001) (Ho et al., 2009). Patients in the intervention group was also more likely to be 
independent in ADL after 3 (29.5 vs 27.8 %, p=0.003) and 12 months (24.5 vs 23.7 %, 
p=0.02). In the article from Leung(Leung et al., 2011), reporting from same patients, the 
authors speculate that the positive effect seen by introduction of the program, by large can be 
explained by the reduction in waiting time for surgery (mean 55 v 45 hours, p=0.02).  
My comment: Historical controls. Usual care seems not so good. Long waiting time for 
surgery, but the huge difference in median (Ho) and mean (Leung) is confusing.   
Deschodt, 2011, 2012. Milisen 2001.(Deschodt et al., 2011, Deschodt et al., 2012, Milisen et 
al., 2001) (not in Kammerlander 2010): These studies were conducted the University Hospital 
in Leuven, Belgium. The orthogeriatric model in use is orthogeriatric care provided by a 
geriatric team. The two most recent reports are from a patient material collected from 
February to December 2007. 177 hip fracture patients above 65 years were included. The 
patients were included in the emergency room, and allocated to one of two trauma wards (one 
intervention and one control) based upon availability of beds. The intervention was 
assessments and advice by the inpatient geriatric consultation team (IGCT).  The intervention 
was not effective in any of the reported outcomes in the first report from this study (functional 
status, length of stay, mortality, new nursing home admissions and readmissions 6 weeks, 4 
months and 12 months after surgery (Deschodt et al., 2011). The intervention was, however, 
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effective in reducing post operative delirium (53 v 37 %, p=0.04) as described in a separate 
report(Deschodt et al., 2012). There was no difference in delirium duration or severity. A 
study from 2001 evaluated a similar orthogeriatric model in the same hospital in a before-after 
design. In this study was delirium duration and severity reduced in patients treated after 
implementation of the intervention (Milisen et al., 2001).    
My comment: In the study from 2011 was the allocation to intervention done in a non-
randomized way and the outcome assessments were not done blinded. Very short delirium 
duration (1 day) raises the suspicion that delirium monitoring has not been optimal.  The 
study from 2001 was a before-after study. 
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Table 4. Overview of studies evaluating an orthogeriatric model in accordance with Kammerlander model 1 
Study Number 
of patients 
Study 
design 
Timing and 
organization of 
follow up controls 
Evaluation Conclusion 
Gilchrist, 
1988. UK 
N=222 Prospective 
randomized 
No follow up. 
Mortality 
registered at 3 and 
6 months.  
LOS, 
mortality, 
medical 
conditions.  
There was no significant difference in 
mortality, LOS or discharge destination. 
More medical conditions were recognized 
in those randomized to orthogeriatric 
care. 
Kennie, 
1988. UK 
N=108 Prospective 
randomized 
No follow up LOS,  
Physical 
independence 
at discharge,  
Discharge 
destination 
More patients treated in the intervention 
group was physical independent at 
discharge. Length of stay was also shorter 
in the intervention group (24 vs 41 days). 
Gustafson
, 1991. 
Sweden 
N=214 Prospective 
with 
retrospectiv
e controls 
No follow up Delirium. 
Delirium 
severity and 
duration. 
LOS. 
Complications 
Fewer patients in the intervention study 
developed delirium (47.6 vs 61.3 %, 
p<0.05). The intervention had also a 
positive impact on delirium severity and 
duration. LOS was reduced after 
implementation of the new model (11.6 
vs 17.4, p<0.001), and fewer patients 
developed postoperative complications. 
Naglie, 
2002. 
Canada 
N=279 Prospective 
randomized 
3 and 6 months. 
Interviews with 
patients and 
caretakers.  
Mobility, 
mortality, 
place of 
recidence 
No effect on outcomes 3 and 6 months 
after surgery. The initial LOS was longer 
in the intervention group (29 v 21 days, p 
< 0.001), but the mean number of days 
spent in an institution over the first six 
months after surgery was similar. 
Shuy 
2005, 
2008, 
2010. 
Taiwan 
N=162 Prospective 
randomized 
(using flip 
of a coin).  
1,3,12 and 24 
months. Face-to-
face evaluation 
with a 
combination of 
performance 
based and self 
reported 
measures. 
Assessors not 
blinded.  
Physical 
function, 
mobility, pain, 
depression 
Significantly more patients randomized to 
intervention had recovered their previous 
walking ability. The effect lasted for 12 
and 24 months. In addition the 
intervention group significantly fewer 
depressive symptoms.  
Ho 2009, 
Leung 
2011. 
Hong 
Kong 
N=565 Retrospectiv
e before and 
after chart 
review 
3 and 12 months. 
Data collected 
from   regular out-
patients visits. 
LOS, waiting 
time for 
surgery, 
mortality,  
The intervention had impressive results 
with shorter LOS (9.7 v 8.3 days, 
p=0.001), lower in hospital (4 v 1 %, 
p=0.02) and 1-year mortality (20 v 11 %, 
p=0.005). More patients were 
independent in ADL after 3 and 12 
months. The authors suggest the 
beneficial effect  in large part could be 
explained by the reduction in waiting 
time for surgery (mean 55 v 45 hours, 
p=0.02). 
Deschodt 
2011, 
2012.  
Milisen 
2001. 
Belgium  
N=177 
(Deschodt
) 
N=120 
(Milisen) 
Deschodt: 
Prospective 
controlled 
study. 
Milisen: 
before/after  
6 weeks, 4 and 12 
months. 
Telephone 
interview with 
patients or 
relatives.  
Functional 
status, LOS, 
mortality, new 
nursing home 
admissions. 
Delirium.  
The intervention was only effective in 
reducing post operative delirium (53 v 37 
%, p=0.04).  
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Orthopedic ward and daily consultative service (Kammerlander 2) 
This is a variant of model 1. The difference is that there is a daily geriatric service. In the 
evenings and weekends is it usually no geriatric service available. 14 studies exist in this 
category.  
Zuckerman JD, 1992(Zuckerman et al., 1992) In august 1985, the Geriatric Hip Fracture 
Program (GHFP) was introduced at an orthopedic ward at The Hospital for Joint Disease, 
New York. The GHFP used a multidisciplinary team (geriatrician, nurse, physiotherapist, 
occupational therapist, nutritionist) with weekly meetings. 431 patients included in the 
program were compared to 60 patients treated before the introduction of the program. There 
were significantly fewer patients with postoperative complications (38 vs 65 %, p<0.001) 
after the introduction of the program and more were able to ambulate independently at 
discharge (56 vs 18 %, p<0.001).  
My comment: Beneficial effect of the model, but before - after design. LOS was approx. 25 
days, so not comparable to today’s standards.  
Anotelli Incalzi R, 1993(Antonelli Incalzi et al., 1993) In the Catholic University of the Sacred 
Heart, a geriatrician was assigned to provide the daily medical care for geriatric patients in the 
orthopedic ward. 287 patients were prospectively included in 1989-1990 (after the 
implementation of the new model) and outcomes were compared to 474 patients treated in 
1985-1988 (before implementation). All patients above 70 years could be included, not only 
hip fracture patients. Mortality dropped from 18 % to 8.4 % (p<0.001) after the 
implementation of the new model. LOS was significantly lower for hip fracture patients (29 
vs 38 days, p<0.003).  
My comment: The intervention was limited, but had huge impact on mortality and LOS. Both 
are, however, much higher than todays standards, also after the implementation of the 
orthogeriatric model.  
Swanson CE, 1998(Swanson et al., 1998): This prospective randomized controlled study from 
Brisbane, Australia, enrolled 71 patients from October 1994 to July 1995. For those 
randomized to intervention (N=38), a multidisciplinary team provided early intervention 
comprising early surgery, early mobilization, daily assessments, weekly multidisciplinary 
meetings, planned discharge and home assessment visits before discharge. Mean LOS was 
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shorter in the intervention group (33 v 21 days, p<0.01). There was no difference in mortality, 
ADL, mobility or complications.  
My comment: the study aimed to include 120, but the effect on LOS (primary endpoint) was 
much larger than expected so the difference was statistically significant even with less 
patients included than planned. Demented patients and patients from nursing homes were 
excluded.  
Marcantonio 2001 (Marcantonio et al., 2001)(not in Kammerlander 2010): This RCT 
included 126 patients with hip fracture. Those randomized to intervention (n=62) received 
geriatric consultation preoperatively or within 24 hours of surgery. The geriatrician performed 
daily visits for the patients randomized to intervention and made recommendations based on a 
structured protocol. The primary outcome was delirium, and fewer patients randomized to 
intervention had delirium (50 v 32 %, p=0.04). The intervention seemed to be most effective 
in those patients free from prefracture dementia, but this was not statistically significant, 
probably because of small numbers. The intervention had no effect on delirium duration or 
LOS.  
My comment: well designed study. The intervention was effective, but was aimed at one 
particular condition (delirium). There is no information about outcomes after discharge.  
Khan R, 2002(Khan et al., 2002): In this study, data was collected prospectively from 745 
patients admitted from January 1992 through December 1996 to three different orthopedic 
wards at Mayday University Hospital, Surrey, UK. In December 1994 a geriatrician was 
hired, and from then orthogeriatric care was introduced in one of the wards. The geriatrician 
saw the patients twice a week, and once a week there was a multidisciplinary meeting. The 
introduction of the program had no effect on LOS (26 days in both groups) or mortality. 
Neither was there any difference in percentage of patients discharged to “pre-admission place 
of residence”.   
My comment: Only historical controls. Details are lacking regarding the intervention, but it 
seems very limited. Nothing is mentioned regarding the multidisciplinary team.  
Koval KJ, 2004(Koval et al., 2004): A new report from the same hospital as in Zuckerman 
1992 (Zuckerman is among the co-authors). In 1990 the orthogeriatric model was further 
developed (Zuckerman described that GHFP was introduced in 1985) and a clinical pathway 
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was introduced for hip fracture patients. In this new model, the multidisciplinary approach 
was further developed and structured, and included also pre-operative elements (“appropriate 
multidisciplinary consultation, as dictated by the patient’s comorbid conditions”). Outcomes 
for 318 patients treated earlier (July 1987 - December 1989) was compared to those of 747 
patients treated after the implementation of the program (January 1990 - December 2001). 
The LOS was significantly reduced after the introduction of the new program (22 v 14 days, p 
< 0.001). In-hospital mortality (5 v 2 %, p < 0.001) and 1-year mortality (14 v 9 %, p < 0.01) 
was also reduced.  
My comment: only historical controls. The intervention is well described, and includes both 
pre- and postoperative elements. No follow up controls with objective assessments.  
Roberts HC, 2004(Roberts et al., 2004): This study evaluated the effect of the implementation 
of “ICP - integrated care pathway” in 2000. From November 1998 to October 1999, 395 
patients were prospectively included in the study. The inclusion was put on hold for seven 
months in order to implement the program, before 369 patients were included from June 2000 
to May 2001. The intervention was provided by a multi-disciplinary team. The primary 
outcome was LOS in the orthopedic unit, and this increased after the implementation of ICP 
(23 v 16 days, p<0.0005). Significantly more patients treated in ICP could walk independently 
at discharge (73 v 63 %, p=0.033). There was also a significant reduction in pressure sores 
and UTIs in the ICP. On the other hand, more cardiac complications were registered in the 
ICP group.  
My comment: the intervention is not well described. No follow up controls.  
Vidán M, 2005(Vidan et al., 2005) (Categorized as « Orthopedic ward and integrated care” 
in Kammerlander 2010): In this study from Madrid, Spain, 321 hip fracture patients were 
included between February and December 1997. All patients shared the same orthopedic 
wards, but those randomized to intervention (n=157) were assessed daily by a geriatric team, 
and the geriatrician had the daily medical responsibility for the patients. The patients were 
randomized after an initial screening performed within the first 48 hours after admission. The 
patients underwent clinical assessments 3, 6, and 12 months after discharge. LOS (the primary 
outcome) was two days shorter in the intervention group (18 vs 16 days, p=0.06). There was 
no difference in waiting time for surgery (76 vs 79 hours, p=0.25). There was a significant 
reduction in in hospital mortality (5.5 vs 0.6 %, p=0.03), and major medical complications (61 
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vs 45 %, p=0.003). There was also a trend towards better ADL recovery in the intervention 
group at the 3 months follow up control (53 vs 43 %, p=0.10).    
My comment: one of the few RCTs. Overall is the impression that patients randomized to 
orthogeriatric care had favorable outcomes, although LOS was the primary outcome. Since 
the patients were assessed up to 48 hours after admission, many patients did probably not 
have any pre-operative intervention. Very long waiting time for surgery. There is limited 
information regarding usual care.   
Niam D, 2005(Wong Tin Niam et al., 2005) (not in Kammerlander 2010): A new clinical 
pathway was introduced in 2001 at this hospital in Fremantle, Austrialia. In this new model 
was a geriatrician assessing hip fracture patients in the orthopedic ward and recommendations 
were given. Patients were included in the study from August to December 2001, 28 patients 
before the implementation of the program (controls) and 71 after the implementation (cases). 
Delirium was the primary endpoint, and this was daily assessed with the CAM (completed by 
the geriatrician). After the intervention delirium was reduced (12.7 vs 37.5 %, p=0.012). 
There was also a non significant reduction in delirium duration (3 vs 5 days, p=0.43). LOS 
was the same (12.1 vs 11.8 days).  
My comment: The intervention had huge impact on delirium rates. There are however several 
methodological weaknesses in addition to the before-after design. The most notable is that 
delirium (the primary endpoint) was assessed by the same geriatrician who did the 
intervention.    
Barone 2006(Barone et al., 2006). Italy(not in Kammerlander 2010): In 2001, an 
orthogeriatric service was established at this hospital in Genoa, Italy. The service provided 
multidisciplinary evaluation of hip fracture patients in the orthopedic unit. A geriatrician was 
responsible for medical care. Rehabilitation continued after discharge. The service ended after 
one year, and to evaluate its efficacy, one compared outcomes for 252 patients treated in the 
unit to 272 patients admitted in the year before the unit was established (control group 1) and 
295 patients admitted the year after the unit was closed (control group 2). Telephone 
interview was conducted 1 year after discharge. Significantly more patients were alive after 1 
year of those treated in the orthogeriatric unit (75%), compared to control group 1 (65%) and 
control group 2 (67%).  
My comment: This is only a letter to editor, so limited information is given. 
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Fisher AA, 2006(Fisher et al., 2006). This is a study from Canberra, Australia that evaluated 
the effect of introduction of a model (GM - geriatric medicine) were a geriatrician from 1998 
began overseeing daily medical care for hip fracture patients. Data were collected 
prospectively from introduction of the program and until 2002 (447 patients) and outcomes 
were compared to those of 504 patients treated before the introduction of GM (1995 - 1997). 
The geriatrician worked daytime (0800 - 1700) in weekdays, and in weekends and at night 
care was provided by geriatricians on call. In-hospital mortality was reduced after the 
introduction of GM (4.7 v 7.7 %, p<0.01). Postoperative complications were also significantly 
reduced. Readmissions to medical wards the first six months after discharge were reduced 
from 28 % to 7.6 %, p<0.001. There was no effect on LOS (median 11 in both groups).  
My comment: only the role of the geriatrician is described, nothing about the rest of the 
multidisciplinary team (the paper refers to the GM-team but it is not further described). The 
intervention started preoperatively. Retrospective controls is not optimal, as noted by Koval in 
a comment after the article. Data collected from charts and registers, no objective testing of 
patients.  
Cogan L, 2010(Cogan et al., 2010): In this study from Dublin, Ireland, the aim was “to show 
that introduction of orthogeriatric services improved care and better patients outcomes”. 
Sometime between 2001 and 2006 (the paper those not describe the exact timing), 
orthogeriatric care was implemented at the hospital. Data was collected from the charts of 103 
patients admitted prior to the introduction of the program (before May 2001), and outcomes 
were compared to 98 patients admitted after January 2006. After the introduction of the 
program, a geriatrician attended hip fracture patients in weekdays and the staff had weekly 
interdisciplinary meetings. The use of protocols was introduced and rehabilitation was 
emphasized. The introduction of the program had no effect on waiting time to surgery (1.9 
days in both groups). LOS increased from 23 to 30 days. In-hospital mortality (20 v 8 %) and 
1-year mortality (45 v 34 %) was reduced.   
My comment: The article lack details regarding the orthogeriatric program and the timing of 
the introduction. The waiting time for surgery is long in both groups, as well as LOS. The 
differences seems not be tested for significance.  
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Gregersen, 2012 (Gregersen et al., 2012)(not in Kammerlander 2010): This retrospective 
before-after study from Aarhus, Denmark evaluated the effect of the implementation of a 
geriatric team (geriatrician, physiotherapist and nurse) in 2003. During daytime in the 
weekdays, the team provided full time geriatric and orthopedic care for hip fracture patients in 
the orthopedic ward, but in the weekends and in the nights the team was not available. 262 
patients treated in 2000 (before the implementation) were compared to 233 patients included 
after the implementation of the program in 2003. LOS was reduced from 15 to 13 days after 
the implementation of the program, but there was no effect on re-admissions or mortality. As 
the data was collected by retrospective chart reviews, no objective measures regarding 
physical or cognitive function was available.  
My comment: Not optimal design. Some relevant data is missing (type of fracture, type of 
surgery, co-morbidities).  
Wagner, 2012(Wagner et al., 2012) (not in Kammerlander 2010): This study is from the 
Catholic University in Santiago, Chile, where an orthogeriatric service was established in July 
2009. From the description of the models it seems like the hip fracture patients were treated in 
the orthopedic ward, but were daily assessed by the geriatric team. After surgery, the geriatric 
team had the primary medical responsibility for the patients, but also gave advice 
preoperatively. To evaluate the new service, patients were prospectively included from July 
2009 to May 2011 (n=92) and outcomes were compared for those admitted between January 
2007 and June 2009 (before the service was established, n=183). There was no difference in 
LOS after implementation of the new model (9 vs 8 days, p=0.51), and also no difference in 
in-hospital mortality (2.2 % vs 1.1 %, p=0.46) or 1 year survival (87 %  in both groups). More 
post-operative complications were registered after the introduction of the orthogeriatric 
service, most notably delirium (60 vs 19 %, p<0.001). This difference was by the authors 
interpreted to be explained by higher awareness of the condition.  
My comment: The geriatric intervention is not well described, and even less is explained 
about usual care.  
Bhattacharyya, 2013(Bhattacharyya et al., 2013) (not in Kammerlander 2010): In August 
2010, an orthogeriatric service was established at this hospital in Glasgow, UK. The 
orthogeriatric team worked on a liaison basis preoperatively and until 48 hours after surgery. 
After that, the orthogeriatric team had the primary responsibility for the patients. Outcomes 
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were compared for 274 patients treated in the old model (admitted between January 2010 and 
July 2010) with those of 249 patients treated in the new model (August 2010 and February 
2011). LOS was reduced in the new model (19.5 vs 25, p=0.22), and a higher percentage of 
the intervention patients returned to pre fracture residence (73 vs 57 %, p<0.001).  
My comment: The primary focus in this study was satisfaction among health care workers, 
not patient outcomes. The majority of staff believed that quality of care had improved.   
Table 5. Overview of studies evaluating an orthogeriatric model in accordance with Kammerlander model 2 
Study Number 
of patients 
Study design Timing and 
organization of 
follow up 
controls 
Evaluation Conclusion 
Zuckerman, 
1992. USA 
N=491 Prospective 
with 
retrospective 
controls 
No follow up LOS, post 
operative 
complication, 
mortality. 
mobility 
There were significantly fewer 
patients with postoperative 
complications (38 vs 65 %, p<0.001) 
after the introduction of the program 
and more were able to ambulate 
independently at discharge (56 vs 18 
%, p<0.001). 
Antonelli 
Incalzi, 
1993. Italy 
N=761 Prospective 
with 
retrospective 
controls 
No follow-up LOS, 
mortality, 
operation rate 
Mortality dropped from 18 % to 8.4 
% (p<0.001) after the implementation 
of the new model. LOS was 
significantly lower for hip fracture 
patients (29 vs 38 days, p<0.003). 
Swanson, 
1998. 
Australia.  
N=71 Prospective 
randomized 
1 and 6 months. 
Data collected 
either at the 6 
months out 
patient control 
or by telephone 
interviews.  
LOS, 
mortality, 
ADL 
Mean LOS was shorter in the 
intervention group (33 v 21 days, 
p<0.01). There was no difference in 
mortality, ADL, mobility, 
complications. 
Marcantoni
o, 2001. 
USA 
N=126 Prospective 
randomized 
No follow up  Delirium, 
LOS. 
Delirium 
assessments 
were done by 
a rater blinded 
to allocation.  
Fewer patients with delirium in those 
randomized to intervention (50 v 32 
%, p=0.04). No effect on delirium 
duration or LOS. 
Khan, 2002. 
UK 
N=745 Prospective 
with 
retrospective 
controls. No 
randomization.  
No follow up LOS, 
mortality, rate 
of discharges 
to «pre-
admissions 
place of 
residence.  
The introduction of the program had 
no effect on LOS (26 days in both 
groups) or the other outcomes.  
Koval, 
2004. USA.  
N=1065 Prospective 
with 
retrospective 
controls 
3,6,12 months 
and then every 6 
months until 
death. 
Interviews with 
patients or 
family member.   
LOS, 
mortality, 
mobility.  
The LOS was significantly reduced 
after the introduction of the new 
program (22 v 14 days, p < 0.001). 
In-hospital mortality (5 v 2 %, p < 
0.001) and 1-year mortality (14 v 9 
%, p < 0.01) was also reduced. No 
effect of ambulation.  
Roberts, 
2004. UK.  
N=395 Prospective 
before and after 
No follow up. 
Mortality and 
re-admissions 
after 1 month 
registered.  
LOS, 
mortality, 
complications, 
readmissions, 
mobility 
LOS increased after the 
implementation of ICP (23 v 16 days, 
p<0.0005). Significantly more 
patients treated in ICP could walk 
independently at discharge (73 v 63 
%, p=0.033). There was also a 
significant reduction in pressure sores 
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and UTI in ICP. On the other hand 
was more cardiac complications were 
registered in the ICP group. 
Vidán, 
2005. Spain 
N=321 Prospective 
randomized 
controlled trial 
3,6,12 months. 
Interviews with 
patients and 
relatives.  
LOS, 
complications, 
mortality, 
ADL recovery 
LOS (the primary outcome) was two 
days shorter in the intervention group 
(16 vs 18 days, p=0.06). There was a 
significant reduction in in hospital 
mortality (0.6 vs 5.5 %, p=0.03), and 
major medical complications (45 vs 
61 %, p=0.003). There was also a 
trend towards better ADL recovery in 
the intervention group at the 3 months 
follow up control (53 vs 43 %, 
p=0.10).    
Niam, 
2005. 
Australia 
N=99 Prospective 
before -after 
No follow up Delirium, 
LOS 
After the intervention delirium was 
reduced (12.7 vs 37.5 %, p=0.012). 
There was also a non significant 
reduction in delirium duration (3 vs 5 
days, p=0.43). LOS was the same 
(12.1 vs 11.8 days). 
Barone 
2006. Italy 
N=819 Retrospective 
before and after  
12 months. 
Telephone 
interview were 
conducted.  
LOS. 
Mortality 
Significantly more patients were alive 
after 1 year of those treated in the 
orthogeriatric unit (75%), compared 
to those admitted before (65%) and 
after (67%) the unit was closed.  
Fisher, 
2006. 
Australia.  
N=951 Prospective 
with 
retrospective 
controls 
No follow up. 6 
months re-
admissions 
registered.  
LOS, 
mortality, 
complications 
In hospital mortality was reduced 
after the introduction of GM (4.7 v 
7.7 %, p<0.01). Postoperative 
complications were also significantly 
reduced. Readmissions to medical 
wards the first six months after 
discharge were reduced from 28 % to 
7.6 %, p<0.001. There was no effect 
on LOS (median 11 in both groups). 
Cogan, 
2010 
N=201 Retrospective 
chart review 
before and after 
No follow up. 
12 months 
mortality 
registered.  
LOS, 
mortality, 
waiting time 
for surgery 
The introduction of the program had 
no effect on reduction of waiting time 
to surgery (1.9 days in both groups). 
LOS increased from 23 to 30 days. In 
hospital mortality (20 v 8 %)  and 1-
year mortality (45 v 34 %) was 
reduced.  
Gregersen, 
2012. 
Denmark 
N=495 Retrospective 
chart review 
before and after 
No follow up. 
Re-admissions 
and mortality 
registered at 3,6 
and 24 months 
LOS, 
mortality, re-
admissions 
LOS reduced from 15 to 13 days after 
implementation of the program. No 
effect on re-admissions or mortality 
Wagner, 
2012. Chile 
N=275 Prospective 
with 
retrospective 
controls 
No follow up. 
Mortality and 
re-admissions 
registered for up 
to 48 months.  
LOS, 
mortality, 
complications 
There was no difference in LOS after 
implementation of the new model (9 
vs 8 days, p=0.51), and also no 
difference in in-hospital mortality 
(2.2 % vs 1.1 %, p=0.46) or 1 year  
survival (87 %  in both groups). More 
post-operative complications was 
registered after the introduction of the 
orthogeriatric service, most notably 
delirium (60 vs 19 %, p<0.001). 
Bhattachary
ya, 2013. 
UK 
N=523 Retrospective 
chart review 
before and after 
No follow up LOS, 
mortality, 
discharge 
destination 
LOS was reduced in the new model 
(19.5 vs 25, p=0.22), and more 
returned to pre fracture residence (73 
vs 57 %, p<0.001). 
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Geriatric and rehabilitation ward and orthopedic consultant service (Kammerlander 3) 
In this model the patients are treated in a geriatric ward, and the geriatricians have the primary 
responsibility for the patients. The orthopedic surgeon is consultative. 12 studies (reporting 
from 6 models) exist in this category.  
Boyd RV, 1983(Boyd et al., 1983): In 1978, a new orthogeriatric unit opened at this hospital in 
Nottingham, UK. The medical staffing was geriatricians with a consultant orthopedic surgeon 
and the ward had also a multidisciplinary team. The orthogeriatric ward received patients 
from eight different orthopedic surgeons in orthopedic wards. Mostly, but not exclusively, hip 
fracture patients were admitted to the ward.  To evaluate this unit the researchers compared 
LOS, waiting time for surgery, in hospital mortality and discharge destination for the female 
hip fracture patients admitted to the unit in 1977 (before the unit opened, n=289) to those 
treated in 1979 (after the unit had opened, n=482). LOS was reduced from 66 to 48 days and 
waiting time for surgery from 3 to 2.6 days. In-hospital mortality was also reduced (22 vs 17 
%). There were only minor changes in discharge destination.   
My comment: Before and after study. Only postoperative intervention. LOS, waiting time for 
surgery and in-hospital mortality is much higher than today. No significance testing of 
differences. Kammerlander have extracted other numbers regarding participants (I think he is 
wrong).  
Adunsky A, 2003, 2005, 2011. Ginsberg 2013(Adunsky et al., 2003, Adunsky et al., 2005, 
Adunsky et al., 2011, Ginsberg et al., 2013): In 1999, an orthogeriatric service was 
established at Sheba hospital in Tel Aviv, Israel(Adunsky et al., 2002). In this model, the 
patients are treated in a geriatric ward based upon the concept that “a hip fracture is a 
geriatric, rather than an orthopedic disease”. In this model is the patients were transferred 
directly from the ER to the orthogeriatric ward, and returned to the ward after surgery. There 
are several reports from the “Sheba-model”. In the study from 2003, patients were included in 
the emergency room and allocated directly to the orthogeriatric ward (n=116) or to orthopedic 
ward (n=204). The allocation was based on availability of beds. The patients allocated to 
intervention had shorter LOS (32 vs 27 days, p<0.01) and an almost two-fold chance of 
successful rehabilitation as defined as more than 50 % increase in “relative functional gain”. 
The effect on waiting time for surgery is not reported in the 2003 article, but in the article 
published in 2005 that included 592 patients treated in the Sheba model, the mean waiting 
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time for surgery was 3.6 ± 3.4 days. Compared to historical controls this model also reduced 1 
year mortality (17.3 vs 14.8 %, p=0.016) (Adunsky 2011) and using register data the model 
was also shown to be cost-effective (Ginsberg 2013).  
My comment: The model is advanced, and seems to be the one that most closely resembles 
the model used at Ullevaal 2008 - 2012. The studies reports beneficial effects, but only the 
study from 2003 had an experimental design (quasi-randomization based on availability of 
beds). In that study also patients randomized to usual care were admitted to the orthogeriatric 
unit postoperatively, so the study mainly assessed the effect of preoperative orthogeriatric 
intervention. The waiting time for surgery was extremely long, also after implementation of 
the orthogeriatic model.  
Stenvall M, 2007, 2012. Lundstrom 2007(Stenvall et al., 2007, Lundstrom et al., 2007, 
Stenvall et al., 2012): In this study from Umea in Sweden were 199 patients included between 
May 2000 and December 2002. This model is a further development of the orthogeriatric 
service at this hospital, as described in earlier reports(Gustafson et al., 1991). The patients 
were randomized to postoperative care in a geriatric ward or usual care in the orthopedic 
ward. In addition to the intervention during the hospital stay, those randomized to intervention 
were assessed four months after surgery to detect and treat any complications. LOS was 
significantly reduced (40 vs 30 days, p=0.028). Ssignificantly more patients allocated to 
intervention had regained independence in personal ADL four (OR 2.5) and 12 months (OR 
3.5) after surgery. There was no difference in re-admissions or mortality. The model was also 
effective in preventing postoperative delirium (75 vs 55 %, p=0.003) and reducing delirium 
duration (10 vs 5 days, p=0.009) (Lundstrom et al., 2007). The intervention was particularly 
effective for patients with dementia, with significant reduction in postoperative delirium (97 
vs 68 %, p=0.002), UTI (64 vs 21 %, p=0.001) and falls (34 vs 1, p=0.006) during the hospital 
stay and with improved outcomes at the follow up controls (Stenvall et al., 2012).  
My comment: Well designed study. Only postoperative intervention, but there was also 
intervention after discharge from hospital. Assessors were not blinded. High delirium rates 
may be indicative of poor quality of the usual care.   
Miura, 2009(Miura et al., 2009) (not in Kammerlander 2010): The Hip Fracture Service 
(HFS) was introduced at this hospital in Oregon, USA, in 2001. This was an interdisciplinary 
geriatrician led program, and was developed in collaboration between geriatricians and 
49 
orthopedic surgeons. The orthogeriatric ward was located in the orthopedic ward, but a 
geriatrician had the primary responsibility for the patients. New practices were initiated in the 
HFS, protocols, preprinted orders and standardized assessments were used. To evaluate the 
HFS were 91 patients prospectively included between 2001 and 2002. Outcomes were 
compared to 72 patients admitted in 2000 (before the program). LOS was reduced after the 
introduction of HFS (6.1 vs 4.6, p<0.001). More patients in HFS were operated before 24 
hours (50.5 vs 22.2 %, p<0.001). HFS was also cost effective. Re-admission the first 30 days 
after surgery was 11 % in the HFS group, but this data was not collected for the control group. 
My comment: Seems like a good design, but only historical controls. No clinical endpoints 
are reported. No follow up.  
Mazzola, 2010(Mazzola et al., 2011) (not in Kammerlander 2010): This study from Monza, 
Italy compared two different orthogeriatric care (OC) programs. In OC-1, patients were 
admitted directly to the orthogeriatric ward from the ER, whereas in OC-2 the patients were 
admitted first to the orthopedic ward and then to the orthogeriatric ward postoperatively. 
Patients were prospectively included in the study from March 2007 to June 2009. Patients 
were included in OC-1 (n=174) when a bed was available, otherwise to OC-2 (n=87). There 
was no significant differences between patients treated in OC-1 and OC-2 with regard to 
waiting time for surgery (mean 2.8 days in both groups) or LOS (13 days in both groups), but 
patients treated in OC-1 had shorter mobilization time (2.9 vs 3.6 days, p=0.01).  
My comment: Only pre-operative intervention differed between groups, and in contrast to 
Adunsky, the effect was limited. Only mobilization time was different, but it is unclear from 
the paper what the authors mean by this variable. Since this is most likely to be a variable 
measured postoperatively, one would expect that this difference emerged by chance since the 
intervention seemed to be identical in both groups postoperatively. Waiting time for surgery is 
long in both groups.  
Sletvold, 2011. Saltvedt, 2012(Sletvold et al., 2011, Saltvedt et al., 2012) (not in 
Kammerlander 2010): Only the protocol and details regarding the intervention have been 
published (Saltvedt et al., 2012, Sletvold et al., 2011) from this RCT of 397 hip fracture 
patients included at St Olav hospital, Trondheim, Norway from April 2008 to December 
2010. The patients were included in the ER and randomized to usual care in the orthopedic 
ward or to an orthogeriatric service provided in the acute geriatric ward. The patients were 
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transferred directly from the ER to the allocated unit. The intervention used CGA as a basis 
for planning of care. The intervention emphasized adequate nutrition, early mobilisation and 
early discharge planning. The primary endpoint was mobility, assessed with SPPB. The main 
results from this RCT have not been published yet, but preliminary results have been 
presented at conferences (Nordic Congress of Gerontology, Copenhagen June 2012), and 
patients randomized to intervention had significantly better SPPB four months after surgery.  
My comment: This is a large RCT with impressive design. Only preliminary data are 
reported.  
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Table 6. Overview of studies evaluating an orthogeriatric model in accordance with Kammerlander model 3 
Study Number 
of patients 
Study design Timing and 
organization of 
follow up 
controls 
Evaluation Conclusion 
Boyd, 
1983. UK 
N=771 Retrospective 
before and 
after 
No follow up.  LOS, 
mortality, 
waiting time 
for surgery, 
discharge 
destination 
LOS was reduced from 66 to 48 days 
and waiting time for surgery from 3 to 
2.6 days. In hospital mortality was also 
reduced (22 vs 17 %). There were only 
minor changes in discharge destination.   
Adunsky, 
2003, 2005, 
2011. 
Gingsberg 
2013. Israel 
N=330  Prospective 
quasi-
randomised 
controlled 
No follow up 
controls, but 
mortality data is 
registered up to 
12 months after 
surgery.  
LOS, 
mortality, 
functional 
function at 
discharge 
Those allocated to intervention had 
shorter LOS (32 vs 27 days, p<0.01) 
and almost two-fold chance of 
successful rehabilitation as defined as 
more than 50 % increase in “relative 
functional gain”. 
Stenvall 
2007, 2012.  
Lundstrom 
2007. 
Sweden.  
N=199 Prospective 
randomized 
controlled 
Home visits 4 
and 12 months 
performed by 
research nurses.   
LOS, 
mortality, 
postoperative 
complications, 
delirium, 
ADL 
functions 
Significantly more patients allocated to 
intervention had regained independence 
in personal ADL performance f (OR 
2.5) and 12 months (OR 3.5) after 
surgery. There was no difference in re-
admissions or mortality. The model was 
also effective in preventing 
postoperative delirium (75 vs 55 %, 
p=0.003) and reducing delirium 
duration (10 vs 5 days, p=0.009). The 
intervention was particular effective for 
patients with dementia, with significant 
reduction in postoperative delirium (97 
vs 68 %, p=0.002), UTI (64 vs 21 %, 
p=0.001) and falls (34 vs 1, p=0.006) 
during the hospital stay. 
Miura, 
2009. USA 
N=161 Prospective 
with 
retrospective 
controls 
No follow up.  LOS, 
mortality, cost 
LOS was reduced after the introduction 
of HFS (6.1 vs 4.6, p<0.001). More 
patients in HFS was operated before 24 
hours (50.5 vs 22.2 %, p<0.001). HFS 
was also cost effective.  
Mazzola, 
2010. Italy 
N=261 Prospective 
quasi-
randomized 
controlled (by 
availability of 
beds) 
No follow up LOS, waiting 
time for 
surgery, 
mobilization 
time 
There was no significant differences 
between patients treated in OC-1 and 
OC-2 in regard to waiting time for 
surgery (mean 2.8 days in both groups), 
LOS (13 days in both groups), but 
patients treated in OC-1 had shorter 
mobilization time (2.9 vs 3.6 days, 
p=0.01). 
Sletvold, 
2011. 
Saltvedt 
2012. 
Norway 
N=397 
(only pre-
liminary 
data 
presented) 
Prospective 
randomized 
controlled 
trial.  
The patients 
were assessed in 
the outpatient 
clinic 1,4,12 
months by 
research 
assistants 
blinded to 
allocation.  
Mobility, 
LOS, 
mortality, 
health 
economics, 
place of 
residence, 
ADL 
The main results from this RCT have 
not been published yet, but preliminary 
results have been presented at 
conferences (Nordic Congress of 
Gerontology, Copenhagen June 2012), 
and patients randomized to intervention 
had significantly better mobility four 
months after surgery 
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Orthopedic ward and integrated care (Kammerlander 4) 
This is the most advanced model were the orthopedic surgeons and geriatricians co-manage 
the patients on a daily basis. Eight studies (reporting from five models) exist in this category. 
Lundström M, 1999(Lundstrom et al., 1999) (not in Kammerlander 2010): From January to 
December 1993 were 49 patients (mean age 79.7 year, 17 men) with femoral neck fractures 
included in this study from Piteå, Sweden. The patients were treated at the Department of 
Rehabilitation where the orthopedic surgeons and the geriatricians co-managed the patients. 
The patients were admitted directly from the ER. The intervention included education of the 
staff, prevention and treatment of delirium, individual planning of care and rehabilitation, 
daily involvement of physiotherapists and occupational therapists, and focus on nutrition. The 
model was compared to historical cohorts of hip fracture patients in the same and other 
hospitals. Compared to 35 patients included in a study conducted at the same hospital from 
April 1983 to May 1984(Brannstrom et al., 1991, Brannstrom et al., 1989), more patients 
returned to independent living on discharge (93 vs 33%, p=0.02), and more could walk 
independently with walking aids at discharge (89 v 60 %, p=0.003) after implementation of 
the new model. There was also a non-significant reduction of postoperative delirium (27 % vs 
43 %, p=0.13). There was no difference in patients living independently 6 months after 
surgery (80 vs 85 %, p=0.62). The LOS was 13 days in both groups.  
My comment: The orthogeriatric model is advanced and well described. The intervention 
started pre-operatively and was very effective. There are however methodological problems 
with the study (small sample size, use of historical controls).  
Khasraghi FA, 2005(Khasraghi et al., 2005): In April 1998 a Hip Fracture Service (HFS) was 
established at Johns Hopkins medical center in Baltimore, USA. This was a cooperation 
between the Department of Orthopedic surgery and the Division of Geriatric Medicine, and 
geriatricians and orthopedic surgeons co-manage the patients. To evaluate this new service, 
patient charts and the hospital discharge database were reviewed for 510 patients (273 in HFS 
group) admitted with hip fracture between January 1995 and December 2000. Postoperative 
complications were significantly reduced after the introduction of HFS (51 vs 36 %,). Waiting 
time for surgery (46 vs 26 hours) and LOS (8.1 vs 5.7 days) were also significantly reduced, 
and significantly fewer were discharged to nursing homes (23 vs 13 %).  
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My comment: Only historical data. No objective measurements and no follow up controls. 
Also no information regarding re-admissions and mortality.  
Friedman S, 2008, 2009. Kates 2010, 2011(Friedman et al., 2008, Friedman SM, 2009, Kates 
et al., 2010b, Kates et al., 2011): A Geriatric Fracture Center (GFC) was developed at the 
Mayo clinic in Rochester, USA in 2004. This model (“The Rochester Model) is an advanced 
orthogeriatric service were the patients on a daily basis are co-managed by geriatricians and 
orthopedic surgeons(Kates et al., 2010a). There are several reports from this model. In the 
study from 2009, outcomes from 193 hip fracture patients admitted to GFC between May 
2005 to April 2006 were compared to outcomes from 121 hip fracture patients admitted to a 
nearby hospital (without orthogeriatric service) in the same period. Those treated in GFC had 
shorter waiting time for surgery (24 vs 37 hours, p=0.007), shorter LOS (4.6 vs 8.3 days, 
p<0.001) and fewer complications 31 vs 46 %, p=0.005). There was no difference in hospital 
mortality or re-admissions the first 30 days after surgery(Friedman SM, 2009). The Rochester 
model is also cost effective compared to historical data (Kates et al., 2011) and to a national 
average (Kates et al., 2010b). 
My comment: The Rochester model is very impressive and is considered the reference model 
for orthogeriatric collaboration based on co-management of elderly patients with hip 
fractures(Pioli et al., 2014). The outcomes are however only compared to historical controls, 
other hospitals, or national averages.  
González-Montalvo JI, 2010(Gonzalez-Montalvo et al., 2010)(not in Kammerlander 2010): 
This study was conducted at La Paz University Hospital in Madrid and compared two 
different orthogeriatric models. Model 1 was established in 1995 in the form of geriatric 
liaison service for patients in the orthopedic ward. In February 2007 was a new service 
(Model 2) established were geriatricians and orthopedic surgeons co-managed the patients on 
a daily basis. To compare these two models, patients were included in the study between 
February and August 2007. The patients were allocated between model 1 (n=123) and model 
2 (101) in a quasi-randomized way (alternate days and depending on bed availability). 
Waiting time for surgery (5 vs 6 days, p<0.001) and LOS (12 vs 18 days, p<0.001) was 
shorter in Model 2.  There was no difference in in-hospital mortality, discharge destinations or 
mobility at discharge.  
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My comment: The waiting time for surgery was extremely long in both groups. Given the 
negative effect waiting time for surgery has on outcome(Pioli et al., 2012a), one would expect 
that any intervention would have only minor effect in this study.  
Dy 2011(Dy et al., 2012)(not in Kammerlander 2010): At this hospital in New York, USA, an 
orthogeriatric model (MOTS - Medical Orthopedic Trauma Service) was introduced in March 
2008. In this model, elderly hip fracture patients were on a daily basis co-managed by 
physicians from Dept. of Internal Medicine and Orthopedic Surgery. To evaluate this model, 
data were collected retrospectively from chart reviews from May to December 2007 (pre-
MOTS, n=144) and May to December 2008 (MOTS, n=162). Fewer patients had 
complications after introduction of MOTS (56 vs 72 %, p=0.002. There was a trend of higher 
1-year mortality after the introduction of MOTS (33 vs 18 %, p=0.16). There was no 
difference in waiting time for surgery (1.4 vs 1.5 days, p=0.62) or LOS (7 vs 8.4, p=0.50).  
My comment: It is not clear whether the medical input was given by geriatricians, although 
the authors describe a multidisciplinary approach to the patients.   
55 
Table 7. Overview of studies evaluating an orthogeriatric model in accordance with Kammerlander model 4 
Study Number 
of patients 
Study design Timing and 
organization of 
follow up 
controls 
Evaluation Conclusion 
Lundström, 
1999. 
Sweden 
N=49 Prospective 
with 
retrospective 
controls 
6 months. 
Interviews with 
patients and 
caregivers.  
Delirium, 
LOS, mobility 
Compared to 35 patients included in a 
study conducted at the same hospital 
from April 1983 to May 1984, did more 
patients return to independent living on 
discharge (93 vs 33%, p=0.02), and 
more could walk independently with 
walking aids at discharge (89 v 60 %, 
p=0.003) after implementation of the 
new model. There was also a non-
significant reduction of postoperative 
delirium (27 % vs 43 %, p=0.13). There 
was no difference in patients living 
independently 6 months after surgery 
(80 vs 85 %, p=0.62). The LOS was 13 
days in both groups. 
Khasraghi, 
2005. USA 
N=510 Retrospective 
before and 
after chart 
review 
No follow up LOS, waiting 
time for 
surgery, 
complications, 
discharge 
destinations 
Postoperative complications were 
significantly reduced after the 
introduction of HFS (51 vs 36 %,). 
Waiting time for surgery (46 vs 26 
hours) and LOS (8.1 vs 5.7 days) were 
also significantly reduced and 
significantly fewer were discharged to 
nursing homes (23 vs 13 %). 
Friedman 
2008, 2009. 
Kates 2010, 
2011.  USA 
N=314 Retrospective 
chart review. 
Data 
compared to 
other 
hospitals, 
historical data 
and national 
average.   
No follow up. 
30 days re-
admissions 
registered.  
LOS, waiting 
time for 
surgery, 
mortality, re 
admissions 
Those treated in GFC had shorter 
waiting time for surgery (24 vs 37 
hours, p=0.007), shorter LOS (4.6 vs 
8.3 days, p<0.001) and fewer 
complications 31 vs 46 %, p=0.005) 
compared to patients treated at a nearby 
hospital without orthogeriatric service.  
There was no difference in in hospital 
mortality or re-admissions the first 30 
days after surgery.  
González-
Montalvo, 
2010 
N=224 Prospective 
quasi-
randomization 
(alternate days 
an bed-
availability) 
No follow up.  LOS, waiting 
time for 
surgery, 
mobility at 
discharge, 
discharge 
destination.  
Waiting time for surgery (5 vs 6 days, 
p<0.001) and LOS (12 vs 18 days, 
p<0.001) was shorter in Model 2.  
There was no difference in in-hospital 
mortality, discharge destinations or 
mobility at discharge.  
Dy, 2012. 
USA.  
N=306.  Retrospective 
chart review 
before after 
No follow up. 
Readmissions 
and mortality 3 
and 12 months 
after surgery is 
reported.  
LOS, waiting 
time for 
surgery, 
mortality, 
complications  
Fewer patients had complications after 
introduction of MOTS (56 vs 72 %, 
p=0.002. There was a trend of higher 1-
year mortality after the introduction of 
MOTS (33 vs 18 %, p=0.16). There was 
no difference in waiting time for 
surgery (1.4 vs 1.5 days, p=0.62) or 
LOS (7 vs 8.4, p=0.50). 
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 Which orthogeriatric model is most effective? 1.2.3
There are considerable methodological problems with most of the published studies. The most 
serious is the use of historical controls. Such design has been criticized because medical and 
surgical improvements can impact results, and it is therefore impossible to judge how much of 
the improvements can be explained by the orthogeriatric service(Koval, 2006).  
Another problem is that most studies evaluate the effect of the orthogeriatric model only by 
register data; LOS, waiting time for surgery and mortality is the most used indicators. 
Although important, these do not necessarily catch the potential benefits (or harms) of an 
orthogeriatric approach. Most studies have no follow up visits, so it is not possible to say if 
the effect of the intervention lasted (or first appeared) after discharge. Of all the studies 
identified in the previous chapter, outcomes after follow up (other than re-admission and 
mortality) was only reported in 11 (Leung et al., 2011, Deschodt et al., 2011, Shyu et al., 
2010, Naglie et al., 2002, Koval et al., 2004, Vidan et al., 2005, Barone et al., 2006, Stenvall 
et al., 2007, Swanson et al., 1998, Lundstrom et al., 1999, Sletvold et al., 2011). Of these, two 
studies use data from regular outpatient visits(Swanson et al., 1998, Leung et al., 2011). In 
five other studies, follow up data were collected by (telephone) interview with patients and/or 
careers (Barone et al., 2006, Deschodt et al., 2011, Koval et al., 2004, Naglie et al., 2002, 
Lundstrom et al., 1999). Only four studies describe a face-to-face evaluation of the 
patients(Shyu et al., 2010, Stenvall et al., 2007, Vidan et al., 2005, Sletvold et al., 2011).  
A third important point is that in most studies, the intervention started postoperatively; a 
paradox since geriatric input might be especially beneficial in the vulnerable period from 
fracture to surgery. A recently published metaanalysis focusing on early orthogeriatric 
treatment(Buecking et al., 2013) identified only five RCTs of orthogeriatric care were there 
was any form of preoperatively intervention(Naglie et al., 2002, Stenvall et al., 2007, Shyu et 
al., 2010, Vidan et al., 2005, Uy et al., 2008). The metaanalysis concluded that there was a 
trend towards improved outcomes in early orthogeriatric intervention programs, but the small 
number of included patients (n=970 in total), did not allow this benefit to be demonstrated 
with certainty. It has to be mentioned that among the studies included in the meta analysis is 
no preoperative intervention described in the study from Canada(Naglie et al., 2002). In the 
Swedish study was the randomization procedure carried out preoperatively, but the 
intervention started after surgery(Stenvall et al., 2007).  Also in the Spanish study (Vidan et 
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al., 2005), it is likely that many patients had already undergone surgery before inclusion, since 
the patients were included and randomized after an initial screening that was performed 
within 48 hours of admission. Lastly it must be noticed that inclusion in the Australian trial 
(Uy et al., 2008) was terminated after inclusion of only 11 patients due to changes in 
Australian health care politics creating financial incentives to have only immobile patients to 
nursing homes, making it impossible to recruit patients (for this reason it is not discussed in 
the previous chapter). So studies where there is any substantial preoperative input is even 
scarcer than indicated by the metaanalysis.  
Patients with dementia are often excluded from hip fracture trails(Hebert-Davies et al., 2012), 
but such patients constitute a huge part of the hip fracture population. One can speculate if 
these particular frail patients would benefit most from geriatric interventions, but even in 
studies of orthogeriatric care such patients are sometimes excluded (Shyu et al., 2010, Koval 
et al., 2004, Swanson et al., 1998).  
Even with all these limitations, the overall conclusion from the literature is that elderly 
patients with hip fractures benefit from orthogeriatric care. This is also supported by a 
Cochrane review on “Multidisciplinary rehabilitation for older people with hip fractures”, 
where there was a trend of lower risk of poor outcome for patients treated with 
multidisciplinary rehabilitation compared to usual care poor outcome (risk ratio 0.89; 95% 
confidence interval 0.78 to 1.01)(Handoll et al., 2009).  
It is, however, difficult to draw firm conclusions regarding the superiority of one particular 
model due to heterogeneity of the organization of care in the different models as well as in the 
research design. Only in one of the reviews of orthogeriatric care (Grigoryan et al., 2014) did 
the authors pool data, and the conclusion was that co-managed care in an integrated model 
seemed to give best results. This was also the conclusion in the other three reviews. To 
facilitate the comparison of different models in the future, an expert panel have recently 
published an article where a set of outcome indicators are identified to be included in the 
evaluation of orthogeriatric models(Liem et al., 2013).  
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 Orthogeriatric models at Oslo University hospital - Ullevaal 1.2.4
The last two decades have different models of orthogeriatric care been in use at Oslo 
University Hospital - Ullevaal.  
1997 - 2002 HOBRUS: postoperative rehabilitation in the geriatric ward 
This was the first model where the Department of Orthopedic Surgery and Department of 
Geriatric Medicine started to collaborate in the treatment of hip fracture patients. From the 
autumn 1997 was a model implemented where patients were transferred to the geriatric ward 
five days after surgery. A nurse was assigned to assess which patients were most likely to 
profit from such rehabilitation. This model was not scientifically evaluated, but in a report 
written for the hospital administration it is concluded that this model functioned satisfactory 
and that the quality of care had been improved. Total LOS in the hospital was reduced by 25 
% after implementation of the model.  
March 2004 - December 2006:  “Eldre med brudd” (Kammerlander model 2) 
“Eldre med brudd” (“Elderly with fractures”) was a project carried out in collaboration 
between Department of Orthopedic Surgery and Department of Geriatric Medicine. In this 
model, 10 beds in the orthopedic ward were reserved for elderly patients with fractures (not 
only hip fractures). A geriatric team (geriatrician, nurse and physiotherapist) assessed the 
patients daily, and had the day to day responsibility for the patients. The team was not 
available in the evenings or in the weekends. This is in line with a Kammerlander model 2.  
This model was also not scientifically tested, but the conclusion from the health care 
personnel involved was that this model improved quality of care. It was, however, 
acknowledged as a problem that there was a geriatric service only at daytime. In the 
termination of the project the plan was to make a joint effort to establish a separate 
orthogeriatric unit with shared care (in line with Kammerlander model 4). Due to 
administrative challenges regarding financing, this was never achieved. 
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June 2008 - January 2012: Hip fracture patients in the acute geriatric ward 
(Kammerlander model 3) 
In connection with a re-organization of the acute geriatric ward in 2008, it was decided that 
four beds should be reserved for hip fracture patients. The patients were admitted to the ward 
directly from the ER and the geriatricians had the primary medical responsibility for the 
patients the entire stay. This is in line with Kammerlander model 3. The allocation to the 
acute geriatric ward was based primarily on availability of beds. The new service had capacity 
to serve approximately half of the hip fractures admitted to the hospital, and it was thus 
decided to randomly allocate patients to the acute geriatric ward and the orthopedic ward in 
order to evaluate the new service in an RCT. The first patient was included in the RCT in 
September 2009, and this serve as the foundation for this PhD.  
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2 Aims of the study 
Based on the knowledge gaps regarding delirium prognosis, delirium pathophysiology and the 
impact on delirium by different models of care, three main aims emerged for this thesis: 
I. To investigate the effect of delirium on cognitive trajectories (paper I) 
II. To evaluate the effect of the orthogeriatric model (Kammerlander model 3) in use at Oslo
University hospital - Ullevaal from June 2008 to January 2012 (paper II) 
III. To explore pathophysiological mechanisms in delirium (paper III and IV)
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3 Patients and methods 
 Participants 3.1
The patients came from four different patient samples (flowchart). For patients included in the 
RCT (paper II, sample 1), I had the daily responsibility for running the study and collecting 
data. I was also involved in planning and organization of the inclusion and data collection in 
sample 4. I have not been involved in collection or planning of sample 2 and sample 3. This 
chapter will describe the different patient samples. Most details will be given for sample 1.   
Sample 1(Watne): 329 hip fracture patients were included between September 2009 and 
January 2012 at Oslo University Hospital, Ullevaal. Inclusion and randomisation took place in 
the ER by the orthopaedic surgeon on call.  Patients were randomised to treatment and care in 
an acute geriatric ward or standard orthopaedic ward. The patients had their entire hospital 
stay in the same ward except for surgery and a few hours in the postoperative care unit.  The 
patients were assessed four and twelve months after surgery by research nurses blinded to 
allocation. The main objective of the study was to evaluate the orthogeriatric service in use at 
the hospital from June 2008 to January 2012. CSF was collected from 143 patients at the 
onset of anesthesia, and has been analyzed in order to investigate pathophysiological 
mechanisms in delirium.  
Sample 2 (Juliebø/Krogseth): 364 hip fracture patients were included between September 
2005 and December 2006 at Oslo University Hospital, Ullevaal and Diakonhjemmet Hospital 
in Oslo. A research team of two researchers and three study nurses performed daily reviews of 
the patient registries to identify patients with hip fracture. Eligible patients were included 
within 48 hours of admission. The main objective was to prospectively investigate the 
prevalence of pre- and postoperative delirium, and to identify important risk factors(Juliebo et 
al., 2009). One-hundred-seventy-four of the included patients were assessed six months after 
surgery by a physician (Maria Krogseth) blinded to delirium status, in order to explore the 
effect of delirium in patients with (paper I) and without prefracture cognitive 
impairment(Krogseth et al., 2011).  
Sample 3 (Hall): 108 hip fracture patients were included at the Royal Infirmary, Edinburgh, 
Scotland from September 9, 2009 to April 27, 2011. The patients were included in the 
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Orthopedic Unit by a geriatrician (Roanna Hall). The patients were closely monitored for 
delirium during a two-week perioperative period, and assessed 3, 6 and 12 months after 
surgery. CSF was collected at the onset of anesthesia, and the main objective was to assess the 
role of cortisol and inflammation in delirium. The study design was similar to the RCT 
(Sample 1), with the same measurements of prefracture cognitive status (IQCODE) and 
delirium (CAM). Data from Oslo and Edinburgh could therefore be pooled (paper III and IV).  
Sample 4 (Idland): 155 Patients above 65 years of age scheduled for elective orthopedic, 
gynecologic or urologic surgery in spinal anesthesia were recruited at three different hospitals 
in Oslo between February 2012 and June 2013 (Oslo University Hospital - Aker, Oslo 
University Hospital - Ullevaal, Diakonhjemmet hospital). The patients were thoroughly 
cognitively tested some days before surgery and CSF was collected at the onset of spinal 
anesthesia. The patients will be followed up with cognitive tests once a year for five years. 
The main objective with this study was to collect serum and CSF from cognitively healthy 
elderly patients that can serve as a reference material for studies on delirium and dementia 
pathology.  
The selection of patients in the different studies was as follow: 
Paper I: This study included hip fracture patients from sample 1 and sample 2. Only patients 
with a prefracture IQCODE ≥ 3.44 were included, n=287.  
Paper II: This study included all patients in the RCT (sample 1), n=329 
Paper III: This study included hip fracture patients from Oslo (sample 1, n=99) and 
Edinburgh (sample 3, n=52) with an available CSF and serum sample by May 2011.  
Paper IV: This study included hip fracture patients from Oslo (sample 1, n=85) and 
Edinburgh (sample 3, n=54) with CSF and preoperative serum samples available. CSF 
samples from 24 randomly selected healthy controls (sample 4) were also included.  
See figure 2 for details regarding selection of patients in the different papers.  
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Figure 2. Selection of patients in the different papers. 
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 Assessments  3.2
Table 8 gives an overview of assessments and timing of assessments in the different patient 
samples. The following sections will give a detailed description of those used in sample 1.  
 Assessment methods 3.2.1
Screening for delirium: All patients were screened once daily for delirium with the 
CAM(Inouye et al., 1990) preoperatively and until the fifth postoperative day (all) or until 
discharge (delirious patients). The study physician or a study nurse (Elisabeth Fragaat (EF) 
from Sept 2009 to May 2010, Tone Fredriksen (TF) from May 2010 to January 2012) did all 
the assessments. The inter-rater agreement between the geriatrician and each of the two study 
nurses was assessed in 13 (LOW and EF) and 23 (LOW and TF) patients, respectively, 
showing excellent agreement in distinguishing delirious from non-delirious patients (both 
showing kappa = 1), and good agreement in distinguishing subsyndromal delirium from 
patients with no signs of delirium (kappa = 0.65 for LOW and EF and kappa = 0.79 for LOW 
and TF). If the nurse was unsure about the diagnosis, the study physician was consulted. The 
CAM score was based on information from nurses, close relatives and hospital records 
reporting symptoms the last 24 hours, in combination with a 10 - 30 minutes interview with 
the patients. Tests of cognition, attention and alertness in the delirium assessments were: Digit 
span forward and backward and orientation and delayed recall from the Memorial Delirium 
Assessment Scale (MDAS) (Breitbart et al., 1997). Delirium severity was measured with 
MDAS. Patients were regularly assessed on weekdays only, but staff members that had been 
working during weekends were interviewed every Monday and the case notes scrutinised in 
order to reveal potential episodes of delirium. The mean number of delirium assessments 
during the stay was 5.7 (SD 2.7).  
Biomedical factors: Diagnosis was collected from previous medical records, and the Charlson 
Comorbidity Index(Charlson et al., 1987) was calculated. The American Society of 
Anesthesiologists (ASA) score was collected from the anesthesiology records, and type of 
fracture and surgery was collected from the surgery records. Height was calculated using 
knee-heel length (Chumlea et al., 1998) and the patients were weighed by a chair scale. BMI 
was calculated. At the follow up controls, height was measured in those able to stand, and 
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knee-heel length in all. Weight at follow-up controls was assessed by a standing scale that 
was calibrated to the chair scale used during hospital stay.  
Process of care: Waiting time for surgery was calculated as time from admission in the ER to 
start of anesthesia. Mobilization after surgery was used as a process measure. This was 
registered the second day after surgery based on case notes and observations. From September 
2011, mobilization and walking was also recorded with the activPAL™ body-worn sensor 
system(Grant et al., 2006). The sensor was attached on the anterior aspect of the non-affected 
thigh as soon as possible after surgery and was worn until discharge.  
Clinical findings: Blood pressure (BP), temperature, oxygen saturation and ECG at admission 
and postoperatively was collected from hospital records. The Acute Physiology and Chronic 
Health Evaluation II (APACHE II)(Knaus et al., 1985) score on admission to hospital was 
calculated as a measure of physiological disturbance, though without information on arterial 
blood gases and hematocrit. Length of anesthesia and surgery and the lowest BP during 
surgery was registered.  
Medications: Medications the patients used at admission, discharge and the follow up controls 
were registered. During the hospital stay the daily use of medications in addition to the 
regular was registered. Medications given in the operating theater were also registered. The 
anticholinergic drug burden of regular medications registered on admission was calculated 
using the Anticholinergic Cognitive Burden (ACB) scale (Boustani et al., 2008).  
Cognitive status: Prefracture cognitive status was estimated with the Informant Questionnaire 
on Cognitive Decline in the Elderly (IQCODE). 3.44 was used as a cutoff for probable 
cognitive impairment(Jorm, 2004, Jorm, 1994).  
At the follow up controls, cognitive function was assessed with several measures. The two 
included in the primary endpoint in the RCT were the 10 words test from Consortium to 
Establish a Registry for Alzheimer’s disease battery (CERAD)(Welsh et al., 1994) and The 
Clinical Dementia Rating scale (CDR)(Hughes et al., 1982). CERAD is a memory test in 
which patients are asked to recall 10 words after having them presented orally or visually. We 
used the immediate and delayed recall tasks of the test. This test is shown to be sensitive for 
memory changes in persons with good cognitive functioning(Karrasch et al., 2005). CDR is 
based on information from the best available sources as a combination of patient and proxy 
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information and is sensitive for cognitive changes in patients with dementia. We used the 
“sum of boxes” scoring adding up to a sum score ranging from zero (no dementia symptoms) 
to 18 (severe dementia). The sum score is in most studies shown to correlate highly with the 
original categorical score of zero to three(Barca et al., 2010).  
Other tests of cognition at follow up were the MMSE(Folstein et al., 1975), clock drawing 
test(Shulman, 2000), and the IQCODE. At the four months control we used a modified 
version of the IQCODE where the relatives were asked for changes since just before the 
fracture. At the 12 months control we used the regular version of IQCODE.  
One specialist in geriatric medicine (Professor Torgeir Wyller) and one specialist in old age 
psychiatry (Professor Knut Engedal) assessed whether the patients fulfilled the ICD-10 
criteria for dementia at baseline and 12 months after surgery. The assessors had access to all 
clinical data, but were blinded to allocation and to delirium status during hospital stay. They 
first classified all patients independently. The inter-rater agreement upon the dementia 
diagnosis was satisfactory (kappa 0.87 at baseline and 0.83 at 12 months). Cases with 
disagreement were discussed until a consensus was reached. 
ADL-functions: Proxies were interviewed regarding pre-fracture activities in daily living 
function (Barthel ADL Index (BADL)(Wade, 1992) and Nottingham Extended ADL Index 
(NEADL)(Gladman et al., 1993). The proxies were asked to describe the condition of the 
patients 14 days prior to the fracture in order to tap the function in a stable clinical phase. 
Proxies were also interviewed the follow up controls, using the same scoring systems as 
during hospital stay. 
Physical function: Hand Grip Strength was examined by hand dynamometry (Jamar, 
Germany, three repetitions per examination) daily throughout the duration of the hospital stay 
and at the follow up controls.  The Short Physical Performance Battery (SPPB)(Guralnik et 
al., 2000) was used to assess mobility at follow up controls. SPPB consists of three parts: a 
test of balance, a test of walking speed, and a test of the ability to rise from a chair. The 
maximum score is 12 points, and a difference of 0.5 is considered clinically meaningful.  
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Table 8. Overview of assessments and timing of assessments in the different patient samples 
Index stay Follow up 
controls 
Domain Test/variable S1 S2 S3 S4 S1 S2 S3 S4 
Cognition IQCODE 
CDR 
MMSE 
Clock drawing test 
CERAD 10 word test 
Kendrick OLT 
Trailmaking A and B 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x x 
x 
x 
x 
x 
Delirium CAM 
MDAS 
DRS-98 
Edinburgh Delirium Test Box 1 
x 
x 
x 
x 
x 
x 
x 
x x x 
x 
x 
ADL function BADL 
Katz 
Lawton 
NEADL 
x 
x 
x 
x 
x 
x x 
x 
x 
x 
x 
x 
x 
Depression Cornell 
Geriatric Depression Scale 
MADRS 
x x 
x 
x 
x 
Clinical data ASA 
APACHE II 
ECG 
Weight, height 
CCI 
Medication 
Surgical and anesthesiological procedures 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x x x 
x 
x 
Physical function SPPB 
Active PAL 
Hand-dynamometry 
x 
x x x 
x 
x 
Biological material CSF 
Blood 
x 
x x 
x 
x 
x 
x x x 
Sample 1 (S1): Watne. Followed up after 4 and 12 months 
Sample 2 (S2): Juliebo/Krogseth. Followed up after 6 months 
Sample 3 (S3): Hall. Followed up after 1,6 and 12 months. In addition to MMSE were several other cognitive 
tests included at the follow up controls.    
Sample 4 (S4): Idland.  Followed up after 1,2,3,4 and 5 years 
 Timing of assessments  3.2.2
During the hospital stay, all patients in the RCT were assessed daily (weekdays) 
preoperatively and until the fifth postoperative day. Patients with delirium were followed 
daily until resolution of delirium or discharge from the hospital.  
Follow up visits in the RCT were carried out by research nurses four and twelve months after 
surgery (with a time window of ± three weeks). The patients were most often assessed where 
they were living, but a few preferred to be assessed at our out patient clinic at the hospital. A 
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follow-up control typically lasted between two and three hours, and the evaluators started the 
assessment with the cognitive tests of the primary endpoint.  
At each follow-up, proxies were interviewed regarding ADL- and cognitive function. Patients 
and proxies were asked for re-admissions since surgery.  
See table 8 for timing of assessments in sample 2 - 4.  
 Blinding of evaluators in the RCT 3.2.3
The follow up visits were done by research nurses blinded to allocation and to all clinical data 
during hospital stay. The research nurses registered cases in which they had become 
unblinded, for instance because patients or relatives disclosed the allocation. This happened in 
5-10% of the cases.  
Data collection during hospital stay could not be done blinded, since the patients were 
assessed in the ward they were allocated to.  
 Collection and handling of biological samples.  3.3
Laboratory procedures 
Blood from patients included in the RCT was collected pre- and postoperatively and at four 
and 12 months after surgery. Serum, plasma, EDTA and Pax Gene (only post operatively) 
were collected. After sampling, the serum tubules were left in the vertical position for 30 
minutes at room temperature for clotting, before they were centrifuged. Plasma was 
centrifuged immediately. Aliquots of 500 microliters were then stored at -80 degrees C in 
polypropylene tubes. CSF was collected at the onset of spinal anesthesia before 
administration of the anesthetic agent. Up to 4 ml was collected in polypropylene tubes. The 
CSF was centrifuged within four hours and the supernatant was stored in aliquots of 100 – 
1000 microliters at – 80 degrees C.  
Similar procedures were used for collection and handling of CSF and blood also in sample 3 
and sample 4.  
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 Anticholinergic activity (AA) 3.3.1
AA in serum and CSF was determined by a modified version of the muscarinic radio receptor 
bioassay developed by Tune and Coyle (Tune and Coyle, 1980, Jakobsen et al., 2011).  
Samples of 20 microliters were applied in 96 well plates for high throughput analysis of AA.  
Atropine was used as a reference, and AA was reported in atropine equivalents (pmol/mL).  
Samples from Edinburgh were transported to Oslo on dry ice. All serum and CSF samples 
from Oslo and Edinburgh were analyzed at the University of Oslo using the same assay by the 
same method operator (blinded to all clinical data) within one laboratory sequence. The 
validation parameters of the bioassay showed good reproducibility with coefficients of 
variation less than 30 % for the estimated binding/displacement constants of repeated atropine 
calibration curves.  
 Measurement of neopterin 3.3.2
For measurement of neopterin were samples of serum and CSF from Oslo and Edinburgh sent 
to Dr Durk Fekkes at Erasmus MC, Rotterdam, The Netherlands. The samples were 
transported frozen on dry ice. Neopterin in serum and CSF were measured with high 
performance liquid chromatography with acid oxidation. Neopterin and dihydroneopterin 
were measured together as described earlier(Van Gool et al., 2003). The analyses were done 
blinded to all clinical data.  
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 Inclusion and randomization in the RCT 3.4
Patients enrolled in the RCT (sample 1) were included and randomized by the orthopedic 
surgeon on call in the emergency room at Oslo University Hospital - Ullevaal. All patients 
with a hip fracture (a femoral neck fracture, a trochanteric or a sub-trochanteric fracture) were 
eligible for inclusion. Patients from nursing homes and patients with dementia could also be 
included as we believed that an orthogeriatric intervention could be of particular importance 
to the frailest patients. Patients were excluded if the hip fracture was a part of a high energy 
trauma (defined as a fall from higher than one meter) or if they were moribund at admittance. 
There was no exclusion criteria related to age. We believed that most of the younger hip 
fracture patients (below 70 years) would have suffered a high energy trauma, and thus were 
excluded. The small number of patients of this age that suffer a hip fracture from a low energy 
trauma can be expected to be frail and could thus potentially benefit from an orthogeriatric 
service. 
The randomization was based on computer-generated random numbers, and carried out by a 
statistician (ES) without any contact with the patients or the personnel involved in the 
inclusion. We used block randomization (blocks of variable and unknown size) to ensure an 
equal group size. The randomization was stratified with respect to whether or not the patient 
was admitted from a nursing home, in order to get the groups balanced regarding pre-fracture 
frailty and cognitive decline. The allocation of each patient (orthogeriatric or orthopedic care) 
was by sealed, opaque, numbered envelopes that were held in the Emergency Department 
(different colors for the two stratification groups). Consent and inclusion procedures were 
carried out by the orthopedic surgeons on call in the emergency room.  
In order to enhance the awareness of the study in the ER, the study physician on several 
occasions taught the personal in the ER about delirium, and gave updates regarding inclusion 
rates in the trial. The same was done for the orthopedic surgeons. The study physician hold 
track of which surgeon that included which patients, and at regular intervals prizes were given 
to the surgeon that had included most patients. Similar rewards were given to the 
anesthesiologists who collected CSF samples. The study physician or study nurse checked 
everyday that the envelope with the lowest number was taken. At 13 occasions occurred an 
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error which a randomization envelope was opened, but the patient was nevertheless not 
included.  
The reasons were as follows: 
• Included in the study before (previous fracture) - 6
• Randomized in a period where the geriatric ward was closed due to outbreak of
gastroenteritis - 3 
• Wrong diagnosis (patient had no hip fracture) - 2
• Patient sent to another hospital from the ER - 1
• Initially opened envelope from the wrong stratum (stratified whether or not the patients lived
in nursing homes), error discovered immediately and new envelope opened - 1. 
These patients were not included (except for the first six who already had been included 
earlier and the last one who was included based on the secondly drawn envelope), no data was 
registered from these hospital stays, and they were not further analyzed. Thus, 13 more 
envelopes were opened than the number of included patients. That 13 errors occurred during 
the inclusion period, must been interpreted in the light of an inclusion period of more than 
two years with a 24/7 inclusion procedure and a high number of surgeons involved.  
 Intervention in the RCT 3.5
The intervention for the patients randomized to the acute geriatric ward included medication 
reviews, early and intensive mobilization, optimizing pre- and postoperative nutrition and 
early discharge planning. A key element of the intervention was a Comprehensive Geriatric 
Assessment (CGA) as a basis for the planning of treatment. All team members (geriatrician, 
nurse, physiotherapist and occupational therapist) were expected to assess patients during 
their first day on the ward, and the team had daily meetings to co-ordinate treatment and to 
plan discharge. Clinical routines were developed based on literature search, experience from 
earlier orthogeriatric models and the pilot phase prior to start of randomization. Checklists 
were printed out and made immediately available for the treatment team for each patient.  
Details about the intervention are described in a separate publication(Wyller et al., 2012). 
72 
 Statistics 3.6
All statistical analyses were performed using IBM SPSS Statistics version 18 - 20, except for 
median differences and corresponding 95% confidence intervals in the RCT (paper II) that 
were estimated by the Hodges Lehmann estimator using StatXact 8.0. 
 Comparing groups (paper I-IV) 3.6.1
Categorical variables were analysed by Chi-square test. Continues variables were analysed by 
Mann-Whitney tests and t-tests depending on data distribution.  
 Linear regression (paper I and II)  3.6.2
Linear regression explores the effect of different independent variables on one continuous 
outcome variable. In paper I was linear regression used to assess what variables could predict 
the modified IQCODE score at follow up. Since the outcome had to be interpreted in the light 
of pre-fracture IQCODE score, we adjusted for pre-fracture IQCODE score in the analysis. 
The inclusion of other covariates was based on a p-value < 0.1 in univariate analyses.  
Regarding the trajectories of the MMSE, we set the date of follow-up as time zero, and 
counted the time backwards to the points of the pre-fracture MMSE tests. We used a linear 
regression analysis to calculate the slope of each patient's change in the MMSE scores over 
time. The regression coefficient of these analyses represents change in the MMSE by time 
measured in years. These slopes were not normally distributed, and a Mann-Whitney test was 
used to calculate whether the regression coefficients differed between the patients with and 
without delirium. 
In paper II was it already in the protocol (Wyller et al., 2012)and the SAP(Wyller et al.) 
established that we should perform a linear regression to adjust for any inequality in the 
distribution of important prognostic variables between the intervention and control group. 
Regardless of the effect of the intervention it would be clinically relevant to perform such an 
analysis in order to explore what variables could predict cognitive performance at the follow-
up controls.  
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Although data was not presented in the paper, linear regression was also used in paper III to 
assess the effect of center on serum AA (see section 6.3.1 for details).  
 Logistic regression (paper III and IV) 3.6.3
Logistic regression is useful to explore the effect of different prognostic variables when the 
outcome variable of interest is categorical, most often binary. In clinical research this is often 
presence or absence of a condition, i.e. mortality, cancer or delirium(Altman, 1991).   
In paper III, logistic regression was used to assess the relationship between AA and delirium 
when adjusting for other covariates. We performed two separate logistic analyses, one with 
serum AA and one with CSF AA as covariates, and both using ‘delirium any time’ as the 
outcome variable (only the table for CSF AA is shown in the paper). The analyses were 
performed on pooled data with samples both from Oslo and Edinburgh. The inclusion of other 
covariates was based on a p-value < 0.1 in univariate analyses. CSF AA and center were 
forced into the final model.  
A similar strategy was used in paper IV to assess the relationship between delirium and 
neopterin in serum and CSF.  The inclusion of other covariates was based on a p-value < 0.1 
in univariate analyses. All analyses were on pooled data from both centers. There was a near 
linear relationship between delirium and neopterin levels in serum. For CSF neopterin levels 
there was a “cutoff” at the 75th percentile with a steep rise in delirium rates above this 
“threshold”. In the logistic regression analysis, serum neopterin was therefore used as a 
continuous variable, whereas CSF neopterin was dichotomized at the 75th percentile.  
 Construction of the composite endpoint in the RCT 3.6.4
The primary outcome was cognitive function four months after surgery, and we expected that 
included patients would perform within a wide range; from severe dementia to no signs of 
cognitive impairment. To be able to measure differences in both the higher and the lower 
spectrum of cognitive function, we combined two scales: The 10 words test from CERAD and 
the CDR. To construct a combined endpoint, we normalized these scales into a 0 - 100 
scoring (CDR had to be reversed since it is scaled in the opposite direction). CDR weighed 50 
% and the immediate and delayed recall parts of the 10 word test weighed 25 % each in the 
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combined measure. Thus, higher score on the primary endpoint means better cognitive 
performance.  
 Statistical analysis plan (SAP) and blinding of analyses in the RCT 3.6.5
A statistical analysis plan was developed (and published online) prior to un-blinding of the 
data(Wyller et al.).  Pre-planned subgroup analyses were done for patients admitted from 
nursing homes or not, and patients with and without pre-fracture dementia. The primary 
analysis was carried out by a statistician (ES) blind to allocation.  
 Ethical considerations 3.7
The study was conducted in accordance with the Declaration of Helsinki. Informed consent 
was obtained from the patients or substitute decision-makers if patients did not have capacity 
to consent. The study was approved by the Regional Committee for Ethics in Medical 
Research in Norway (REK S-09169a) and the Data Protection Officer at Oslo University 
Hospital (Ref. 1361). 
Inclusion in the RCT was not considered to have any substantial harmful effects. Most 
patients and their relatives were positive for an opportunity of an admission to the acute 
geriatric ward. Those patients that refused to participate in the study were younger those 
included (median 81 versus 85 years; P ≤0.001). Several of those who refused explained that 
they felt much too vigorous to fit in a geriatric ward and considered it an unattractive scenario 
to be admitted there.    
Cognitively intact patients were included on the basis of written, informed consent. We 
developed a full information leaflet for cognitively intact patients and a simplified and 
shortened one for patients with somewhat reduced competence. When the latter version was 
used, a close relative received the full version of the patient information. Those who were 
totally unable to give a valid informed consent were included on the basis of assent from the 
nearest relative. Since the relatives often were difficult to reach while the patients were in the 
ER, some patients could not be included in the trial. After some weeks, we therefore were 
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allowed by REK to also include such patients in the ER, and obtain assent from the relatives 
afterwards.  
A high proportion of hip fracture patients is either demented or delirious (or both) on 
admittance. These groups are presumed to be more vulnerable to the quality of hospital care 
than those cognitively intact, and thus important to include in studies of this kind.  
76 
4 Main results 
Of 466 eligible patients admitted to Oslo University Hospital - Ullevaal between September 
2009 and January 2012, were 329 included in the RCT (see figure 4 for a flowchart of 
patients). Non-included patients were younger than included patients (median 81 v 85 years; p 
≤ 0.001) and more of them were men (35.3 % v 25.1 %, p=0.01). Half of the included patients 
were considered to have dementia, and one third was living in nursing homes. Patients 
randomized to the intervention group and the control group were well matched in all 
important baseline variables. In total 35 patients (11 %) were lost to the follow up control 
after four months (and thus the primary endpoint in the RCT), 14 from the intervention group 
and 21 from the control group (p=0.23). Of patients lost to the four months follow up control, 
only 2 (7 %) were living in a nursing home before the fracture, compared to 73 (30 %) of 
patients tested (p=0.002). Patients lost to follow up were younger (median age 83 v 85; 
p=0.19) and fewer were considered having dementia before the fracture (12/35 (34%) v 
112/242 (46%), p=0.18), these differences were, however, not significant. The last twelve 
months follow up control was done in December 2012. 
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 Delirium superimposed on dementia (paper I) 4.1
Results: 201 of the 287 patients developed delirium in the acute phase. Using linear 
regression, delirium was a significant predictor of a more prominent cognitive decline at 
follow-up measured by the IQCODE-SF questionnaire (p=0.002). Among patients having a 
pre-fracture MMSE score, the patients developing delirium had a median (IQR) yearly 
decline on the MMSE of 2.4 points (1.1-3.9), compared to 1.0 points (0-1.9) in the group 
without delirium (p=0.001, Mann-Whitney test). 
Conclusions: Hip fracture patients with pre-fracture dementia run a high risk of developing 
delirium. Delirium superimposed on dementia is a significant predictor of further cognitive 
decline measured by the IQCODE-SF questionnaire, as well as by the MMSE in a subgroup 
of our patients.    
78 
 The effect of orthogeriatrics on cognitive function 4.2
(paper II) 
Results: 329 patients were included. There was no significant difference in cognitive function 
four months after surgery between patients treated in the acute geriatric and the orthopaedic 
ward (mean 54.7 v 52.9, 95 % confidence interval for the difference -5.9 to 9.5;  p=0.65). 
There was also no significant difference in delirium rates (49 % v 53 %, p=0.51) or four 
month mortality (17 % v 15 %, p=0.50) between the intervention and the control group.  In a 
pre-planned sub-group analysis, participants living in their own home at baseline who were 
randomised to orthogeriatric care had better mobility four months after surgery compared 
with patients randomised to the orthopaedic ward, measured with SPPB (median 6 v 4, 95 % 
confidence interval for the median difference 0 to 2; p=0.04).  
Conclusion: Pre- and postoperative orthogeriatric care given in an acute geriatric ward was 
not effective in reducing delirium or long-term cognitive impairment in patients with hip 
fracture. The intervention had, however, a positive effect on mobility in patients not admitted 
from nursing homes. 
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 Delirium pathophysiology (paper III, paper IV) 4.3
Paper III: Anticholinergic activity in CSF and serum in hip fracture patients with and 
without delirium 
Results: Fifty-two (54 %) of the patients in Oslo and 20 (39 %) of the patients in Edinburgh 
developed delirium. There was no statistically significant difference in AA between patients 
with and without delirium in Oslo (serum: 7.02 vs 6.08 pmol/mL, p=0.54, CSF: 0.39 vs 0.48 
pmol/mL, p=0.26) or in Edinburgh (serum: 1.35 vs 1.62 pmol/mL, p=0.76, CSF: 0.36 vs 0.31 
pmol/mL, p=0.93). Neither was there any difference in SAA (Oslo p=0.74, Edinburgh 
p=0.51) nor in CSF AA (Oslo p=0.21, Edinburgh p=0.93) when patients were subdivided into 
prevalent, incident, subsyndromal and never delirium. Stratifying the patients according to 
pre-fracture cognitive status (IQCODE) gave the same results.  
Conclusion: This is the first study of AA in CSF of people with and without delirium. The 
study does not support the hypothesis that central (CSF) or peripheral (serum) AA is an 
important mechanism of delirium in hip fracture patients.   
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Paper IV: Cerebrospinal fluid levels of neopterin are elevated in delirium after hip 
fracture. A role for cellular immunity or oxidative stress? 
Results: Sixty-four (46%) of 139 hip fracture patients developed delirium during the peri-
operative period. Neopterin levels were higher in the delirium group in both serum (median 
(IQR) 37.0 (26.2 – 51.1) nmol/mL vs 27.1(22.6 – 40.7) nmol/mL, p=0.003) and in CSF 
(median (IQR) 29.6 (22.3 – 40.4) nmol/mL vs 24.7 (19.4 – 30.6) nmol/mL, p=0.003, with 
highest levels in those about to develop delirium in the post-operative period. CSF neopterin 
remained significantly associated with delirium after controlling for other risk factors using 
logistic regression analysis. Those with higher neopterin levels were more likely to have a 
poorer outcome (death or new institutionalization) at one year (CSF: median (IQR) 29.2 (22.8 
– 39.6)  nmol/L v 24.9 (19.4 – 33.2) nmol/L, p=0.02; serum: median (IQR) 37.9 (26.8 – 54.4)
nmol/L v 29.2 (23.1 – 41.7)  nmol/L, p=0.03). 
Conclusions: This study is the first to examine neopterin in CSF in delirium, and our findings 
suggest potential roles for activation of cell-mediated immune responses or oxidative stress in 
the delirium process. High levels may also be useful in predicting poor outcomes. These 
findings need to be expanded by examining other components of these pathological pathways, 
and examination in other patient groups. 
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5 Discussion 
 Effect of delirium on cognitive trajectories (paper I) 5.1
This study included only patients with pre-fracture cognitive impairment (IQCODE ≥ 3.44). 
Our findings are in support of a theory that delirium is an independent risk factor for 
acceleration of cognitive decline in patients with already established cognitive impairment.  
Only a few studies have explored the long term cognitive effects of delirium superimposed on 
dementia (Gross et al., 2012, Fong et al., 2009, Davis et al., 2012), and like in our study they 
report an acceleration of the cognitive decline. The delirium diagnosis in the earlier studies 
was, however, based on chart reviews only, a method that is reported to have low 
sensitivity(Saczynski et al., 2014). Our study is the first where the delirium diagnosis is based 
on daily evaluations of the patients with validated bed side instruments.  
In contrast to earlier studies in this field, a major methodological weakness with our study is 
the lack of a documented dementia diagnosis before the delirious episode. The use of 
IQCODE is, however, supported by validations studies(Jorm, 2004), and is commonly used as 
a measure of cognitive impairment in delirium studies. Our use of a modified IQCODE at the 
follow up controls, where the care-givers were asked for cognitive changes after the fracture 
instead of after 10 years, has not been validated and can indeed be criticized.  
In order to explore the true effect of delirium on long term cognitive trajectories, one have to 
design a prospective longitudinal study that combines a pre-delirium objective measure of 
cognition, repeated bedside delirium assessments and objective cognitive testing several 
months after the delirious episode has ended. This is an extremely demanding design, and 
such a study has not been conducted yet. Since hip fracture is an acute event, an objective 
measure of prefracture cognitive status is hard to obtain. Our strategy to overcome this 
problem was to include MMSE scores documented in patient charts before the fracture. 
Patients with delirium had a more rapid decline in MMSE scores from pre fracture to those 
collected at the follow up controls.  
Taken together, we believe that our approach gives some new information regarding cognitive 
prognosis after delirium. Both strategies gave the same result, and this support our conclusion 
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that delirium has a negative impact on long term cognition also in patients with established 
cognitive impairment.  
 Orthogeriatrics (paper II) 5.2
We found no evidence that cognitive function four months after surgery was improved in 
patients treated pre- and postoperatively in an acute geriatric ward, compared to usual care in 
an orthopaedic ward. There was, however, a trend that the intervention had a positive effect 
on mobility on patients not admitted from nursing homes.  
 Why so limited effect of our model?  5.2.1
Despite the comprehensive intervention, the effect on the primary endpoint was limited. There 
are several possible explanations for this.  First, the choice of endpoint might have been too 
audacious. For the intervention to be effective in this regard, two presuppositions had to be 
true. First, the primary outcome assumes that delirium lies on the causal pathway towards the 
development of dementia.  The major criticism against studies that implies that delirium has a 
negative impact on cognitive trajectories, is that delirium is only unmasking dementia and is 
not causing it. If this is true, one could not expect delirium prevention to have any effect on 
long term outcomes. As described earlier, a growing amount of evidence suggests that 
delirium can lead to dementia, but since delirium occurs in relation to acute illness it is 
difficult to design good prospective studies to address this very important question. 
The second presupposition was that the orthogeriatric intervention had to be effective in 
delirium prevention. Other studies have shown that geriatric intervention is effective in 
reducing delirium in hip fracture patients, also when the intervention is limited to a liaison 
service (Marcantonio et al., 2001) and an Inpatient Geriatric Consultant Team(Deschodt et al., 
2012).  Since the limited geriatric intervention given in these studies was effective in reducing 
delirium, one should expect that continuously pre- and postoperative geriatric care, as 
provided in our model, should be even more effective. Our intervention failed, however, to 
prevent delirium or reduce delirium severity. This was surprising and can in part be explained 
by the good quality of usual care in our study. Compared to other models reported in the 
literature, waiting time for surgery was short in our study. Introduction of an orthogeriatric 
service is usually reported to reduce waiting time for surgery, but in our study it was two 
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hours longer for the patients in the acute geriatric ward. This difference was not statistically 
significant, but could nevertheless have had a negative impact for patients allocated to 
intervention since waiting time for surgery is known to have a sincere negative impact on 
outcomes in hip fracture patients(Pioli et al., 2012b).   
The personnel in the orthopaedic ward had also experience from earlier orthogeriatric models 
and was familiar with usual strategies for delirium prevention (use of single rooms, adequate 
management of pain, orientation etc.). In order to obtain a precise delirium diagnosis was the 
personnel at the orthopaedic ward daily interviewed regarding cognitive changes of the 
patients, and this inevitably raised the awareness of delirium in the orthopaedic ward.   
But most importantly were several factors with the orthogeriatric model not optimal. The 
ward was often over-crowded. During the inclusion period was on average 101 % of the beds 
occupied. This means that usually there were more patients in the ward than it had capacity to 
serve so patients had to be treated in the corridor. In order to avoid randomization violations, 
was the ward was instructed (and managed!) to admit all randomized hip fracture patients. 
Since patients tend to come in clusters, there were times when several patients had to be 
treated in the corridor, and the work load was too large to handle and it inevitably influenced 
quality of care. The orthopaedic ward was equally staffed as the acute geriatric ward and had 
a 90 % bed occupancy during the project period. The orthopaedic patients are in general less 
demanding than a geriatric patient.  
The hip fracture patients included in the trial was the only surgical patients in the acute 
geriatric ward, and some of the personnel never got used to handle orthopaedic patients. 
Especially were many nervous to mobilize the patients postoperatively. Before the inclusion 
started we had a pilot phase of 14 months, and this was probably too short for implementation 
of procedures. The fact that the hip fracture patients often represented extra work load and 
was an unfamiliar patient category impacted negatively on the enthusiasm regarding the 
project. The hip fracture patients are demanding patients, and one should not underestimate 
the importance of a factor as enthusiasm.  
Despite the lack of effect on the primary endpoint, and the weaknesses with our orthogeriatric 
model, it is important to point out that the intervention had a positive effect on mobilisation, 
the most important secondary endpoint in our trial. A difference on SPPB of 0.5 is considered 
clinically meaningful, and the effect seen in our study (6 v 4 points) is likely to be important 
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and should be further explored in future studies. Data from the subgroup of patients that had 
mobilization recorded with the activPAL™ body-worn sensor system, indicated that patients 
in the acute geriatric ward, received a more intensive mobilization compared to patients in the 
orthopedic ward.     
 What is the optimal orthogeriatric model? 5.2.2
An integrated model (Kammerlander model 4) is considered the best orthogeriatric model. 
This is the conclusion in all four reviews on orthogeriatric care, and from a clinical point of 
view it is logical that this must be the superior model. When hip fracture patients are treated 
in an integrated ward, one can recruit personnel that are interested in such patients, and it will 
be easier to implement routines. With daily co-management between orthopedic surgeons and 
geriatrician planning of surgery and medical optimization is easier and the problem with 
disintegration of responsibility would be avoided.  
A model of integrated care has however never been evaluated in a RCT, and it unlikely that it 
ever will. In order to design such a study one would need to keep two separate wards for 
treatment of hip fracture patients. To implement an integrated ward demand a joint effort from 
orthopedic surgeons and geriatricians, and not least must administrative and financial issues 
be solved. In order to succeed with such a demanding process there are professional and 
administrative arguments not to keep two parallel treatment paths, but instead focus all the 
recourses to build up an integrated ward.  
 Delirium pathophysiology (paper III and IV) 5.3
 Anticholinergic activity 5.3.1
Several studies have reported an increased anticholinergic activity in patients with delirium. 
Theoretically this makes perfect sense; acetylcholine is a neurotransmitter involved in many 
of the processes that are impaired in delirium (attention, arousal, learning) and cholinergic 
deficiency is among the major theories in delirium pathophysiology. Anticholinergic activity 
in CSF had however never been measured in delirious patients before our study.  
85 
We did not find that CSF or serum AA was associated with delirium. AA in serum in hip 
fracture patients has only been measured in one other study in addition to ours, and like ours 
they found no difference in AA between patients with and without delirium(van Munster et 
al., 2012). AA therefore seems to be less important in the pathogenesis of delirium in hip 
fracture patients, compared to other patient groups. A possible explanation for this is that the 
hip fracture patients are a particular frail patient group with a high degree of chronic cognitive 
impairment. In our study CSF AA was associated with severity of delirium in those patients 
without chronic cognitive impairment, suggesting that AA might be of some importance in 
patients free from dementia.   
Unexplained differences in serum AA between Edinburgh and Oslo 
There was no difference in the median CSF AA between Oslo and Edinburgh (0.43 vs 0.35 
pmol/mL p=0.29). However there was a significant difference in median SAA between the 
two hospitals with levels in Oslo more than four times higher than in Edinburgh (6.37 vs 1.48 
pmol/mL p<0.001). Center remained a significant predictor of SAA levels after adjusting for 
IQCODE, delirium status and ACB in a linear regression model with SAA as outcome.  
We carefully reviewed the possible sources for the discrepancies between the serum AA 
values for Edinburgh vs. Oslo. The serum AA analyses from the two centeres were carried out 
within one laboratory sequence (same run), making potential issues associated to the assay 
unlikely. As the sampling procedures were merely the same at the two centeres, including 
type of containers, it is also difficult to point on potential reasons for the discrepancies 
associated to sample collection or handling. The correlation between AA in serum and CSF 
was stronger in samples collected in Oslo compared to those collected in Edinburgh 
(Spearman’s Rho 0.62, p<0.001 vs Spearman’s Rho 0.26, p=0.07). Other studies have also 
reported a strong correlation between AA in serum and CSF(Miller et al., 1988, Plaschke et 
al., 2007, Plaschke et al., 2010), and the weak correlation seen in the samples from Edinburgh 
could suggest that the serum AA in those samples was falsely low. This could theoretically 
have been explained with increased adsorption of anticholinergic agents (drugs and 
metabolites) to the inner ‘dry’ surface of the containers. This is however also unlikely since 
CSF and serum was transported to Oslo in identical containers. There have also not been any 
systematic differences between levels measured in serum and Oslo in other analyses 
performed (CRP, cytokines, neopterin). Although we can not rule out the possibility that 
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patients from Edinburgh actually display lower serum AA values than those from Oslo, we 
suspect that something related to the sample logistic caused lower SAA levels in the serum 
samples from Edinburgh.  
Challenges in the measurements of anticholinergic drug burden 
Since medications with anticholinergic properties are associated with a high risk of adverse 
effects in elderly patients (Lam and Cheung, 2012), tools have been developed to calculate the 
anticholinergic drug burden. Several scales exist where different medications are ranked 
based on their anticholinergic activity. The anticholinergic burden is estimated by calculating 
the total anticholinergic score of all the medications a patient use(Boustani et al., 2008, 
Rudolph Jl, 2008, Carnahan et al., 2006). By using such anticholinergic scales several 
researchers have found an association with high anticholinergic burden and adverse outcomes, 
including an association with delirium and dementia (for an overview, see(Campbell et al., 
2009, Kersten and Wyller, 2014).  
There has however been critique against such scales(Kersten and Wyller, 2014, Duran et al., 
2013). Firstly there is a wide heterogeneity among the scales with different estimates of the 
anticholinergic potency of the same drug. This makes it difficult to compare studies that use 
different scales. There is also a lack of adjustment for dose, drug-drug interactions and age of 
the patients. It has been argued that this simplification of complex pharmacological 
mechanisms is particularly problematic in a geriatric patient, since biological variation 
increases with age(Kersten and Wyller, 2014). There have also been difficult to show that a 
reduction in anticholinergic burden leads to improved clinical outcomes for the patients. In a 
recently published RCT including nursing home patients was the intervention effective in 
reducing the anticholinergic burden (measured with the Anticholinergic Drug Scale (ADS), 
but this had no significant effect on cognitive performance (Kersten et al., 2013).  
In 1980, Tune and Coyle developed a bioassay making it possible to quantify the 
anticholinergic activity (AA) in vitro in biological samples (Tune and Coyle, 1980). The 
assay technique measures the AA of compounds present in the biological samples by the 
degree of displacement of a radioactively labeled ligand (3H-QNB) from muscarinic receptors 
rat brain receptors. High AA in the biological samples is proportional with a high degree of 
displacement and low radioactive counts per minute (CCPM) from the undisplaced 
radioligand. Atropine is used as a reference compound and the AA in a biological sample is 
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given as “atropine equivalents”. The in vitro AA of many drugs have been measured using 
this bioassay technique (Chew et al., 2008) and there have also been several reports of an 
association between high serum AA and dementia and delirium(Campbell et al., 2009, 
Carnahan et al., 2002, Kersten and Wyller, 2014).  
There has been some criticism against this assay(Carnahan et al., 2002, Kersten and Wyller, 
2014). The assay quantify the total degree of muscarinic receptor displacement of different 
compounds in the sample solution, but  do not distinguish between agonists and antagonists, 
or between receptor affinity for different muscarinic receptor subtypes. It is also important to 
understand that not only drugs that are considered to have anticholinergic properties can cause 
an elevated AA(Chew et al., 2008), and there are also reports of poor correlation between 
serum AA and anticholinergic burden calculated from the medications patients used(Lampela 
et al., 2013). Acute illness in itself has been associated with higher AA in serum (Flacker and 
Lipsitz, 1999). AA has most often been measured in serum, and this does not necessarily 
reflect anticholinergic burden in the brain which depends on the blood-brain permeability of 
the drug. There is also a huge difference in AA levels among studies, so a “cutoff” between 
“low” and “high” serum AA have not been possible to determine(Carnahan et al., 2002). In 
addition to all these weaknesses the assay is too demanding to perform to be introduced in 
daily clinical work.     
 Neopterin 5.3.2
Neopterin was elevated in both CSF and serum in hip fracture patients with delirium. These 
findings suggest potentially greater activation of the cellular immune response in delirium. It 
may also represent a role for oxidative stress in delirium, and this finding should be combined 
with other measures of antioxidant levels, enzymes involved in oxidative stress systems and 
reactive oxygen species.  
The relative levels of neopterin demonstrated in delirium and dementia are intriguing, as the 
pattern is what you might expect to see in microglial priming, where patients with no 
underlying cognitive impairment and no delirium have the lowest levels, those with dementia 
who might be expected to have a degree of low level inflammation have slightly higher levels, 
those with delirium only have even higher levels, but those with delirium super-imposed on 
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dementia have the highest levels. It may be that both delirium and dementia processes activate 
these systems with a cumulative effect in those with both diagnoses.  
Other factors that influence neopterin levels 
Given the “dose-response” pattern seen in CSF from hip fracture patients, with an increase in 
neopterin with more severe cognitive impairment (as a combination of dementia and 
delirium), one could suspect that the cognitively healthy controls would have even lower 
levels. This was not the case, as neopterin in CSF from the healthy controls was as high as hip 
fracture patients with delirium (median 30.9 vs 29.6 nmol/L, p=0.73) and higher than hip 
fracture patients without delirium (median 24.7 nmol/L, p=0.003).  One possible explanation 
for the surprisingly high neopterin levels is that 13 of the elective patients had either a history 
of cancer or an active infection and this group had higher levels of CSF neopterin compared 
to elective patients without cancer or infection (median 35.4 nmol/L v 27.7 nmol/L, p=0.06). 
When elective patients with cancer and/or infection were excluded, there were no significant 
differences in neopterin levels in CSF between the controls and the hip fracture patients, 
neither in those with (p=0.11) or without (p=0.47) delirium. A possibility is that while 
neopterin analysis for the hip fracture patients were done in one batch, the analyses for the 
healthy controls were done in a separate one.  
The introduction of an additional control group is strength with this study, although the 
neopterin levels measured in the healthy controls did not “fit” perfectly in with the levels 
measured in the hip fracture patients. Firstly it demonstrated that it is not possible to use our 
data to define a “cutoff” of neopterin to identify patients of particular high risk of delirium in 
other studies. It also demonstrates some of the difficulties in delirium research. Many of the 
candidate biomarkers in delirium (such as neopterin), are also associated with other 
comorbidities. In studies on delirium pathophysiology it is therefor very important to define 
relevant control groups; e.g. to compare levels of biomarkers in delirious hip fracture patients 
with healthy age matched controls is probably of limited relevance.  
On the other hand, as the variation in risk factors (co-morbidities, medication use, cognitive 
capacity) increases with age, it is challenging to recruit patients that are phenotypically 
equally matched in studies on delirium pathophysiology. As the current knowledge of 
delirium pathophysiology is so limited, compromises in study design must be accepted.  
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 Hip fractures: The perfect setting for delirium pathophysiology 5.3.3
research? 
Several of the studies that exist on delirium pathophysiology have been performed in hip 
fracture patients(MacLullich et al., 2011, van Munster et al., 2012, Westhoff et al., 2013). 
There are several reasons for this. First is delirium extremely prevalent among hip fracture 
patients, affecting 40 - 50 % of the patients. In most of the patients delirium is triggered by  
the same exposure; the fracture and surgery. And at last there is the unique possibility to 
acquire CSF from those operated in spinal anesthesia.  
There are however also some disadvantages with this model. A huge part of the hip fracture 
population has dementia already before the fracture. Since many of the candidate biomarkers 
in delirium also seems to play a role in dementia, it is difficult to sort out the effect of 
delirium. The fracture and surgery itself trigger the immune system in all patients, so one can 
measure pro-inflammatory compounds  also in patients without delirium. There is also a 
possibility that delirium have different pathophysiologic entities depending on the 
precipitating factor. To study delirium pathophysiology in different patient groups is therefore 
of great value.  
 Challenges in delirium pathophysiology research 5.3.4
Although clearly a CNS phenomenon, most studies on delirium pathophysiology have been 
done by the use of serum samples. This demonstrates the ethical and practical difficulties in 
acquiring CSF from delirious patients. There is also a lack of animal models in delirium, and 
all published animal studies so far are from a single research group(Cunningham et al., 2005). 
When reading studies about delirium pathophysiology, is it important to take into account the 
extreme complexity of the different biological systems. In most delirium studies, the 
biomarkers have only been measured once, and the patients included are often on different 
time course in their delirium development (there is often a mix of patients with prevalent, 
incident, subsyndromal and never delirium in studies). Since the explored biologic processes 
are dynamic, this mix of “delirium phenotypes” makes it very difficult to interpret the results. 
A longitudinal design with repeated delirium assessments and collection of biomarkers would 
be valuable, but it would be difficult to overcome practical and ethical challenges involved in 
repeated sampling of CSF.   
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 Methodological considerations 5.4
 Patient selection 5.4.1
RCT 
The inclusion of nursing home patients in the RCT can be considered as strength as well as a 
weakness with the study. It improves the external validity of the study that nursing home 
patients and demented patients were included since they represent a major part of the hip 
fracture population and are at high risk of delirium. On the other hand, nursing home patients 
are so frail and cognitively impaired that they may be unlikely to benefit from the 
intervention. To assess the efficacy in such patients, other endpoints than we chose might be 
more feasible(Goldberg et al., 2013).  
Pathophysiology 
There were different exclusion and inclusion criteria in Oslo and Edinburgh, making the Oslo-
cohort significantly frailer. It is difficult to rule out that there might also have been some 
differences in diagnostic judgment between the two centers. The assessment tools were, 
however, similar and thorough, and center was not a significant explanatory factor for 
delirium risk in the logistic regression analyses in any study.  
 Assessment methods 5.4.2
Measures of cognition 
IQCODE has been criticized as a crude measure of cognitive function, since it is based upon 
proxy information. Because hip fracture is an acute event, ascertaining prefracture cognitive 
status is challenging. Many community-dwelling patients with dementia do not have a 
documented diagnosis(Wergeland et al., 2014). Thus, relying on past records alone would 
underestimate the prevalence of prefracture dementia. IQCODE has been validated(Jorm, 
2004) and is often used in delirium studies(van Munster et al., 2012). Most patients in our 
study had relatives, friends or health care personnel that could inform IQCODE.  
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DRS conversion to MDAS 
The delirium diagnosis both in Oslo and Edinburgh was both based on the CAM. The 
delirium severity was however measured by two different tools; MDAS in Oslo and DRS-98 
in Edinburgh. A literature search did not provide any direct comparisons between the scales, 
or a clearly defined cut-off for severe delirium in either scale. Advice was sought from an 
expert in the field with considerable experience administering both scales (David Meagher), 
and MDAS was therefore rated retrospectively on patients in Edinburgh based on his advice. 
This was done by transforming scores from the Richmond Agitation Sedation Scale (RASS) 
(MDAS item 1) and the closest equivalent MMSE (MDAS items 2-4) and DRS-R98 (MDAS 
items 5-10) items, to produce equivalent MDAS items. This method has not been validated, 
and can be criticized.  
 Statistical considerations 5.4.3
Use of composite endpoint 
Our combined endpoint was designed to measure cognition in patients representing a broad 
spectrum of cognitive functioning. It was based upon well validated components, but our 
specific way of combining them has not been validated and we can thus not be sure that the 
composite had the intended sensitivity or validity. 
Inter-rater agreement 
As explained in section 4.2.1, the inter-rater agreement for the CAM based diagnosis of 
delirium was calculated for LOW and each of the two study nurses, both showing kappa =1. 
This implies that there was 100 % agreement in the jugdement whether the patients had 
delirium or not. With a kappa = 1 it should be unnecessary for the study nurses to discuss 
patients where they were unsure about the delirium diagnosis, but during the inclusion period 
there were several occasions where it was difficult to decide whether the patients had delirium 
or not. The reason why the interrater agreement showed a kappa = 1 was presumably that we 
assessed too few patients together and also that in the assessed patients the diagnosis was 
quite obvious. In retrospect it is clear that the interrater agreement should have been assessed 
in more patients in order to obtain a more trustworthy estimate.  
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Missing values 
Missing values for the primary endpoint in the RCT were imputed in different ways in order 
to explore their potential influence on the results:  
- if a patient had the combined endpoint available after 12 but not four months, those values 
were imputed in the four months dataset (10 patients).  
- imputation of the worst possible score for all patients that had died.  
- imputation of the worst possible score for all missing patients.   
- imputation of the mean score for the randomisation group the patient belonged to for all 
missing patients. 
These analyses showed no substantial differences from the primary analysis. 
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6 Conclusions 
Hip fracture is a serious event with dramatic short and long-term consequences for the 
patients.  Delirium is common and is associated with poorer outcome.  
x The orthogeriatric model in use at Oslo University Hospital - Ullevaal between June 
2008 and January 2012 was not effective in preventing delirium or long-term 
cognitive decline.  
x The intervention had a positive effect on mobility in patients not admitted from 
nursing homes. 
x Delirium is a common complication, affecting half of the hip fracture patients. 
x Chronic cognitive impairment is a strong risk factor for delirium. 
x Delirium had a strong negative impact on cognitive function in the long-term.   
x Anticholinergic activity in CSF and serum seems not to be an important mechanism in 
the development of delirium in hip fracture patients. In patients without pre-fracture 
cognitive impairment, increasing CSF AA might enhance delirium severity.  
x Neopterin is elevated in CSF and serum in patients with delirium. This suggests 
activation of cell-mediated immune responses or oxidative stress in the delirium 
process.  
x High levels of neopterin can predict poor outcome.  
x The pathophysiologic mechanisms in delirium are different in patients with and 
without chronic cognitive impairment. 
94 
7 Suggestions for future research 
This thesis has focused on orthogeriatrics and delirium; two topics that are receiving an 
increased interest from researchers. There are however several unanswered questions.  
Orthogeriatrics 
It is widely believed that to involve geriatricians in the care of elderly patients with fractures 
improves outcome. An orthogeriatric approach seems to be particular effective in treating hip 
fracture patients, and orthogeriatric care is already implemented in many countries. Several 
important questions remains however unanswered and future studies should aim at:  
x Further explore how the orthogeriatric care is best organized. More RCTs should be 
carried out, particularly to evaluate the more integrated models (Kammerlander model 
3 and 4).  
x Long term outcomes of orthogeriatric care need to be further explored. Most of the 
studies so far have focused outcomes collected from registers (LOS, re-admissions, 
mortality). Future studies should aim to include face-to-face evaluation of patients 
with objective measures of function.  
x As an increase in hip fractures can be expected in the future and it would be of great 
value if future studies could identify those hip fracture patients that benefit most on 
orthogeriatric care. A comprehensive orthogeriatric model is demanding, and with 
limited resources available, it is important to know how the resources are best 
prioritized.  
Delirium  
Despite an increase in studies on outcomes after delirium and pathophysiology, even the most 
basic questions remains mostly unanswered. Future studies should aim at:  
x To get at more precise estimate of the impact delirium has on cognition in the long 
term, one should conduct several studies were different cohort of patients were closely 
monitored for delirium with repeated measures of cognitive function.  
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x Future studies on delirium prevention should also include objective cognitive testing 
at follow up controls.  
x Large biobanks of CSF and serum should be established. Analysis should be done 
with methods with sufficient sensitivity. 
x All the published animal studies on delirium so far come from one single research 
group. There is clearly a need for more models for delirium on different genetic 
backgrounds.  
The existing studies on pathophysiology have most often used a simple delirium yes/no 
dichotomization. This is an oversimplification since 1) delirium in reality is not a binary 
phenomenon but represent a continuum and 2) because the patients show a wide 
heterogeneity in terms of predisposing and precipitating factors for delirium as well as in 
delirium symptomatology. Larger samples sizes are therefor needed in order to do be able to 
better phenotype patients and to do subgroup analyses. To succeed in this, international 
collaboration with exchange of samples is needed.   
Many of the suggested studies are costly and demanding, but given the magnitude of the 
problem, it should be possible to write convincing applications to get funding.   
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Abstract
Background: Delirium is a common complication in patients with hip fractures and is associated with an increased
risk of subsequent dementia. The aim of this trial was to evaluate the effect of a pre- and postoperative
orthogeriatric service on the prevention of delirium and longer-term cognitive decline.
Methods: This was a single-center, prospective, randomized controlled trial in which patients with hip fracture were
randomized to treatment in an acute geriatric ward or standard orthopedic ward. Inclusion and randomization took
place in the Emergency Department at Oslo University hospital. The key intervention in the acute geriatric ward
was Comprehensive Geriatric Assessment including daily interdisciplinary meetings. Primary outcome was cognitive
function four months after surgery measured using a composite outcome incorporating the Clinical Dementia
Rating Scale (CDR) and the 10 words learning and recalls tasks from the Consortium to Establish a Registry for
Alzheimer’s Disease battery (CERAD). Secondary outcomes were pre- and postoperative delirium, delirium severity
and duration, mortality and mobility (measured by the Short Physical Performance Battery (SPPB)). Patients were
assessed four and twelve months after surgery by evaluators blind to allocation.
Results: A total of 329 patients were included. There was no significant difference in cognitive function four months after
surgery between patients treated in the acute geriatric and the orthopedic wards (mean 54.7 versus 52.9, 95% confidence
interval for the difference −5.9 to 9.5; P = 0.65). There was also no significant difference in delirium rates (49% versus
53%, P = 0.51) or four month mortality (17% versus 15%, P = 0.50) between the intervention and the control group. In a
pre-planned sub-group analysis, participants living in their own home at baseline who were randomized to orthogeriatric
care had better mobility four months after surgery compared with patients randomized to the orthopedic ward,
measured with SPPB (median 6 versus 4, 95% confidence interval for the median difference 0 to 2; P = 0.04).
Conclusions: Pre- and postoperative orthogeriatric care given in an acute geriatric ward was not effective in
reducing delirium or long-term cognitive impairment in patients with hip fracture. The intervention had, however,
a positive effect on mobility in patients not admitted from nursing homes.
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Background
More than 30% of individuals 65-years-old or older
experience at least one fall each year, and the prevalence
increases with age [1]. Ten percent of falls result in
serious injuries [2], with hip fracture as one of the most
feared consequences. In the European Union it was esti-
mated that 615,000 new hip fractures occurred in 2010,
and the number of hip fractures is expected to increase
in the years to come [3].
Patients with hip fracture are often frail, have multiple
co-morbidities including cognitive impairment, and there
is usually polypharmacy [4]. To address these patients'
needs, different models of orthogeriatric co-management
have been developed. Models range from a limited con-
sultation or liaison service through to integrated orthoger-
iatric units [5]. Few of these models have been evaluated
in randomized controlled trials (RCTs), and the hetero-
geneity of interventions, outcomes and populations makes
it difficult to draw conclusions regarding the superiority of
one particular model [5-7]. Geriatric intervention might
be especially beneficial in the vulnerable period prior
to surgery, but most studies are limited to postoperative
orthogeriatric intervention [8].
A common complication of hip fracture is delirium,
a syndrome of acute change in cognition and alertness,
and altered, often psychotic, behavior [9]. About 40%
to 50% of hip fracture patients are reported to develop
delirium in the peri-operative period [10]. Delirium is
particularly common in patients with pre-existing de-
mentia [11], despite which patients with dementia are
often excluded from studies [12]. Delirium in the peri-
operative phase is associated with increased risk of death,
institutionalization and subsequent dementia [13]. Multi-
factorial intervention can prevent delirium in hip fracture
patients [14-16], but it is not yet established if preventing
delirium can reduce long-term cognitive decline.
In 2008, we established an orthogeriatric service at our
hospital, comprising pre- and postoperative care of hip
fracture patients in the acute geriatric ward. We evaluated
this model by a RCT in which hip fracture patients re-
ceiving usual care in the orthopedic ward comprised the
control group. We hypothesized that the intervention
could prevent delirium-associated long-term cognitive
decline and, thus, chose cognitive function four months
after surgery as the primary outcome.
Methods
Project context
In 2008, orthogeriatric care at Oslo University Hospital
was reorganized and became a part of the acute geriatric
ward. The new service had the capacity to serve approxi-
mately half of the patients admitted with hip fracture.
The remaining patients were treated in the orthopedic
ward. To evaluate the new model, we randomly allocated
patients between the acute geriatric and the orthopedic
wards. The first hip fracture patient was admitted to the
acute geriatric ward in June 2008 and after a pilot period in-
clusion in the study started in September 2009. The recruit-
ment ended in January 2012. The study protocol containing
further information is published elsewhere [17].
Study design
We carried out a randomized, controlled, single-blind trial
comparing pre- and postoperative orthogeriatric care inte-
grated in the acute geriatric ward to usual care in the ortho-
pedic ward. Inclusion and randomization took place in the
emergency department, overseen by the duty orthopedic
surgeon. Allocation was by sealed, opaque, numbered enve-
lopes. Randomization was based on computer-generated
random numbers (blocks of variable and unknown size)
and was carried out by a statistician (ES) not involved in
the clinical service. Randomization was stratified according
to whether or not the patients were admitted from nursing
homes. Included patients were transferred directly from the
emergency department to the allocated ward, and had their
entire hospital stay in the same ward except for time in the
operating theater and a few hours in the postoperative care
unit. Operative and anesthetic procedures were the same in
the two groups.
Study participants
All patients admitted acutely to Oslo University Hospital
with a hip fracture (a femoral neck fracture, a trochanteric
or a sub-trochanteric fracture) were eligible for inclusion.
Patients were excluded if the hip fracture was a part of a
high energy trauma (defined as a fall from higher than
one meter) or if they were moribund on admission.
Intervention and control
Patients randomized to intervention were treated in the
acute geriatric ward (Table 1). This was a 20 bed ward,
mainly admitting patients suffering from acute medical
disorders superimposed upon frailty, co-morbidities and
polypharmacy. The only surgical patients treated in the
ward were the hip fracture patients included in the trial.
On average during the inclusion period, two to four beds
were used for hip fracture patients. The acute geriatric ward
was regularly full or over-crowded. To avoid randomization
violation, the ward was instructed to admit included hip
fracture patients even if the ward was full. Thus, some hip
fracture patients had to be treated in the corridor until a
room was available, usually within the first 24 hours.
A key element of the intervention was a Comprehensive
Geriatric Assessment (CGA) as a basis for treatment
planning. All team members (geriatrician, nurse, physio-
therapist and occupational therapist) were expected to
assess patients during their first day on the ward, and the
team had daily meetings to co-ordinate treatment and to
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plan discharge. Clinical routines were developed based on
a literature search, experience from earlier orthogeria-
tric models and the pilot phase prior to the start of
randomization. Checklists were printed out and made
immediately available for the treatment team for each
patient. Details about the clinical routines have been
published [17] and included medication reviews, early and
intensive mobilization, optimizing pre- and postoperative
nutrition and early discharge planning.
The control group was treated in the orthopedic ward, a
52 bed ward admitting a range of elective and non-elective
orthopedic patients. The staff-patient ratio was similar
to that of the acute geriatric ward (Table 1). There were,
however, no multidisciplinary meetings and no geriatric
assessments. Early mobilization was emphasized, and
hip fracture patients were seen by a physiotherapist soon
after surgery. The postoperative care unit was within the
orthopedic ward, where all patients (including those allo-
cated to intervention) were observed after surgery.
All patients included in the trial were offered a control in
the orthopedic outpatient clinic four months after surgery.
There was no additional intervention after discharge
from hospital.
Measurements
Social and demographic information was collected during
the acute stay. Information regarding surgical and anesthetic
procedures, medical diagnoses (Charlson comorbidity index
[18]), drug use and complications was also collected. Proxies
were interviewed regarding pre-fracture Activities of Daily
Living (Barthel ADL Index (BADL [19]) and Nottingham
Extended ADL Index (NEADL [20])) and cognitive function
(Informant Questionnaire on Cognitive Decline in the
Elderly (IQCODE [21])). Estimated height was derived
using knee-heel length [22] and the patients were weighed
using a chair scale. Mobilization after surgery was used
as a process measure, recorded on day two post-surgery
from case notes and observations. From September 2011,
mobility was recorded with the activPAL™ body-worn sen-
sor system [23]. The sensor was attached on the anterior
aspect of the non-affected thigh as soon as possible after
surgery and worn until discharge.
All patients were screened once daily for delirium using
the Confusion Assessment Method (CAM) [24] preopera-
tively and until the fifth postoperative day (all) or until dis-
charge (delirious patients). The study geriatrician or a study
nurse completed all the assessments. If the nurse was
unsure about the diagnosis, the study geriatrician was
consulted. The CAM score was based on information
from nurses, close relatives and hospital records related
to the preceding 24 hours, in combination with a 10 to
30 minute interview with the patient. Tests of cognition,
attention and alertness included the digit span test
(forward and backward), orientation and delayed recall
(from the Memorial Delirium Assessment Scale (MDAS)
[25]). Delirium severity was measured with MDAS. Patients
were assessed regularly on weekdays, but staff members
who had been working during weekends were interviewed
every Monday, and the case notes scrutinized in order to
ascertain potential episodes of delirium. The mean number
of delirium assessments during the stay was 5.7 (SD 2.7).
Follow up visits were carried out four and twelve months
after surgery (with a time window of ± three weeks) by
study nurses blind to allocation and to all clinical data
Table 1 Organization of treatment in the acute geriatric ward and the orthopedic ward
Description of ward Acute geriatric ward Orthopedic ward
Department Clinic of Internal Medicine, Department
of Geriatrics
Department of Orthopedic Surgery
Number of beds 20 52
Average number of beds occupied 101% 90%a
Organization of ward Hip fracture patients spread among
other medical patients
Hip fracture patients spread among
other surgical patients
Staff-order (number per bed)
- nurses 1 1.18
- nursing assistants 0.28 0.06
- physiotherapists 0.08 0.07
- occupational therapists 0.07 0
- nutritionists available on request 0
- social worker available on request 0.02
Interdisciplinary meetings Daily No
Intervention after discharge Patients offered control at orthopedic
outpatient clinic four months after surgery
Patients offered control at orthopedic
outpatient clinic four months after surgery
aFor the orthopedic ward, only figures from 2011 were available.
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during the original hospital stay. The patients were assessed
in their current place of residence. Each visit typically lasted
for two to three hours, and the evaluators started the
assessment with the cognitive tests of the primary outcome.
At each follow-up visit, proxies were interviewed
regarding physical (ADL) and cognitive function, using
the same scoring systems as during the index stay. Mobility
at the follow-up visits was assessed with the short physical
performance battery (SPPB) [26]. Weight at follow-up was
assessed using a standing scale that was calibrated to the
chair scale used during hospital stay. Patients and proxies
were asked about any hospital readmissions since surgery.
One specialist in geriatric medicine (TBW) and one
specialist in old age psychiatry (KE) independently assessed
whether the patients fulfilled the International Classification
of Diseases, version 10 (ICD-10) criteria for dementia at
baseline and 12 months after surgery. The assessors had
access to all clinical data, but were blinded to allocation
and delirium status during hospital stay. The inter-rater
agreement upon the dementia diagnosis was satisfactory
(kappa 0.87 at baseline and 0.83 at 12 months); disagree-
ments were resolved through discussion.
Primary outcome
The primary outcome was cognitive function four months
after surgery, which was expected to show a wide range of
severity from severe dementia to no cognitive impairment.
To be able to measure differences in both the higher
and the lower spectrum of cognitive function, we com-
bined two scales:
– The 10 words test from the Consortium to Establish
a Registry for Alzheimer’s disease battery (CERAD) [27].
In this memory test patients are asked to recall 10 words
after having them presented orally or visually. We used
the immediate and delayed recall tasks of the test. This
test is shown to be sensitive for memory changes in
persons with good cognitive functioning [28].
– The Clinical Dementia Rating scale (CDR [29]). CDR
is based on information from the best available sources as
a combination of patient and proxy information and is
sensitive for cognitive changes in patients with dementia.
We used the ‘sum of boxes’ scoring adding up to a sum
score ranging from zero (no dementia symptoms) to 18
(severe dementia). In most studies the sum score is shown
to correlate highly with the original categorical score
of zero to three [30].
To construct the combined outcome measure, we nor-
malized these scales into a 0 to 100 scoring (CDR had to
be reversed since it is scaled in the opposite direction).
The CDR carried a 50% weighting, and the immediate
and delayed recall parts of the 10 word test each con-
tributed 25% in the combined measure. Thus, a higher
score on the primary outcome indicated better cogni-
tive performance.
Secondary outcomes
Secondary outcomes included preoperative delirium,
delirium severity, length of stay, mortality, mobility,
place of residence, ADL function and weight changes
at the follow up controls. CDR and the 10 words test
were analyzed separately, in addition to other measures
of cognition (Mini-mental state examination (MMSE)
[31], clock drawing test [32], IQCODE).
Statistical analyses
No pre-trial data were available to carry out precise power
estimates. Based upon previous experience with the CDR,
we judged 300 patients to be sufficient to detect clinically
meaningful differences [30]. As 20% of hip fracture patients
can be expected to die within four months of surgery, we
aimed to randomize 370 patients. Recruitment ended after
randomization of 332 patients due to resource constraints.
A statistical analysis plan (SAP) was developed (and
published online) prior to un-blinding of the data [33].
The primary analysis was carried out blind to allocation
by the study statistician (ES).
The primary analysis was carried out as a modified
intention-to-treat analysis including patients with CDR
and a complete 10-word test at the four-month con-
trol. Two patients were sent to the ward opposite to
randomization allocation, and these patients were ana-
lyzed according to the group in which they were treated
(Figure 1). Three moribund patients (two randomized to
the acute geriatric ward and one to the orthopedic ward)
were recruited in error, and were excluded from the
primary analysis.
The primary outcome was not normally distributed
but the sample size was large and parametric methods
could therefore be applied. To adjust for any inequality
in the distribution of important prognostic variables
between the intervention and control group, we per-
formed a linear regression with the primary outcome
as the dependent variable, and variables with known or
believed influence on the outcome were included in
the model in a stepwise manner, in addition to the
randomization group. If their introduction to the model
changed the effect estimate for the randomization
variable by 10% or more, they were included in the
final model. Variables were removed by stepwise back-
wards elimination until the final model was reached.
Age (negatively skewed) and waiting time to surgery
(positively skewed) had non-normal distributions, and
were squared and log transformed, respectively, to
achieve better fit of the model. Secondary outcomes
were analyzed by the Mann–Whitney test, t-tests and
Chi-square tests depending on data distribution. Pre-
planned subgroup analyses were carried out in patients
admitted from nursing homes, and in patients with and
without pre-fracture dementia.
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All statistical analyses were performed using IBM SPSS
Statistics version 20, except for median differences and cor-
responding 95% confidence intervals that were estimated
by the Hodges Lehmann estimator using StatXact 8.0.
Sensitivity analyses
As a sensitivity analysis we analyzed the primary outcome
with the non-parametric Mann–Whitney test. We also
carried out sensitivity analyses including the three mori-
bund patients who were erroneously recruited, and a strict
intention to treat analysis with all patients analyzed accord-
ing to allocation. Missing values for the primary outcome
were imputed in different ways in order to explore their
potential influence on the results:
– if a patient had the combined outcome available after
twelve but not four months, those values were imputed
in the four-month dataset (ten patients).
– imputation of the worst possible score for all patients
who had died.
– imputation of the worst possible score for all missing
patients.
– imputation of the mean score for the randomization
group the patient belonged to for all missing patients.
Assessed for eligibility (n=466)
Excluded  (n=134)
Not meeting inclusion criteria (n=53)
- Uncertain diagnosis (awaiting further 
diagnostics) - 20
- Too ill to approach - 9
- Included earlier - 7
- Foreign citizen -1
- High energy trauma-16
Declined to participate (n=22)
Other reasons (n=59)
- Study temporarily stopped due to outbreak 
of Norovirus gastroenteritis - 20
- Cared for at another hospital -16
- Erroneously admitted to orthopaedic 
ward - 4
- Competing research project - 4
- Project logistics
- Surgeon forgot study - 13
- Other - 2
Tested (n=121)
- With complete primary outcome (CDR + 10WT) – 112
- With incomplete primary outcome (10WT missing) - 9
Dead – 28
Lost to follow up (n=14)
- Did not want to participate – 10
- Hospitalized/too ill to approach – 4
- Not reached/moved - 0
Allocated to acute geriatric ward (n=163)
Received allocated intervention (n=162)
Did not receive allocated intervention (n=1)
- Randomized to acute geriatric ward, but 
erroneously sent to orthopaedic ward
Tested (n=121)
- With complete primary outcome (CDR + 10WT) – 116
- With incomplete primary outcome (10WT missing) - 5
Dead – 24
Lost to follow up (n=21)
- Did not want to participate – 16
- Hospitalized/too ill to approach – 4
- Not reached/moved - 1 
Allocated to orthopedic ward (n=166)
Received allocated intervention (n=165)
Did not receive allocated intervention (n=1)
- Randomized to orthopaedic ward, but 
erroneously sent to acute geriatric ward
Allocation
Follow-Up after 12 months
Follow-Up after 4 months
Randomized (n=332)
Enrollment
Moribund patients erroneously 
included (n=3)
Tested (n=98)
- With complete primary outcome (CDR + 10WT) – 94
- With incomplete primary outcome (10WT missing) - 4
Dead – 46
Lost to follow up (n=19)
- Did not want to participate – 18
- Hospitalized/too ill to approach – 0
- Not reached/moved - 1
Tested (n=95)
- With complete primary outcome (CDR + 10WT) – 92
- With incomplete primary outcome (10WT missing) - 3
Dead – 43
Lost to follow up (n=28)
- Did not want to participate – 23
- Hospitalized/too ill to approach – 4
- Not reached/moved - 1
Figure 1 CONSORT flow diagram. CDR, Clinical Dementia Rating; 10 WT, 10 word test (from CERAD, Consortium to Establish a Registry for
Alzheimer’s Disease).
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Ethical considerations
The study was conducted in accordance with the Declar-
ation of Helsinki. Informed consent was obtained from
the patients or substitute decision-makers if patients did
not have capacity to consent. The study was approved
by the Regional Committee for Ethics in Medical Re-
search in Norway (REK S-09169a) and the Data Protec-
tion Officer at Oslo University Hospital (Ref. 1361).
Results
Between 17 September 2009 and 5 January 2012, 446 pa-
tients were assessed for eligibility and 332 were included
(Figure 1). Non-included patients were younger than in-
cluded patients (median 81 versus 85 years; P ≤0.001)
and more were men (35.3% versus 25.1%, P = 0.01). Half
of the included patients at baseline were considered to
have dementia, and one third were living in nursing homes.
Patients randomized to the intervention group and the
control group were well matched in all important baseline
variables (Table 2). In total, 35 patients (11%) were lost to
follow up at four months, 14 from the intervention group
and 21 from the control group (P = 0.23). Of patients lost
to the four month follow up, only 2 (7%) were living in a
nursing home before the fracture, compared to 73 (30%)
patients who were followed-up (P = 0.002). Patients lost to
follow up were younger (median age 83 versus 85, P = 0.19)
and fewer were considered to have dementia before the
fracture (12/35 (34%) versus 112/242 (46%), P = 0.18); how-
ever, these differences were not significant. The final twelve
month follow up was completed in December 2012.
Impact of intervention during hospital stay
There was no difference in delirium rates between the
intervention and control groups (49% versus 53%, P = 0.51)
(Table 3). There was also no difference in delirium
duration (median three versus four days, P = 0.85) or
delirium severity measured with MDAS (median 21.5
versus 20, P = 0.44). Fewer patients treated in the acute
geriatric ward were discharged with ongoing delirium
(15% versus 26%, P = 0.01).
The median length of stay was three days longer
in the intervention group (median eleven versus eight
days, P ≤0.001). Patients in the intervention group had a
longer waiting time for surgery, but this difference was
not statistically significant (median 26 versus 24 hours,
P = 0.54).
There was a trend to greater mobilization in the
intervention group on the second day after surgery
(86% versus 80%). In 46 patients, mobilization after
surgery was assessed with activPAL™ activity sensors.
During the first five days after surgery, the patients
were mobilized for a longer time in the standing or
stepping position in the intervention group (median
29 minutes versus 17 minutes).
Primary outcome - cognitive function four months
after surgery
The primary outcome could be computed in 228 patients
and there was no significant difference between patients
treated in the acute geriatric ward and the orthopedic ward
after four months (mean 54.7 versus 52.9, 95% confidence
interval for the difference −5.9 to 9.5; P = 0.65) (Table 4).
There was also no difference in the combined outcome
after twelve months (mean 51.0 versus 49.1, 95% confi-
dence interval for the difference −7.7 to 11.4; P = 0.69).
Table 2 Baseline characteristics
Characteristics Acute geriatric ward
(number = 163)
Orthopedic ward
(number = 166)
Age, median (range) 84 (55 to 99) 85 (46 to 101)
Male (%) 42 (26) 38 (23)
IQCODE >3.44 (%)a 93 (58) 91 (58)
Dementia, expert opinion (%)b 80 (49) 82 (49)
BADL, median (IQR)c 18 (13 to 20) 18 (15 to 20)
NEADL, median (IQR)d 28 (9 to 52) 30.5 (12 to 52)
APACHE II score, mean (SD) 9.5 (2.8) 9.3 (2.7)
CCI, median (IQR) 1 (0 to 2) 1 (0 to 2)
Number of medications
used regularly, median (IQR)
5 (2 to 7) 4 (2 to 6)
BMI, mean (SD)e 24.4 (4) 24.4 (4.6)
Living in an institution (%) 52 (32) 50 (30)
Type of fracture (%):
- Femoral neck 98 (60) 97 (58)
- Intertrochanteric 64 (39) 67 (40)
- Subtrochanteric 1 (1) 2 (1)
Type of surgery (%):
- Hemiarthroplasty 74 (45) 71 (43)
- Osteosynthesis 88 (54) 91 (55)
- Total hip replacement 0 (0) 1(1)
- Girdlestone 1 (1) 0 (0)
- Not operated 0 (0) 3 (2)
Type of anesthesia (%)
- General 8 (5) 14 (9)
- Spinal 147 (94) 143 (91)
- Epidural 2 (1) 0 (0)
Injury occurred indoors (%) 136 (84) 139 (84)
aIQCODE was missing in two patients from the acute geriatric ward and in
eight patients from the orthopedic ward; bbased upon consensus in an expert
panel (TBW and KE); cBarthel ADL was missing in one patient from the acute
geriatric ward and three patients from the orthopedic ward; dNEADL was
missing in four patients from the acute geriatric ward and in two patients
from the orthopedic ward; eBMI was missing in 30 patients from the acute
geriatric ward and in 69 patients from the orthopedic ward. APACHE II, Acute
Physiology and Chronic Health Evaluation II; BADL, Barthel Activities of Daily
Living; BMI, body mass index; CCI, Charlson Comorbidity Index score; IQCODE,
Informant Questionnaire on Cognitive Decline in the Elderly; IQR, interquartile
range; NEADL, Nottingham Extended ADL Index.
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The Mann–Whitney test gave essentially the same results
as the t-test at four and twelve months. A linear regression
with the primary outcome as the dependent variable
(Table 5) identified four significant predictors associated
with poorer score: if the patient was admitted from a
nursing home, IQCODE at baseline above 3.44, older age,
and delirium during the hospital stay.
Secondary outcomes and subgroup analyses
Patients treated in the acute geriatric ward performed
better on all cognitive measures; CERAD immediate
recall (median 12.5 versus 11.5) and delayed recall
(median 3 versus 2) , approved clock drawing test (49%
versus 40%), MMSE (median 24 versus 23) and CDR
(1.5 versus 2.5). They also had better ADL function
measured with the BADL Index (median 17 versus 16) and
NEADL (median 26.5 versus 22). None of these differences
were, however, statistically significant.
Patients randomized to the acute geriatric ward had
better mobility four months after surgery, measured with
SPPB (median 4 versus 3, 95% confidence interval for the
median difference 0 to 2; P = 0.13) (Table 4). This difference
was statistically significant in the pre-specified subgroup
analysis restricted to patients living in their own home
before the fracture (median 6 versus 4, 95% confidence
interval for the median difference 0 to 2; P = 0.04). Sub-
group analyses stratified according to pre-fracture dementia
status and nursing home residence gave no other significant
Table 3 Impact of intervention during hospital stay
Variable Acute geriatric ward
(number = 163)
Orthopedic ward
(number = 166)
P-value
Delirium any time during hospital stay (%)a 80 (49) 86 (53) 0.51
Pre-operative delirium (%)b 47 (31) 50 (35) 0.41
Delirium severity MDAS, median (IQR)c 21.5 (15.3 to 25) 20 (13.8 to 26) 0.44
Delirium duration in days, median (IQR)d 3 (2 to 7) 4 (2 to 6) 0.85
Discharged with ongoing delirium (%) 24 (15) 43 (26) 0.01
Waiting time for surgery in hours, median (IQR)e 26.2 (15.9 to 42.7) 23.9 (16.5 to 38.1) 0.54
Length of stay in days, median (IQR) 11 (8 to 15) 8 (4.8 to 11) ≤ 0.001
Medical complications, any 72 (44) 76 (46) 0.82
- Cardiac complications 22 (14) 19 (11) 0.58
- Cerebral complications 2 (1) 0 (0) 0.25
- Thrombo-embolic complications 2 (1) 0 (0) 0.25
- Pulmonary complications 21 (13) 13 (8) 0.15
- Renal failure 6 (4) 2 (1) 0.18
- Urinary tract infections 26 (16) 41 (25) 0.05
- Pressure ulcer 3 (2) 8 (5) 0.22
- Gastro-intestinal complications 5 (3) 4 (2) 0.75
Surgical complications, any 4 (3) 6 (4) 0.75
- surgical site infection 1 (1) 1 (1) 1
- wound problem 2 (1) 4 (2) 0.69
- osteosynthesis failure 1 (1) 0 (0) 1
- dislocation of prosthesis 0 (0) 1 (1) 0.5
Fall (%) 14 (9) 11 (7) 0.5
In-hospital mortality (%) 6 (4) 3(2) 0.21
Mobilized out of bed the second day after surgery (%)f 139 (86) 119 (80) 0.13
Time mobilized in standing or stepping position the first five days
after surgery in minutes, median (IQR)g
29.3 (10.8 to 42.7) 16.8 (4.3 to 68.2) 0.24
aDelirium status defined by CAM. CAM was missing in four patients from the orthopedic ward; bpreoperative delirium status unknown in nine patients from the
acute geriatric ward and in 23 patients from the orthopedic ward; chighest MDAS in patients with delirium. MDAS was missing in four patients in the acute
geriatric ward and in eight patients from the orthopedic ward; dnumber of days from first to last positive CAM; etime from admission to start of anesthesia. Three
patients from the orthopedic ward did not undergo surgery; fmissing in two patients from the acute geriatric ward and in 17 patients from the orthopedic ward;
gmasured with activPAL™ in 22 patients from the acute geriatric ward and in 24 patients from the orthopedic ward. CAM, Confusion Assessment Method; IQR,
interquartile range; MDAS, Memorial Delirium Assessment Scale.
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differences, except that patients from nursing homes
randomized to intervention were more often mobilized the
second day after surgery (Additional files 1, 2 and 3).
Twenty-eight (17%) patients treated in the acute geriatric
ward and 24 (15%) treated in the orthopedic ward were
dead four months after the surgery (P = 0.50). In both
groups, 21% of the patients were readmitted during the first
four months after surgery. The results at the 12-month
follow up were similar to those after four months.
Sensitivity analyses
Several sensitivity analyses were performed and they showed
no substantial differences from the primary analysis.
Discussion
In this randomized controlled trial of patients with hip
fracture, we found no evidence that cognitive function four
months after surgery was improved in patients treated
pre- and postoperatively in an acute geriatric ward, com-
pared to usual care in an orthopedic ward. Delirium rates
were equally high in both groups. There was, however, a
trend that the intervention had a positive effect on mobility.
Strength and weaknesses
The main strength of this study was the randomized
controlled design with blinded outcome assessments.
Also, the inclusion of process measures, such as objective
mobilization scores, confirms that the intervention was
being delivered as intended. The inclusion of patients
from nursing homes and those with dementia enhances
generalizability as such patients are frequently excluded
from trials [34]. On the other hand, nursing home pa-
tients are so frail and cognitively impaired that they may
be unlikely to benefit from the intervention. To assess
the efficacy in such patients, other outcomes than those
we chose might be more feasible [35]. The combined
Table 4 Impact of intervention four and twelve months after surgery
Four months follow up Twelve months follow up
Outcome Acute geriatric
ward (n = 121)
Orthopedic
ward (n = 121)
P-value Acute geriatric
ward (n = 98)
Orthopedic
ward (n = 95)
P-value
Primary outcome, mean (SD)a 54.7 (30.3) 52.9 (29.1) 0.65 51.0 (33.4) 49.1 (32.3) 0.69
CERAD 10 word test, median (IQR)
- immediate recall, 12.5 (6 to 17) 11.5 (5.3 to 18) 0.77 11.5 (5 to 18) 11 (5 to 17.8) 0.89
- delayed recall 3 (0 to 6) 2 (0 to 5) 0.35 3 (0 to 6) 2.5 (0 to 5) 0.41
- recognition 18 (13.4 to 19) 17.5 (13 to 19.8) 0.93 17 (11 to 20) 17 (12 to 20) 0.93
CDR sum of boxes, median (IQR) 1.5 (0 to 9) 2.5 (0 to 9.5) 0.39 1.75 (0 to 14) 2.5 (0 to 14) 0.52
MMSE, median (IQR)b 24 (16 to 28) 23 (16 to 27) 0.28 24 (16.3 to 27) 22 (13.3 to 26) 0.34
Approved clock drawing test (%)c 48 (49) 42 (40) 0.20 39 (46) 28 (35) 0.12
NEADL, median (IQR)d 26.5 (7.8 to 50.3) 22 (9 to 46.5) 0.85 25 (8.8 to 51) 18 (10 to 47) 0.65
BADL, median (IQR)e 17 (10 to 20) 16 (12 to 20) 0.80 17 (9.5 to 19) 16 (11 to 19) 0.44
SPPB, median (IQR)f 4 (1 to 8) 3 (1 to 6) 0.13 3 (1 to 7) 3 (1 to 6) 0.14
IQCODE, median (IQR)g 3 (3 to 3.25) 3 (3 to 3.19) 0.74 3.69 (3 to 5) 3.75 (3.13 to 4.94) 0.45
Weight change from index stay in kg, mean (SD)h - 3.4 (4.3) - 4.4 (5.0) 0.25 - 2.4 (6.3) - 3.4 (7) 0.43
New nursing home admissions (%) 19 (16) 18 (15) 0.86 16 (16) 18 (19) 0.63
Incident dementiai 7 (7) 3 (3) 0.33
Re-admissions 21 (17) 21 (17) 0.95 32 (33) 33 (35) 0.76
aTo construct the primary outcome, we normalized CDR and the 10 word test from CERAD into a 0 to 100 scoring (CDR had to be reversed since it is scaled in the
opposite direction). CDR weighed 50% and the immediate and delayed recall parts of the 10 word test weighed 25% each in the combined measure. The primary
outcome was missing in nine patients from the acute geriatric ward and five patients from the orthopedic ward at four months and in four patients from the
acute geriatric and three from the orthopedic ward at twelve months; bMMSE was missing in 11 patients from the acute geriatric ward and in nine patients from
the orthopedic ward at the four-month control and in six and three patients, respectively, at the 12-months control; c ≥ 4 points. Clock drawing test was missing
in 23 patients from the acute geriatric ward and in 16 patients from the orthopedic ward at the four-month control and 14 and 14 patients, respectively, at the
12-month control; dNEADL was missing in seven patients from the acute geriatric ward and in eight from the orthopedic ward at the four-month control and in
two patients from the orthopedic ward from the 12-month control; eBarthel ADL was missing in two patients from the acute geriatric ward and in one from the
orthopedic ward at four months and in one and two patients, respectively, at the 12-month control; fSPPB was missing in seven patients from the acute geriatric
ward and two from the orthopedic ward at four months and in five and three patients, respectively, at the 12-month control; ga modified version of IQCODE was
used at the four-month control; instead of asking for changes in the last 10 years, we asked for changes since just before the hip fracture. At the 12-month control
we used the regular IQCODE. This was missing in two patients from the acute geriatric ward and three from the orthopedic ward at the four-month control and in
three and four patients, respectively, at the 12-month control; hweight was missing in 33 patients from the acute geriatric ward and 29 patients from the orthopedic
ward at the four-month control and in 19 and 22 patients, respectively, at the 12-month control; ibased upon consensus in an expert panel (TBW and KE). BADL, Barthel
Activities of Daily Living; CDR, The Clinical Dementia Rating scale; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; IQCODE, Informant Questionnaire
on Cognitive Decline in the Elderly; IQR, interquartile range; MMSE, Mini Mental State Examination; NEADL, Nottingham Extended ADL Index; SD, standard deviation;
SPPB, Short Physcial Performance Battery.
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outcome measure was designed to measure cognition in
patients representing a broad spectrum of cognitive
function and was based upon well-validated compo-
nents. However, the scale combination has not been
validated and, thus, we cannot be sure that it was sensitive
to the intervention. As with all service evaluations, blinding
of assessments during hospital stay was impossible and
may have introduced bias.
Inclusion was terminated before the intended sample
size aim was reached. However, as there were few differ-
ences between the groups in any of the secondary cognitive
outcomes, and sub-group analyses also failed to show any
substantial differences, it is reasonable to conclude that this
intervention had no effect on cognition.
Comparison with other studies
The impact of orthogeriatric intervention on long-term
cognitive function has not previously been assessed. Several
studies have demonstrated that orthogeriatric care can pre-
vent delirium in hip fracture patients. A recently published
non-randomized controlled trial from Belgium [15] showed
that an intervention provided by an inpatient geriatric
consultation team was effective in reducing the incidence
of delirium (37.2% versus 53.2%, P = 0.04), in keeping
with a similar American RCT [16]. In both the American
and the Belgian studies, all patients received standard
treatment from the orthopedic team, whereas in our
model orthopedic treatment (besides surgery) was limited
to consultation service. A possible explanation for the lack
of effect of our model could, therefore, be limited access
to orthopedic expertise.
Few studies have compared pre- and postoperative
intervention provided in a geriatric ward with usual care
in an orthopedic ward. In comparison with usual care,
such models have shown promising results, but cogni-
tion has seldom been assessed [5,6]. To our knowledge,
the only RCT evaluating a geriatrician-led fracture ser-
vice (were geriatricians have the primary responsibility
for the patients) is a Swedish study [36]. Although no
preoperative intervention was included, the study showed
that significantly more patients allocated to intervention
regained independence in personal ADL performance
at four and twelve months after surgery. The model
was also effective in preventing postoperative delirium
and reducing delirium duration [14]. In spite of the fact
that we also included preoperative intervention, we were
not able to prevent delirium. A likely explanation is that
usual care was better in our study since the delirium rates
both in the intervention and the control group were lower
than in the Swedish study. The orthopedic ward in our
study provided a short waiting time for surgery, similar
staffing as in the geriatric ward, personnel with earlier
experience with orthogeriatric models and delirium pre-
vention, physiotherapy for most hip fracture patients,
and an integrated post-operative care unit.
Orthogeriatric intervention is often reported to reduce
waiting time for surgery (see Liem [37] for an overview).
In our study, however, the waiting time for surgery was
two hours longer in the intervention group. Both the
intervention (26 hours) and the control group (24 hours)
waited, however, for a short time compared to other
orthogeriatric studies reporting a waiting time of two
to three days and even longer [38-42], indicating that
the control group received a good quality service.
Mobility has been assessed in several studies, but
mostly by questionnaire. Some, but not all, studies
have found that orthogeriatric services provide better
mobility [36,40,43,44]. In our study there was an over-
all trend that patients treated in the intervention group
performed better at SPPB four months after surgery,
and the difference was statistically significant in those
living in their own homes before surgery. A difference
on SPPB of 0.5 is considered clinically meaningful, and
the effect seen in our study (six versus four points) is
likely to be important and should be further explored
in future studies.
Table 5 Multiple linear regression model with the primary outcome at the four-month follow up control as the
dependent variable (number = 228)
Variable Unadjusted coefficients (95% CI) P-value Adjusted coefficients (95% CI) P-value
Randomization group (reference: orthopedic ward) 1.8 (−5.9 to 9.5) 0.65 −2.5 (−7.1 to 2.2) 0.29
Admitted from nursing home −44.5 (−50.8 to −38.2) ≤0.001 −25.0 (−31.1 to −18.8) ≤0.001
Agea −0.006 (−0.009 to −0.004 ) ≤0.001 −0.002 (−0.003 to 0.000) 0.03
Gender (reference: male) 6.94 (−2.4 to 16.3) 0.14
Delirium during hospital stayb −31.7 (−38.3 to −25.0) ≤0.001 −11.7 (−17.1 to −6.3) ≤0.001
Number of years of higher educationc 2.17 (−0.19 to 4.16) 0.03
IQCODE >3.44d −42.3 (−47.9 to 36.7) ≤0.001 −23.4 (−29.4 to −17.5) ≤0.001
Preoperative waiting timee 1.93 (−4.0 to 7.85) 0.52
APACHE II −0.78 (−2.2 to 0.66) 0.29
R = 0.82. aAge squared; bnumber = 226; cnumber = 203; dIQCODE obtained during hospital stay (number = 222); enatural logarithm of preoperative waiting time.
APACHE II, Acute Physiology and Chronic Health Evaluation II; IQCODE, Informant Questionnaire on Cognitive Decline in the Elderly.
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Interpretation of the results
Despite our comprehensive intervention, the effect on
the primary outcome was limited. There are several pos-
sible explanations for this. First, the choice of cognitive
function as the primary outcome may have been too am-
bitious. For the intervention to be effective in this regard,
two pre-suppositions had to be true. First, the orthogeria-
tric intervention had to be effective in reducing delirium.
However, our intervention failed to prevent delirium or
reduce delirium severity. This might be explained by the
good quality of usual care at the orthopedic ward in our
hospital, combined with sub-optimal circumstances in an
often over-crowded acute geriatric ward.
Secondly, the primary outcome assumes that delirium
lies on the causal pathway towards the development of
dementia. Since delirium usually occurs in relation to
acute illness, it is challenging to design studies that can
address this question, but some evidence exits suggest-
ing that delirium is associated with long term cognitive
decline [13,45,46]. Our study is in keeping with this; the
regression analysis showed that delirium was associated
with a poorer score on the primary outcome, also when
adjusting for potential confounders.
The study may have influenced treatment in the control
group. The patients in the orthopedic ward were assessed
daily, and in order to make a precise delirium diagnosis
personnel in the orthopedic ward were interviewed re-
garding the patients cognitive status. This inevitably raised
the awareness of delirium in the orthopedic ward.
Conclusions
This randomized controlled trial of hip fracture patients
found no evidence that cognitive function four months
after surgery was improved in patients treated with
pre- and postoperative orthogeriatric care provided in
an acute geriatric ward, compared to usual care in an
orthopedic ward. The intervention had a positive effect
on mobility in patients not admitted from nursing homes.
Delirium had a strong negative impact on long-term cogni-
tive performance, and delirium prevention and treatment
should be given high priority in orthogeriatric care. For
further orthogeriatric improvements, we recommend a
model with stronger integration of orthopedic and geri-
atric input than we achieved, in line with recommendations
from recent reviews [5,7].
Additional files
Additional file 1: Impact of intervention during hospital stay.
Patients stratified according to prefracture residential status (1a) and
dementia status (1b).
Additional file 2: Impact of intervention four months after surgery.
Patients stratified according to prefracture residential status (2a) and
dementia status (2b).
Additional file 3: Impact of intervention 12 months after surgery.
Patients stratified according to prefracture residential status (3a) and
dementia status (3b).
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
TBW initiated the study, led the work on the study design and was involved
in analyzing and interpreting the data. TBW is the manuscript’s guarantor.
LOW had the daily responsibility for running the study and collecting data.
LOW was also involved in planning of the study, has analyzed and
interpreted the data and drafted the manuscript. ACT had particular
responsibility for collecting nutritional data and was involved in planning the
study. FF and GH had the primary responsibility to remind and motivate the
orthopedic surgeons to include patients in the study. KE participated in all
aspects of the planning, in particular regarding the cognitive outcomes. ES
carried out the randomization procedure and was extensively involved in the
statistical planning and analyses. Together with LOW and TBW, she wrote
the statistical analysis plan. FF, VJ, IS, JR, ES and SC all made important
contributions to the planning of the study and writing the protocol. All
authors participated in critical revision of the article for intellectual content.
All authors read and approved the final version of the manuscript.
Acknowledgments
The authors would like to thank the patients and staff at the Orthopedic
Department and the Geriatric Department at Oslo University Hospital. They
also thank research nurses Elisabeth Fragaat, Tone Fredriksen, Camilla Marie
Andersen, Julie Ask Ottesen and Linda Feldt for assisting in data collection.
The manuscript’s guarantor affirms that this manuscript is an honest,
accurate, and transparent account of the study being reported; that no
important aspects of the study have been omitted; and that any
discrepancies from the study as planned (and, if relevant, registered) have
been explained.
Funding
The Oslo Orthogeriatric Trial was mainly funded by the Research Council of
Norway through the program ‘Improving mental health of older people
through multidisciplinary efforts’ (grant no. 187980/H10). Further, we have
received funding from Oslo University Hospital, The Sophies Minde
Foundation, The Norwegian Association for Public Health and Civitan’s
Research Foundation. The sponsors had no role in the design, methods,
subject recruitment, data collection, analysis or preparation of the
manuscript.
Author details
1Oslo Delirium Research Group, Department of Geriatric Medicine, Oslo
University Hospital, Oslo, Norway. 2University of Oslo, Institute of Clinical
Medicine, Oslo, Norway. 3Department of General Internal Medicine, Oslo
University Hospital, Oslo, Norway. 4Department of Cardiovascular Sciences,
University of Leicester School of Medicine, Leicester, UK. 5Norwegian Centre
for Ageing and Health, Vestfold Mental Health Trust, Vestfold, Norway.
6Department of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway.
7Department of Cardiology, Oslo University Hospital, Oslo, Norway.
8Department of Anesthesiology, Oslo University Hospital, Oslo, Norway.
9Department of Geriatrics, St. Olav Hospital, University Hospital of Trondheim,
Trondheim, Norway. 10Department of Neuroscience, Norwegian University of
Science and Technology (NTNU), Trondheim, Norway. 11School of Pharmacy,
University of Oslo, Oslo, Norway.
Received: 28 January 2014 Accepted: 17 March 2014
Published: 15 April 2014
References
1. Rubenstein LZ, Josephson KR: The epidemiology of falls and syncope.
Clin Geriatr Med 2002, 18:141–158.
2. Tinetti ME, Kumar C: The patient who falls: "It's always a trade-off". JAMA
2010, 303:258–266.
3. Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J,
McCloskey EV, Jonsson B, Kanis JA: Osteoporosis in the European
Watne et al. BMC Medicine 2014, 12:63 Page 10 of 12
http://www.biomedcentral.com/1741-7015/12/63
Union: medical management, epidemiology and economic burden:
a report prepared in collaboration with the International
Osteoporosis Foundation (IOF) and the European Federation of
Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos
2013, 8:136.
4. Juliebo V, Bjoro K, Krogseth M, Skovlund E, Ranhoff AH, Wyller TB: Risk
factors for preoperative and postoperative delirium in elderly patients
with hip fracture. J Am Geriatr Soc 2009, 57:1354–1361.
5. Kammerlander C, Roth T, Friedman S, Suhm N, Luger T, Kammerlander-
Knauer U, Krappinger D, Blauth M: Ortho-geriatric service: a literature
review comparing different models. Osteoporos Int 2010, 21:637–646.
6. Giusti A, Barone A, Razzano M, Pizzonia M, Pioli G: Optimal setting and
care organization in the management of older adults with hip fracture.
Eur J Phys Rehabil Med 2011, 47:281–296.
7. Grigoryan KV, Javedan H, Rudolph JL: Orthogeriatric care models and
outcomes in hip fracture patients: a systematic review and meta-analysis.
J Orthop Trauma 2014, 28:e49–e55.
8. Buecking B, Timmesfeld N, Riem S, Bliemel C, Hartwig E, Friess T, Liener U,
Ruchholtz S, Eschbach D: Early orthogeriatric treatment of trauma in
the elderly: a systematic review and metaanalysis. Dtsch Arztebl Int
2013, 110:255–262.
9. Diagnostic and Statistical Manual of Mental Disorders. Fifthth edition.
Washington DC: American Psychiatric Association; 2013.
10. Bruce AJ, Ritchie CW, Blizard R, Lai R, Raven P: The incidence of delirium
associated with orthopedic surgery: a meta-analytic review.
Int Psychogeriatr 2007, 19:197–214.
11. Inouye SK: Predisposing and precipitating factors for delirium in
hospitalized older patients. Dement Geriatr Cogn Disord 1999, 10:393–400.
12. de Jonghe A, van de Glind EM, van Munster BC, de Rooij SE:
Underrepresentation of patients with pre-existing cognitive
impairment in pharmaceutical trials on prophylactic or therapeutic
treatments for delirium: a systematic review. J Psychosom Res 2014,
76:193–199.
13. Krogseth M, Wyller TB, Engedal K, Juliebo V: Delirium is an important
predictor of incident dementia among elderly hip fracture patients.
Dement Geriatr Cogn Disord 2011, 31:63–70.
14. Lundstrom M, Olofsson B, Stenvall M, Karlsson S, Nyberg L, Englund U,
Borssen B, Svensson O, Gustafson Y: Postoperative delirium in old patients
with femoral neck fracture: a randomized intervention study. Aging Clin
Exp Res 2007, 19:178–186.
15. Deschodt M, Braes T, Flamaing J, Detroyer E, Broos P, Haentjens P, Boonen
S, Milisen K: Preventing delirium in older adults with recent hip fracture
through multidisciplinary geriatric consultation. J Am Geriatr Soc 2012,
60:733–739.
16. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM: Reducing delirium after
hip fracture: a randomized trial. J Am Geriatr Soc 2001, 49:516–522.
17. Wyller TB, Watne LO, Torbergsen A, Engedal K, Frihagen F, Juliebo V,
Saltvedt I, Skovlund E, Raeder J, Conroy S: The effect of a pre- and
post-operative orthogeriatric service on cognitive function in patients
with hip fracture. The protocol of the Oslo Orthogeriatrics Trial.
BMC Geriatr 2012, 12:36.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of
classifying prognostic comorbidity in longitudinal studies: development
and validation. J Chronic Dis 1987, 40:373–383.
19. Wade D: Measurment in Neurological Rehabilitation. Oxford: Oxford
University Press; 1992.
20. Gladman JR, Lincoln NB, Adams SA: Use of the extended ADL scale with
stroke patients. Age Ageing 1993, 22:419–424.
21. Jorm AF: A short form of the Informant Questionnaire on Cognitive
Decline in the Elderly (IQCODE): development and cross-validation.
Psychol Med 1994, 24:145–153.
22. Chumlea WC, Guo SS, Wholihan K, Cockram D, Kuczmarski RJ, Johnson CL:
Stature prediction equations for elderly non-Hispanic white,
non-Hispanic black, and Mexican-American persons developed from
NHANES III data. J Am Diet Assoc 1998, 98:137–142.
23. Grant PM, Ryan CG, Tigbe WW, Granat MH: The validation of a novel
activity monitor in the measurement of posture and motion during
everyday activities. Br J Sports Med 2006, 40:992–997.
24. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI: Clarifying
confusion: the confusion assessment method. A new method for
detection of delirium. Ann Intern Med 1990, 113:941–948.
25. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S:
The Memorial Delirium Assessment Scale. J Pain Symptom Manage
1997, 13:128–137.
26. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV,
Studenski S, Berkman LF, Wallace RB: Lower extremity function and
subsequent disability. J Gerontol A Biol Sci Med Sci 2000, 55:M221–M231.
27. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A:
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD),
Part V. A normative study of the neuropsychological battery. Neurology
1994, 44:609–614.
28. Karrasch M, Sinerva E, Gronholm P, Rinne J, Laine M: CERAD test
performances in amnestic mild cognitive impairment and Alzheimer's
disease. Acta Neurol Scand 2005, 111:172–179.
29. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale
for the staging of dementia. Br J Psychiatry 1982, 140:566–572.
30. Barca ML, Engedal K, Laks J, Selbaek G: A 12 months follow-up study of
depression among nursing-home patients in Norway. J Affect Disord
2010, 120:141–148.
31. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical
method for grading the cognitive state of patients for the clinician.
J Psychiatr Res 1975, 12:189–198.
32. Shulman KI: Clock-drawing: is it the ideal cognitive screening test?
Int J Geriatr Psychiatry 2000, 15:548–561.
33. Statistical analysis plan - the Oslo Orthogeriatric Study. Available at: [http://
www.med.uio.no/klinmed/forskning/grupper/klinisk-geriatrisk-forskning/
dokumenter/statistical_analysis_plan_oslo_orthogeriatric_study_final.pdf]
34. Handoll HH, Cameron ID, Mak JC, Finnegan TP: Multidisciplinary
rehabilitation for older people with hip fractures. Cochrane Database Syst
Rev 2009, 4, CD007125.
35. Goldberg SE, Bradshaw LE, Kearney FC, Russell C, Whittamore KH,
Foster PE, Mamza J, Gladman JR, Jones RG, Lewis SA, Porock D,
Harwood RH, Medical Crises in Older People Study Group: Care in
specialist medical and mental health unit compared with standard
care for older people with cognitive impairment admitted to
general hospital: randomised controlled trial (NIHR TEAM trial).
BMJ 2013, 347:f4132.
36. Stenvall M, Olofsson B, Nyberg L, Lundstrom M, Gustafson Y: Improved
performance in activities of daily living and mobility after a
multidisciplinary postoperative rehabilitation in older people with
femoral neck fracture: a randomized controlled trial with 1-year
follow-up. J Rehabil Med 2007, 39:232–238.
37. Liem IS, Kammerlander C, Suhm N, Blauth M, Roth T, Gosch M, Hoang-Kim
A, Mendelson D, Zuckerman J, Leung F, Burton J, Moran C, Parker M, Giusti
A, Pioli G, Goldhahn J, Kates SL, Investigation performed with the assistance
of the AOTrauma Network: Identifying a standard set of outcome
parameters for the evaluation of orthogeriatric co-management for hip
fractures. Injury 2013, 44:1403–1412.
38. Cogan L, Martin AJ, Kelly LA, Duggan J, Hynes D, Power D: An audit of hip
fracture services in the Mater Hospital Dublin 2001 compared with 2006.
Ir J Med Sci 2010, 179:51–55.
39. Adunsky A, Arad M, Levi R, Blankstein A, Zeilig G, Mizrachi E: Five-year
experience with the Sheba model of comprehensive orthogeriatric
care for elderly hip fracture patients. Disabil Rehabil 2005, 27:1123–1127.
40. Vidan M, Serra JA, Moreno C, Riquelme G, Ortiz J: Efficacy of a
comprehensive geriatric intervention in older patients hospitalized for
hip fracture: a randomized, controlled trial. J Am Geriatr Soc 2005,
53:1476–1482.
41. Mazzola P, De Filippi F, Castoldi G, Galetti P, Zatti G, Annoni G: A comparison
between two co-managed geriatric programmes for hip fractured elderly
patients. Aging Clin Exp Res 2011, 23:431–436.
42. Gonzalez-Montalvo JI, Alarcon T, Mauleon JL, Gil-Garay E, Gotor P, Martin-Vega
A: The orthogeriatric unit for acute patients: a new model of care that
improves efficiency in the management of patients with hip fracture.
Hip Int 2010, 20:229–235.
43. Shyu YI, Liang J, Wu CC, Su JY, Cheng HS, Chou SW, Chen MC, Yang CT:
Interdisciplinary intervention for hip fracture in older Taiwanese: benefits
last for 1 year. J Gerontol A Biol Sci Med Sci 2008, 63:92–97.
44. Naglie G, Tansey C, Kirkland JL, Ogilvie-Harris DJ, Detsky AS, Etchells E,
Tomlinson G, O'Rourke K, Goldlist B: Interdisciplinary inpatient care for
elderly people with hip fracture: a randomized controlled trial. CMAJ
2002, 167:25–32.
Watne et al. BMC Medicine 2014, 12:63 Page 11 of 12
http://www.biomedcentral.com/1741-7015/12/63
45. Davis DH, Terrera GM, Keage H, Rahkonen T, Oinas M, Matthews FE,
Cunningham C, Polvikoski T, Sulkava R, MacLullich AM, Brayne C: Delirium is
a strong risk factor for dementia in the oldest-old: a population-based
cohort study. Brain 2012, 135:2809–2816.
46. Fong TG, Jones RN, Shi P, Marcantonio ER, Yap L, Rudolph JL, Yang FM,
Kiely DK, Inouye SK: Delirium accelerates cognitive decline in Alzheimer
disease. Neurology 2009, 72:1570–1575.
doi:10.1186/1741-7015-12-63
Cite this article as: Watne et al.: The effect of a pre- and postoperative
orthogeriatric service on cognitive function in patients with hip
fracture: randomized controlled trial (Oslo Orthogeriatric Trial). BMC
Medicine 2014 12:63.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Watne et al. BMC Medicine 2014, 12:63 Page 12 of 12
http://www.biomedcentral.com/1741-7015/12/63
III
IV
